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Alkaloids containing a hexahydropyrrolo[2,3-b] indole (pyrroloindoline) core constitute a sizeable group 
of natural products. In these systems the most common functionality at the C3a position is perhaps the 
hydroxyl group. In this work oxoammonium salt 4-acetamido-2,2,6,6-tetramethyl-1-oxopiperidinium 
tetrafluoroborate (Bobbitt’s salt) rapidly reacts with tryptamine and tryptophan derivatives to provide the 
C3a oxygenated pyrroloindolines. These conditions exclude the use of expensive transition metal catalyst, 
LED lamps and long reaction times. This new method wasa then utilized in a synthetic study on the natural 
product pestalazine A. 
  1,1′-diaryl ethanes are an important functionality in many biologically active compounds. A pioneering 
study was done to access these systems by displacement of tricholoracetimidates with stoichiometric 
amounts of alkylmetal reagent (trimethylaluminium). Most benzylic substrates except the electron poor 
substrates undergo ready displacement. In case of an enantiopure imidate, a significant racemization was 
observed, implicating the formation of a cationic intermediate in the transformation. 
  The success of trimethylaluminium was further extended with allyltributylstannane to synthesize 1, 1’-
diarylbutyl. The 1,1’-diarylbutyl group is a common structural motif found in many pharmaceutically active 
compounds. Commonly a strong base, transition metal catalyst, Brønsted acid or Lewis acid promoter is 
required to affect the displacement of diarylmethyl leaving groups. However, in this work simply heating 
diarylmethyl trichloroacetimidates with the allyltributylstannane gives easy access to these systems. 
Electron rich benzylic trichloroacetimidate systems gave the best results, where excellent yields are 
achieved just by refluxing the reactants together in nitromethane. Mechanistic studies conducted suggests 
both cationic and radical pathways may be active in this transformation. 
  Application of trichloroacetimidates for the synthesis of esters under mild conditions in the absence of an 
exogenous promoter is explored in this study. These conditions avoid the undesired decomposition of 
substrates with sensitive functional groups. With heating, these reactions have been extended to benzyl 
esters without electron donating groups. 
 
   Ghrelin is a peptide hormone which plays a key role in regulating hunger and energy balance within the 
body. Inhibition of ghrelin O-acyltransferase (GOAT), which catalyzes an essential octanoylation step in 
ghrelin maturation, offers a potential target for controlling ghrelin signaling. Through screening a small 
molecule library by our collabrators, a class of synthetic triterpenoids (CDDO) was identified that 
efficiently inhibit ghrelin acylation. To verify which functional group was responsible for hGOAT activity, 
some minimally functionalized steroid derivatives were synthesized in this project. These compounds act 
as covalent reversible inhibitors, providing the first evidence of the involvement of a nucleophilic cysteine 
residue in hGOAT catalysis. The Michael acceptor group plays the most important role in inhibition. This 
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Chapter 1- Oxidative Cyclization of Tryptamines with 4-Acetamido-2,2,6,6-tetramethyl-1-
oxopiperidinium Tetrafluoroborate; Application Towards the Synthesis of Pestalazine A 
Abstract 
The oxoammonium salt 4-acetamido-2,2,6,6-tetramethyl-1-oxopiperidinium tetrafluoroborate (Bobbitt’s 
salt) rapidly reacts with tryptamine derivatives to provide the C3a oxygenated pyrroloindolines, which are 
found in a number of complex natural products. The yield of the cyclization is related to the acidity of the 
nucleophile, with sulfonamides and alcohols providing significantly high yields. This new method provides 
rapid access to cyclized pyrroloindoline core structures, and is utilized in a synthetic study on the natural 















  Alkaloids containing a pyrroloindoline (hexahydropyrrolo[2,3-b]indole)core constitute a significant group 
of natural products.1 Hundreds of alkaloids with this core structures have been reported from various natural 
resources. Although many simple pyrroloindolines appear to come from tryptamine, others appear to be 
derived from tryptophan or from tryptophan containing peptides. These systems can also be classified 
depending upon the functionality at the C3a position of the pyrroloindoline, which is commonly decorated 
with carbon, nitrogen or oxygen substituents. The most common functional group at the C3a is perhaps the 
hydroxyl group, which is present on a variety of biologically active pyrroloindolines (Figure 1.1).2,3 For 
example, the okaramines (like 1.1 and 1.2, Figure 1.1) target glutamate gated chloride channels and show 
insecticidal activity.4a,b  
----------------------------------------------------------------------------------------------------------------------------- 



























okaramine U  
       Figure 1.1 Pyrroloindoline Containing Natural Products with Oxygenation at the C3a position 
---------------------------------------------------------------------------------------------------------------------  
   Given the potent and diverse biological activity of these structures, synthetic organic chemists have been 
active in discovering methods for the formation and decoration of the pyrroloindoline core.1,5 Our own work 
in the area has focused on developing methods for facile synthesis of pyrroloindoline core. Recently we 
developed a useful method to access these systems from C3a-hydroxy pyrroloindolines through the use of 
trichloroacetimidates (Scheme 1.1).6 This chemistry facilitates the introduction of alkyl, aryl or amino 
groups at the C3a position, and provides an attractive alternative to displacement of the C3a-bromide which 
requires using stoichiometric amounts of silver salts and a phase transfer agent7,8 or a stoichiometric amount 
of strong base (like KOtBu, Scheme 1.1).9 In the case of the trichloroacetimidate 1.3 which is generated 
 3 
from the corresponding hydroxy derivative (1.7, Scheme 1.2), the substitution occurs at low temperature 
with Lewis acid catalysts, which are typically less expensive than stoichiometric silver salts. These 
substitutions are facilitated by rearrangement of the imidate to the corresponding acetamide, which 
contributes to the mild reaction conditions. 































Ag Salt (1 equiv)
18-crown-6 (1 equiv)
Previous Work:
or KOtBu (1 equiv)
CO2MeCO2Me
1.5 1.6  
  Understanding the ease of imidate chemistry, we began to evaluate methods to access C3a-hydroxy 
pyrroloindolines, which were a key intermediate in the synthesis of these compounds (Scheme 1.2). With 
this goal, the known oxidative cyclization with m-CPBA10 was explored on the suitably protected 
tryptophan derivatives but unfortunately only a complex mixture resulted (Scheme 1.3). Additional 
attempts with some other reported systems including DMDO11a,b and in highly oxygenated system12 were 
also found to be problematic and gave sporadic yields and/or complex mixtures depending on the oxidant 
and substrate employed. Moreover, reaction with selenium-based regent was not cost effective (Scheme 
1.3). While continuing the need for new and better methods for synthesis of C3a-hydroxylated 
pyrroloindolines, use of oxoammonium salts to effect cyclization was now explored.  
Scheme 1.2.  Synthesis of the trichloroacetimidate 






















Scheme 1.3.  Easy access to hydroxy pyrroloindolines 



















3) N-PSP    
PPTS, Na2SO4    
CH2Cl2
1) mCPBA, K2CO3    
CH2Cl2, 0°C
2) O2, sensitizer, hv    






  Oxoammonium salts are attractive electrophilic oxidizing agents because they are environmentally 
friendly, easy to prepare and recyclable.13a,b Some early work with oxoammonium salts on tryptophan 
systems in water has been reported ( Scheme 1.4),14 and the cyclization of tryptamine derivatives with 
TEMPO under oxidative photo redox conditions has also been recently reported (Scheme 1.4).15 These 
reports show that the reaction of tryptophan and tryptamine systems with oxoammonium salts are dependent 
on the structure of the substrate and the reaction conditions. With this information in hand reactions with 
tryptamine 1.3 were explored with 4-acetamido-2,2,6,6-tetramethylpip- eridine-1-oxoammonium 


















































1.Reaction with tryptophan in a short peptide






















1.1.1 Proposed reaction mechanism 
  The mechanism for the proposed reaction is suggested in scheme 1.5. An initial attack from electron rich 
indole 1.20 on to the Bobbitt’s salt 1.18 will start the reaction. This will lead to the formation of an iminium 
ion intermediate 1.21 with an expected C-O bond formed at C3 position of the indole. An intramolecular 
attack of the protected amine will now close the ring giving the final product 1.23. The acid generated 










































1.2 Results and Discussion 
1.2.1 Optimization of reaction conditions                                             
   Based on the prior work a reaction of tryptamine with Bobbitt’s salt was investigated (Table 1.1). Initially, 
a 28% yield of the desired cyclization product could be isolated (entry 1, Table 1.1) by performing the 
reaction in acetonitrile at room temperature in the presence of DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) 
as a base to neutralize the HBF 4  generated in the transformation. The addition of a strong amine base, either 
DBU or 1,1,3,3-tetramethylguanidine (TMG), was shown to be necessary for high yields of the 
oxidation/cyclization product. This may be because the base deprotonates the sulfonamide, providing the 
sulfonamide salt which cyclizes on the activated indole. Other bases like pyridine and potassium tert-
butoxide were less effective. In these cases, the less hindered base may bind or react with the N-
oxoammonium, leading to the lower yields. Lower temperatures improved the yield (entry 3, Table 1.1), 
with less product being isolated when the reaction was heated (entry 1, 2, Table 1.1). This is attributed to 
the sensitivity of the N, N-acetal, which may be hydrolyzed at higher temperatures by the ammonium salt 
of HBF 4  formed during the reaction. The use of DBU became problematic when a small amount of what 
appeared to be oxidized DBU was isolated from the reaction mixture (entry 1, 3, Table 1.1). While this 
likely had a minimal impact on the yield, it was difficult to separate from the reaction product, so the base 
was switched to tetramethylguanidine (TMG) which gave no such issues (entry 4, Table 1.1). Reaction was 
also tried at subzero temperatures for different time durations (entry 8, 7, Table 1.1). Optimal conditions 
appeared with 1.2 equiv of N-oxoammonium salt 1.18, 1.2 eq of TMG in tetrahydrofuran at 0 °C for 15 
minutes (entry 8, Table 1.1). Longer reaction times or higher temperatures led to lower isolated yields.  
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Reaction Conditions: Tryptamine derivative (1 equiv), Bobbitt's salt (1.2 equiv), base (1.2 equiv), 0.2 M). aYield in parentheses is 
based on recovered starting material. b2 equiv of Bobbitt's salt and 4 equiv of TMG were used. 
1.2.2. Scope of the reaction 
  A number of tryptamine derivatives were utilized in the oxoammonium salt mediated cyclization. 
Protecting groups like mesyl and nosyl (compounds 1.19a, 1.19b, Table 1.2) worked well. However, no 
clear trend can be seen with increasing electron withdrawing ability. Compound 1.19e with diester groups 
also gave good yield, but this could be because of the electron withdrawing esters lowering the pka of the 
protected amine, facilitating the cyclization. Different substituents on the aromatic ring were also explored 
and gave satisfying results. To our surprise, methyl substitution at the 2 position of the indole ring 1.19j 
also showed the transformation with 48% of the product. This is notable as oxoammonium salts are known 
Entry        Conditions Yielda 
1 MeCN, DBU, rt, 1h 28 
2 MeCN, DBU, reflux, 1h 0 
3 MeCN, DBU, -40 °C, 10 min 45 (90) 
4 MeCN, TMG, -40 °C, 10 min 65 (89) 
5 DCM, TMG, -50 °C, 5 min 65 (90) 
6 DCM, TMG, -50 °C, 10 min 52 (69) 
7 THF, TMG, -50 °C, 10 min 37 (50) 
8 THF, TMG, 0°C, 15 min 78 (88) 
9 DCM, TEA, -50 °C, 5 min 7 (60) 
10 DCM, pyridine, -50 °C, 5 min 0 
11 DCM, KOtBu, -50 °C, 5 min 0 
12b DCM, TMG, -50 °C, 5 min 63 (99) 
 8 
to oxidize alcohols to aldehydes, but the oxidative cyclization was more rapid in this case. However, Indole-
3-acetic acid delivered no product 1.19f. 










NHAcA. 1.2 eq Bobbitt's salt     
1.2 eq TMG     
THF, 0oC, 15min
B. 1.5 eq Bobbitt's salt     





























































*A &B represents isolated yields of the compound 
-------------------------------------------------------------------------------------------------------------------- 
  Reactions of tryptamines with both the nitrogen’s protected (Scheme 1.6) were also explored to get a better 
understanding of the proposed reaction mechanism (Scheme 1.5). No product was obtained in both the 
cases with electron rich / electron poor substituent at the indole nitrogen, suggesting that the indole NH is 
essential for the reaction. The presence of the tosyl group on the indole ring may deactivate the electron 
rich aromatic ring 1.25, which could explain the low yield in this case. The methylated tryptamine 1.24, 
however, should have similar electronic properties as the parent tryptamine 1.17, so its low reactivity cannot 
be explained in the same manner. A hydrogen bond may form between the indole N-H and the 
oxoammonium salt as a prerequisite for activation of the indole by the oxoammonium salt, and this may 






































1.3 Advances towards the synthesis of pestalazine A 
  Synthesis of pestalazine A 1.26b (Figure 1.2) was undertaken to explore the application of our research. 
Pestalazine A with its dimeric diketopiperazine possesses high molecular complexity and therapeutic value 
16 that regularly nourishes the advancement of new synthetic methodologies.  
------------------------------------------------------------------------------------------------------------------------------- 



























































Asperazine (1.27)  
------------------------------------------------------------------------------------------------------------------ 
   The greatest challenge to access these structures has been the introduction of the quaternary stereocenter 
and the C-C bond at the heart of this alkaloid. Overman’s synthesis of (+)-asperazine (1.27), another 
member of the same family used early introduction of the C3-quaternary stereocenter by an intramolecular 
Heck reaction followed by formation of the diketopiperazines (Scheme 1.7). The first complete synthesis 
and structure revision of pestalazine A 1.26b is given by Movassaghi 17 after we had begun work on this 
target. A novel approach involving late-stage union of complex diketopiperazines, to secure the challenging 
C-C linkage through the Friedel−Crafts reaction is the highlight of this work. However, use of 
stoichiometric amounts of silver salts to remove the bromo substituent is still the major drawback of this 
synthesis (Scheme 1.7). A synthesis of the structurally related pestalazine B was recently disclosed from 
 10 
Tokuyama and co-workers, which also employed a similar C3a-bromopyrroloindoline structure and 
stoichiometric silver salts.18 We are trying to overcome this issue by using a trichloroacetimidate as the 
leaving group instead of a bromine. Only a catalytic amount of a Bronsted or Lewis acid is required to 
activate the trichloroacetimidate thereby minimizing the waste and reducing cost. 
Scheme 1.7.  Different approaches for C3-C7 bond formation 
         1.  Heck reaction in asperazine synthesis by Overman 































































1.3.1 Retrosynthesis of pestalazine A (1.26b) 
 A retrosynthetic analysis of pestalazine A 1.26b is shown in Scheme 1.8. The molecule can be divided into 
two diketopiperazines by breaking the C3-C7 bond. The two parts 1.26b (Scheme 1.8) informally can be 
termed as southern (lower portion) and northern (upper portion) diketopiperazine. Late stage union of these 
diketopiperazines with a Friedel-Crafts alkylation will be attempted to form the necessary C-C bond. 
Synthesis of the individual diketopiperazine can be carried out simultaneously. Larock indolization of 
iodoaniline 1.31 with 1.28 will complete the structure of northern diketopiperazine. And the imidate 1.30 
will be generated from the corresponding hydroxy derivative using the TCAN and DBU.As an alternative 
route Friedel-Crafts alkylation will be carried out first with the imidate 1.30 followed by the completion of 
the northern diketopiperazine. 
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1.3.2 Synthesis of the Pyrroloindoline Core of Pestalazine A 
   Boc protected D-leucine was coupled with L-tryptophan methyl ester hydrochloride using EDCI as the 
coupling agent (Scheme 1.9). Without further purification, Boc deprotection was carried out with TFA. The 
literature based cyclization procedure19 with methanol and ammonium hydroxide at room temperature was 
poor yielding. Refluxing the same reaction mixture improved the yield for diketopiperazine to 90%. Now, 
the cyclization of diketopiperazine 1.34 was done with NBS. Both the diastereomers obtained in this 
reaction were separated using silica gel column chromatography. The required isomer 1.35 was then 
hydrolyzed to 1.36 and the imidate 1.30 was synthesized in high yield (86%). The imidate is a yellow solid 







































































(A) 1. SOCl 2 , MeOH 2. Boc 2 O, DMAP 3. CbzCl, NaOH, TBAHS, DCM, 62% (over 3 steps) (B) 1.TFA, DCM, 2. N-Boc-D-
Phe, EDC, HOBt, DCM, 69% (over 2 steps) (C) TFA, DCM 7. NH 4 OH, MeOH, 75% (over 2 steps) (D) NBS, BF 3 OEt 2 , ACN, 
60% (E) AgSbF 6 , H 2 O, MeNO 2 , 91% (F) TCAN, DBU, DCM, 86%. 
 
1.3.2.1 Synthesis of Diketopiperazine 1.28 
   Literature procedure was followed to synthesize compound 1.38 (Scheme 1.10).20 A transmetallation 
reaction between compound 1.38 and 1.39 gave the required product 1.40. Then the routine procedure17 
was followed to synthesize the diketopiperazine 1.28. In this process, compound 1.40 was subjected to 
peptide coupling with D- phenylalanine using EDCI as coupling agent. The coupled product was deboc 
with TFA and then cyclized to form the diketopiperazine ring with ammonium hydroxide in methanol as 
the solvent. 
------------------------------------------------------------------------------------------------------------------------- 

























(A) PPh 3 , I 2 , imidazole, DCM, 85% (B) 1. Activated Zn, TMSCl 2. CuCN, LiCl, 44% (C) EDC, HOBt DCM, 85% (D) 1.TFA, 
DCM 2. NH 4 OH, MeOH, 88% 
 
 
1.3.2.2 Larock Indolization 
  A model reaction was developed with iodoaniline 1.31 and compound 1.28 to check the feasibility of 
Larock indolization (Scheme 1.11). In the very first attempt 33% of the required product was isolated using 
 13 
























33%1.281.31 1.42  
Scheme 1.11 Model reaction for Larock indolization . 
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
                                                                  
                                                                  1.4 Future work 
 To complete the synthesis of pestalazine A 2.6 (Scheme 1.12) electrophilic aromatic substitution at C3a 
position needs to be followed by a Larock indolization. Ultimately, removal of bromine and cbz group 
through hydrogenation is expected to give the final compound. 
------------------------------------------------------------------------------------------------------------------------------ 























10 mol % Pd(dppf)Cl2
LiCl, Cs2CO3
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 In conclusion a rapid cyclization reaction of tryptamine and tryptophan derivatives is designed to provide 
the C3a oxygenated pyrroloindoline core. This reaction requires no expensive transition metal catalyst, 
LED lamps and complex reaction set up. Application of this methodology towards the synthesis of 





General procedure for cyclization of tryptamines 
Method A- Tryptamine (1 eq) was dissolved in THF (0.2M). The reaction mixture was then cooled to 0 oC. 
Base (1.2 eq) was added and stirred for a minute. Bobbitt’s salt (1.2eq) was now added and reaction was 
continued for 15 min at 0 oC. Reaction was quenched by addition of dil. HCl with diethyl ether and the 
organic layer was separated, dried, filtered and purified by column chromatography. 
Method B- Tryptamine (1 eq) was dissolved in DCM (0.2M). The reaction mixture was then cooled to -50 
oC. Base (1.5 eq) was added and stirred for a minute. Bobbitt’s salt (1.5eq) was now added and reaction 
was continued for 5 min at 0 oC. Reaction was quenched by addition of dil. HCl and the organic layer was 
separated, dried, filtered and purified by column chromatography. 





H 1.19a  
1.19a) Pink solid (90 mg, 60% {yield by method B}), TLC R f  = 0.35 (100% ethyl acetate); Purified by 
silica gel chromatography (40% ethyl acetate/60% hexanes). 1H NMR (400 MHz, CDCl 3 ) δ 7.33 (d, J = 
7.4 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1 H), 6.87 (t, J = 7.4 Hz, 1H), 6.62 (d, J = 7.8Hz, 1H), 6.14 (s, 1H), 5.15 
(brs, 1H), 4.57 (s, 1H), 4.14-4.07 (m, 1H), 3.67 (t, J = 8.6 Hz, 1 H ), 3.07-3.02 (m,1H), 3.0 (s, 3H), 2.84-
2.74 (m, 1H), 2.44 (dd, J = 12.1, 5.4 Hz, 1H), 1.92 (s, 3H), 1.76 (t, J = 12.8Hz, 2 H), 1.22 (s, 3H), 1.12 (s, 
3H), 1.01 (s, 3H), 0.57 (s, 3H) . 13C NMR (100 MHz, CDCl 3 ) δ 169.3, 150.3, 131.1, 130.2, 125.6, 120.2, 
110.5, 98.2, 79.7, 60.5, 59.6, 46.7, 46.3, 46.2, 40.9, 40.8, 39.3, 33.3, 32.5, 23.6, 21.3, 21.0. Anal. Calcd for 





H 1.19b  
1.19b) white solid (197mg, 61% {yield by method B}), TLC R f  = 0.37 (100% ethyl acetate); Purified by 
silica gel chromatography (30% ethyl acetate/ 70% toluene). 1H NMR (300 MHz, CDCl 3 ) δ 8.05 (dd, J = 
 15 
7.1, 1.4 Hz, 1H), 7.71-7.62 (m, 3H),7.29 (d, J= Hz, 1H), 7.10 (t, J = 6.7 Hz, 1 H), 6.78 (t, J = 7.2 Hz, 1 H), 
6.48 (d, J = 7.9 Hz, 1H), 6.17 (s, 1H), 5.10 (brs, 1H),  4.89 (brs, 1H), 4.09 (brs, 1 H ), 3.84 (t, J = 10.1 Hz, 
1H), 3.15 (sextet, J = 6.3Hz, 1H), 2.72 (sextet, , J = 7.9Hz, 1H ), 2.40 (dd, J = 12.2, 5.3 Hz, 1H), 1.92 (s, 
3H), 1.75-1.72 (m, 2H), 1.18 (s, 3H), 1.11(s, 3H), 0.82 (s, 3H), 0.66 (s, 3H) . 13C NMR (100 MHz, CDCl 3 ) 
δ169.4, 150.2, 148.2, 133.6, 131.7, 130.5, 130.1, 129.7, 125.6, 124.1, 119.3, 109.4, 98.6, 79.8, 60.4, 59.7, 
47.6, 46.5, 46.1, 41.1, 40.9, 32.7, 32.5,23.6, 21.2, 20.9. Anal. Calcd for C 27 H 35 N 5 O 6 S: C, 58.15; H,6.33; 









1.19e)  orange oil (80 mg, 78% { yield by method A}), TLC R f  = 0.30 (100% ethyl acetate); Purified by 
silica gel chromatography (50% ethyl acetate/ 50% hexanes). 1H NMR (400 MHz, CDCl 3 ) δ 8.30 (s, 1H) 
7.29 (d, J = 8.2 Hz, 1H), 7.09 (t, J = 7.6 Hz, 1H),6.74 (t, J= 7.2Hz, 1H), 6.47 (d, J = 7.8 Hz, 1 H), 6.12 (s, 
1 H),  5.12 (s, 1H),  5.07 (brs, 1H), 4.28 (q, J = 7.0 Hz, 2 H ), 4.09 (brs, 1H), 3.82-3.70 (m, 2H), 3.42 (d, J 
=13.0 Hz, 1 H), 3.15 (d, J =13.0 Hz, 1 H), 1.92(s, 3H), 1.76 (t, J= 11.5Hz, 1H), 1.57 (d, 1H),1.30-1.26 (m, 
6H), 1.17 (d, J = 8.0, Hz, 6H), 0.97(t, J = 7.1 Hz, 3H), 0.84 (d, J = 8.2 Hz, 6H) . 13C NMR (100 MHz, 
CDCl 3 )169.2, 150.8, 143.1, 137.3, 130.0, 129.5, 128.4, 127.1, 126.2, 117.9, 109.5, 94.2, 90.4, 60.5, 59.8, 
46.9, 46.4, 40.9, 38.0, 34.9, 30.3, 23.6, 22.4, 22.0, 21.5, 21.4 . Anal. Calcd for C28 H 40 N 4 O 7 : C, 61.75; 







1.19j) orange oil (80 mg, 48% {yield by method A}), TLC R f  = 0.44 (100% ethyl acetate); Purified by 
silica gel chromatography (60-70% ethyl acetate/ 40-30% hexanes). 1H NMR (400 MHz, CDCl 3 ) δ 7.64 
(d, J = 8.2 Hz, 1H), 7.23 (t, J = 6.2 Hz, 1H),7.05 (t, J= 7.6Hz, 1H), 6.67 (t, J = 7.4 Hz, 1 H), 6.42 (d, J = 
7.8 Hz, 1 H),  5.39 (s, 1H),  5.12 (brs, 1H), 4.05 (brs, 1 H ), 3.34 (t, J = 8.5 Hz, 1H),2.83 (m, 1H), 2.59 (dd, 
J = 11.7, 5.6 Hz, 1 H), 2.38 (s, 3H),   2.26 (sextet, J = 8.2Hz, 1H), 1.89(s, 3H), 1.84(s, 3H), 1.34(s, 3H), 
1.24(s, 3H), 1.12(s, 3H), 0.97 (t, J = 12.4Hz, 1H), 0.19 (s, 3H) . 13C NMR (100 MHz, CDCl 3 )169.2, 150.8, 
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143.1, 137.3, 130.0, 129.5, 128.4, 127.1, 126.2, 117.9, 109.5, 94.2, 90.4, 60.5, 59.8, 46.9, 46.4, 40.9, 38.0, 
34.9, 30.3, 23.6, 22.4, 22.0, 21.5, 21.4. Anal. Calcd for C 29 H 40 N 4 O 4 S: C, 64.42; H,7.46; N,10.36 Found: 
C, 64.04; H,7.57; N,10.26. 
Experimental procedures for Pestalazine A 












1.30   
1.30 A flame dried flask was charged with the alcohol 1.36 starting material (250mg, 1 equiv) under argon. 
Dry DCM was then added to form a 0.5 M solution, and the flask was cooled to 0 °C. 1, 8-Diazabicyclo 
[5.4.0] undec-7-ene (0.012ml, 0.2 equiv) was then added to the solution, followed by trichloroacetonitrile 
(0.063ml, 1.5 equiv). The reaction mixture was monitored by TLC until no more alcohol starting material 
was detected. The reaction mixture was then concentrated in vacuo, and the residue was purified by silica 
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Chapter 2- Synthesis of 1,1′-Diarylethanes and Related Systems by Displacement of 
Trichloroacetimidates with Trimethylaluminum 
Abstract 
A convenient method to access 1,1′-diarylethanes and related systems from benzylic trichloroacetimidates 
with trimethylaluminum under Lewis acid promoted conditions has been invented. 1,1′-diarylethanes play 
a very important role in pharmaceutical chemistry, with a number of systems owing their biological activity 
to this functionality. Except for the electron deficient substrates, most benzylic substrates undergo ready 
displacement. Also, significant racemization was observed during the reaction with an enantiopure imidate, 
















 1,1′-Diarylethanes are an important functionality in many biologically active molecules like those shown 
in Figure 1.1 In this section a new method to synthesize 1,1'-diarylethanes from benzylic 
trichloroactimidates is presented. The application of trichloroacetimidates in the formation of ethers2, thiols3 
and amines4 is well known. However, substitution of imidates with carbon nucleophiles has been less 
thoroughly explored. Usually trichloroacetimidates are activated with Lewis acids, therefore a carbon 
nucleophile must be compatible with these conditions. So far, these substitutions are mostly shown with 
Friedel−Crafts-type reactions, involving electron rich aromatic rings acting as nucleophiles5. Examples of 





















2.3 R = H, antiviral agent








Figure 2.1. Biologically active 1,1’-diarylethanes 
------------------------------------------------------------------------------------------------------------------------------- 
  1,1′-diarylethane systems are typically generated by hydrogenation of an alkene,7 displacement of a 
leaving group (like a halide,8 ammonium salt,9 or ether10), or through Friedel−Crafts processes11. However, 
a pioneering study of displacement of the imidate using a compatible alkylmetal nucleophile was carried 
out under this project. Trimethylaluminum was selected for this study as it is readily available. Also, 
trimethylaluminum addition reactions are tolerant of exogenous Lewis acids,12 which are also known to 
facilitate trichloroacetimidate displacements13. This alkylmetal has been used as a source of methyl anions 
previously to displace halides,14 sulfonates,15,16 and Meldrum’s acid derivatives.17 Moreover, it can open 
benzylic epoxides18 and benzylic sulfites,19 with the addition of the new methyl group occurring 
preferentially at the benzylic position in these cyclic systems. 
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2.2 Results and Discussion 
2.2.1 Optimization reactions 
  The reaction of trimethylaluminum with diphenylmethyl trichloroacetimidate 2.6 was studied (Table 2.1) 
as an initial substrate. Solvent effects were prevalent in the reaction, as only DCM provided 1,1-
diphenylethane 2.7 in an appreciable yield at room temperature (entries 1−5, Table 2.1). More polar solvents 
like Et 2 O, THF, and MeCN may coordinate to the Lewis acidic trimethylaluminum and lower reactivity, 
reducing conversion. Alternatively, the less polar toluene may disfavor formation of the diphenylmethyl 
carbocation, which may be necessary for product formation. Heating the reaction in toluene did provide 
some product (entry 6, Table 2.1); however, no conversion was observed in refluxing THF (entry 8, Table 
2.1). The use of Lewis acid promoters was explored in order to improve conversion and yields (entry 9-16, 
Table 2.1). Initially TMSOTf and BF 3 · OEt 2  were studied, as these Lewis acids are commonly employed 
with trichloroacetimidates. However, when these Lewis acids were employed the major product was the 
rearranged trichloroacetamide 2.8 in both the cases.  A number of other Lewis acids were then screened for 
their ability to facilitate the substitution reaction (entries 11− 15, Table 2.1) at the expense of the competing 
rearrangement. Aluminum trichloride emerged as the most promising promoter from these investigations, 
providing the desired product 2.7 in a 91% yield (entry 11, Table 2.1). The stability of the imidate in the 
absence of the trimethylaluminum was also explored, with mainly rearrangement of the imidate to the 
acetamide being observed under these conditions (entry 16, Table 2.1). 
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Table 2.1. Addition of Trimethylaluminium to Tricholoroacetimidate 2.6 
















Entry Conditionsa Promoterb Yield (2.7) Yield (2.8) 
1 toluene, rt, 24h  0 0 
2 DCM, rt, 4h  68 13 
3 Et 2 O, rt, 24 h  0 0 
4 THF, rt, 18 h  0 0 
5 MeCN, rt, 30 min  0 60 
6 toluene, reflux, 22 h  23 13 
7 DCM, reflux, 22h  27 25 
8 THF, reflux, 22 h  0 0 
9c DCM, rt, 30 min TMSOTf 0 50 
10c DCM, rt, 30 min BF 3 •OEt 2 37d 63d 
11c DCM, rt, 30 min AlCl 3 91 8 
12c DCM, rt, 30 min SnCl 2 56d 44d 
13c DCM, rt, 30 min ZnF 2 68 0 
14c DCM, rt, 30 min ZnI2 68 0 
15c DCM, rt, 30 min Sc (OTf) 3 45 0 
16 DCM, rt, 30 min AlCl 3 0 60e 
 
 
    
a AlMe 3  (1.5 equiv) was added at 0 °C, and then the reaction was warmed to the reported temperature. b 1 equiv of the Lewis acid 
was added. c 3 equiv of AlMe 3  was used. d Ratio of products observed in the crude 1 H NMR. e No AlMe 3 was added 
 
2.2.2 Substrate Scope 
   The scope of the displacement with respect to trichloroacetimidate was next investigated (Table 2.2). 
Initially, diarylmethane type trichloroacetimidates bearing different functionality on the aromatic rings 
were evaluated. Electron rich aromatic substrates all provided the corresponding products in excellent 
yields (entries 2 − 5, Table 2.2). Rearrangement (28%) to the corresponding trichloroacetamide was 
observed only in the case of the methoxy containing imidate (entry 5, Table 2.2). This competing 
transformation appears to be most competitive in highly activated electron rich systems. The conditions 
were also compatible with aryl halides (entries 6 − 8, Table 2.2). The incorporation of stronger electron 
withdrawing groups like nitro and trifluoromethyl groups were also tolerated (entries 9 and 10, Table 2.2). 
These results are comparable to Friedel−Crafts reactions that have been reported with electron-poor 
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trichloroacetimidates, which also proceed in good yield.20 Bicyclic aromatic systems like naphthalene and 
benzothiophene were incorporated without issue (entries 11−14, Table 2.2). The synthesis of the 
benzothiophene containing 1,1′-diarylethane 2.24 is important, as this compound is an intermediate in the 
synthesis of benzothiophene 2.5, a compound designed to treat insomnia.21 After the reactions with 
diarylmethyl trichloroacetimidates, attention was focused on the less activated substrates. Competing 
elimination reaction cannot take place in diarylmethanes, so some systems that could be susceptible to 
elimination were evaluated (Table 2.2, entries 15−19). Most of these substrates performed well, including 
the hindered substrate (entry 17). Substitution in this case had to be started at a lower temperature, as when 
the reaction was started at 0 °C, the alkene derived from elimination of the imidate was the major product. 
Primary benzylic trichloroacetimidates (Table 2.2, entries 20 −26) did not require the addition of aluminum 
trichloride to provide the ethyl-substituted aromatics in useful yields. In addition, reactions at low 
temperatures were carried out with primary imidates to avoid decomposition and or elimination.  4-
nitrobenzyl trichloroacetimidate showed no reaction. Attempts to force displacement of imidate by heating 
the reaction in DCE at reflux were also futile (entry 26, Table 2.2). The aliphatic imidate was also unreactive 






2.2.3 Displacements in more complex systems 
  More complex substrates such as tertiary benzylic trichloroacetimidates and cyclic allylic 
trichloroacetimidates were also evaluated (Scheme 2.1). Displacement of the tertiary benzylic 
trichloroacetimidate 2.38 may provide simple and expeditious route to analogues of physostigmine 2.40.22 
However, all the attempts to convert imidate 2.38 to the desired methyl compound were unsuccessful, and 
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only the corresponding chloride 2.39 was obtained.  While reaction of imidate 2.38 with HCl23 is known to 
give chloride substitution for many trichloroacetimidates, the formation of chloride 2.39 was surprising as 
chloride ion typically is a weaker nucleophile than the trimethylaluminum. Other Lewis acid promoters 
with less nucleophilic counterions like TMSOTf and Zn (OTf) 2  provided the starting material at room 
temperature or below, while heating led to decomposition. 






























  No methylation product was detected with chloride 2.39 with 3 eq of trimethylaluminum in refluxing 
DCE. Although the displacement of tertiary chlorides with trimethylaluminum is known, the reactions are 
slower in the presence of Lewis basic functional groups like amides.24 This deceleration results from the 
complexation of the trimethylaluminum to the amide leading to a slower substitution reaction. In the more 
complex system 2.38, the carbamate, ester and sulfonamide functional groups may complex with the 
trimethylaluminium, therefore displacement by the methyl group may be slow leading to the formation of 
chloride 2.39. The formation of chloride 2.39 was then assumed to be the intermediate in the methyl 
displacement reaction. To verify this hypothesis, chlorodiphenylmethane was treated with 
trimethylaluminum (DCM rt, 0 °C to rt), providing 1,1′-diphenylethane 2.7 in 65% yield, supporting the 
possibility that if the chloride was formed it would be rapidly displaced by trimethylaluminum. 
  However, reaction of imidate 2.6 with AlCl 3  in DCM gave predominantly the rearrangement product, 
acetamide 2.8 (60% yield, Table 2.1, entry 16) with only trace amounts of chlorodiphenylmethane that 
appeared in the crude 1H NMR. It is therefore difficult to conclude that the chloride is an intermediate in 
the transformation, and it is also unclear why chloride displacement is favored over imidate rearrangement 
or elimination for imidate 2.38. 
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Scheme 2.2. Methylation of allylic imidate 2.41 
NSO2PhHO




(3 equiv)    
AlCl3
 













  The instability of the imidate of allylic alcohol 2.41 stymied the evaluation of displacement with trimethyl 
aluminium under normal conditions. Therefore, the imidate was formed and used without purification in 
the alkylation reaction following a procedure similar to that developed by Dalla and coworkers.25 This 
provided alkene 2.42 as the sole product of the reaction in 63% yield over two steps. Surprisingly, the direct 
substitution product 2.43 was not detected in the crude in the crude 1H NMR. 
2.2.4 Reaction with triethylaluminum 
------------------------------------------------------------------------------------------------------------------------------- 




















Reaction of diphenylmethyl imidate 2.6 with triethylaluminum as the nucleophile was also briefly evaluated 
(Scheme 2.3). However, in contrast to the reaction with trimethylaluminum, triethylaluminum provided the 
rearranged acetamide 2.7 (60%) as the major product of the reaction. It was also accompanied with trace 
amount of the ethyl addition product 2.43 and the reduced product diphenylmethane 2.44 as an inseparable 
mixture. With a major rearranged product, added complexity of the competitive reduction and separation 
issues of the product mixture, the use of triethylaluminum was not explored further. 
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2.3 Mechanistic Discussions 
  In order to gain some insight into the mechanistic pathway of the rearrangement some additional studies 
were conducted. The enantioenriched imidate (S)-2.56 was prepared from the known aminoalcohol 2.55 
and subjected to the reaction conditions, providing the product 2.57 in 49% yield (Scheme 2.4). The product 
obtained was subjected to chiral HPLC analysis and showed a racemic mixture. The racemization of the 
stereocenter, coupled with high yields for imidates that are precursors to relatively stable carbocations and 
observed trends in the substrate scope are consistent with a cationic S N 1 pathway. 
---------------------------------------------------------------------------------------------------------------------------- 




































This work represents the first conditions for the displacement of trichloroacetimidates with an alkylmetal 
reagent that is trimethyl aluminum. It provides a useful method for the transformation of alcohols to the 
corresponding methyl analogues. The transformation goes through cationic intermediate. This reaction is 







General Procedure for Trichloroacetimidate Synthesis. A flame dried flask was charged with the 
alcohol starting material (1 equiv) under argon. Dry DCM was then added to form a 0.5 M solution, and 
the flask was cooled to 0 °C. 1,8-Diazabicyclo [5.4.0] undec-7-ene (0.2 equiv) was then added to the 
solution, followed by trichloroacetonitrile (1.5 equiv). The reaction mixture was monitored by TLC until 
no more alcohol starting material was detected. The reaction mixture was then concentrated in vacuo, and 
the residue was purified by silica gel column chromatography using the listed solvent system to provide the 
desired trichloroacetimidates. Imidates 2.12a, 2.13a, 2.14a, 2.15a, 2.16a, 2.17a, 2.18a, 2.20a, 2.22a, 2.23a, 
2.24a, 2.25a, 2.26a, 2.27a, 2.28a, 2.29a, 2.30a, 2.33a, 2.34a, 2.35a, 2.36a, 2.37a, 2.38and 2.56 were 
synthesized from the corresponding alcohols using the general procedure. Imidates 2.6,26 2.19a,27 2.21a,28 






(4‐Methylphenyl)(phenyl)methyl 2,2,2‐trichloroacetimidate (2.12a). Purified by silica gel chromatography 
(10% ethyl acetate/ 1% triethylamine/ 89% hexanes). Viscous oil (1.17 g, 87%). IR (DCM) 3340, 1662, 
1286, 1066, 998 cm-1; 1H NMR (400 MHz, CDCl 3 ) δ 8.39 (s, 1H), 7.43-7.41 (m, 2H), 7.36- 7.25 (m, 5H), 
7.15 (d, J = 7.9 Hz, 2H), 6.91 (s,1H), 2.32 (s, 3H); 13C{1H} NMR (100 MHz CDCl 3 ) δ 161.3, 139.9, 137.8, 
136.8, 129.2, 128.4, 127.9, 127.0, 126.8, 91.6, 81.3, 21.6. Anal. calcd for C 16 H 14 Cl 3 NO: C, 56.09; H, 4.12; 






(2‐Methylphenyl)(phenyl)methyl 2,2,2‐trichloroacetimidate (2.13a). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Clear oil (2.38 g, 92%); TLC R f = 0.59 (10% ethyl 
acetate/90% hexanes); IR (DCM) 3339, 3053, 3032, 2983, 1664, 1286, 1265, 1075, 913, 741 cm–1; 1H NMR 
(400 MHz, CDCl 3 ) δ 8.39 (brs, 1H), 7.46-7.43 (m, 1H), 7.38-7.28 (m, 5H), 7.24-7.16 (m, 3H), 7.12 (s, 1H), 
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2.37 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 161.3, 138.9, 137.5, 136.2, 130.5, 128.4, 128.1, 128.0, 
127.3, 127.2, 126.1, 91.6, 79.0, 19.4. Anal. calcd for C16 H 14 Cl 3 NO: C, 56.09; H, 4.12; N, 4.09. Found: C, 






[1,1'‐Biphenyl] ‐4‐yl](phenyl)methyl 2,2,2-trichloroacetimidate (2.14a). Purified by silica gel 
chromatography (1% triethylamine/ 99% hexanes); White solid (0.35 g, 75%); IR (DCM) 3339, 3052, 1664, 
1493, 1265, 1075, 984, 798, 739, 703 cm–1; 1H NMR (300 MHz, CDCl 3 ) δ 8.42 (brs, 1H), 7.58-7.29 (m, 
14H), 6.97 (s, 1H). 13C{1H} NMR (100 MHz, CDCl 3 ) δ 161.4, 141.0, 140.7, 139.8, 138.8, 128.9, 128.6, 
128.2, 127.5, 127.4, 127.2, 127.0, 91.7, 81.3 (one aromatic resonance was unresolved). Anal. calcd for 






(4‐Methoxyphenyl)(phenyl)methyl 2,2,2‐trichloroacetimidate (2.15a). Purified by silica gel 
chromatography (1% ethyl acetate/ 1% triethylamine/ 98% hexanes); Yellow viscous oil (1.32 g, 92%); IR 
(DCM) 3335, 1663, 1609, 1512, 1268, 1054, 915, 739 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.38 (s, 1H), 
7.42-7.25 (m, 7H), 6.90-6.86 (m, 3H), 3.79 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 161.4, 159.4, 
140.0, 131.9, 128.6, 128.5, 127.9, 126.8, 113.9, 91.7, 81.2, 55.3. Anal. calcd for C 16 H 14 Cl 3 NO 2 : C, 53.58; 






(3-Chlorophenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (2.16a). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Viscous oil (1.23 g, 78%); TLC R f  = 0.65 (10% ethyl 
acetate/90% hexanes); IR (DCM) 3341, 1664, 1354, 1266, 1007, 791, 720, 701 cm–1; 1H NMR (400 MHz, 
CDCl 3 ) δ 8.44 (brs, 1H), 7.41 (d, J = 8.9 Hz, 3H), 7.37-7.21 (m, 6H), 6.90 (s, 1H); 13C{1H} NMR (100 
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MHz, CDCl 3 ) δ 161.2, 141.9, 139.1, 134.5, 129.9, 128.7, 128.4, 128.3, 127.1, 127.0, 125.1, 91.4, 80.6. 






(4‐Bromophenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (2.17a). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); White solid (2.08 g, 90%); TLC R f  = 0.59 (10% ethyl 
acetate/90% hexanes); IR (DCM) 3054, 2986, 2305, 1667, 1487, 1421, 1265, 705 cm–1; 1H NMR (400 
MHz, CDCl 3 ) δ 8.43 (brs, 1H), 7.48 (d, J = 8.5 Hz, 2H), 7.34-7.29 (m, 7H), 6.89 (s, 1H); 13C{1H} NMR 
(100 MHz, CDCl 3 ) δ 161.2, 139.2, 138.8, 131.7, 128.7, 128.6, 128.3, 126.9, 122.1, 91.4, 80.7. Anal. Calcd 






(3-Fluorophenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (2.18a). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Clear oil (0.97 g, 56%); TLC R f  = 0.61 (10% ethyl 
acetate/90% hexanes); IR (DCM) 3054, 1666, 1076, 999, 797, 735 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 
8.44 (brs, 1H), 7.43-7.41 (m, 2H), 7.38-7.28 (m, 4H), 7.21-7.13 (m, 2H), 7.00-6.95 (m, 1H), 6.92 (s, 1H); 
13C{1H} NMR (100  MHz, CDCl 3 ) 162.8 (d, J = 245.1 Hz), 161.2, 142.3, 142.3, 139.1, 130.1, 130.0, 128.6, 
128.3, 127.0, 122.5, 114.9 (d, J = 21.0 Hz), 113.9 (d, J = 22.2 Hz), 91.4, 80.6. Anal. Calcd for 








[3,5‐Bis(trifluoromethyl)phenyl](phenyl)methyl 2,2,2-trichloroacetimidate (2.20a). Purified by silica gel 
chromatography (10% ethyl acetate/ 1% triethylamine/ 89% hexanes); Off-white solid (1.25 g, 89%); TLC 
R f = 0.52 (10% ethyl acetate/90% hexanes); IR (DCM) 3342, 1668, 1625, 1379, 963, 798 cm-1; 1H NMR 
(400 MHz, CDCl 3 ) δ 8.52 (s, 1H), 7.89 (s, 2H), 7.82 (1H), 7.42-7.36 (m, 5H), 7.03 (s, 1H); 13C{1H} NMR 
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(100 MHz, CDCl 3 ) δ 160.9, 142.5, 137.9, 132.0 (q, J = 45.0 Hz), 129.0, 128.9, 123.2 (q, J = 361.7 Hz), 
122.1 (hept, J = 4.9 Hz), 91.1, 79.0 (two aromatic resonances did not resolve). Anal. Calcd for 




(Naphthalen‐1‐yl)(phenyl)methyl 2,2,2-trichloroacetimidate (2.22a). Purified by silica gel chromatography 
(1% triethylamine/ 99% hexanes); Clear oil (1.84 g, 70%); TLC R f  = 0.61 (10% ethyl acetate/90% 
hexanes); IR (DCM) 3055, 1665, 1265, 1074, 981, 735 cm–1; 1H NMR (300 MHz, CDCl 3 ) δ 8.47 (brs, 1H), 
8.08-8.05 (m, 1H), 7.88-7.83 (m, 1H), 7.70 (s, 1H), 7.61 (d, J = 7.0 Hz, 1H), 7.49-7.44 (m, 5H), 7.37-7.29 
(m, 3H ), 7.23 (s, 1H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 161.5, 139.1, 134.8, 133.9, 130.9, 129.1, 128.8, 
128.5, 128.1, 127.3, 126.4, 126.0, 125.8, 125.2, 124.0, 91.6, 79.2. Anal. Calcd for C 19 H 14 Cl 3 NO: C, 60.26; 






(1-Benzothiophen-3-yl)(phenyl)methyl 2,2,2-trichloroacetimidate (2.23a). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Viscous oil (0.34 g, 61%); IR (DCM) 
3335, 1664, 1264, 702, 563, 484 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.49 (brs, 1H), 7.86-7.84 (m, 1H), 
7.78-7.75 (m, 1H), 7.52 (d, J = 7.0 Hz, 1H), 7.40-7.32 (m, 7H), 7.25 (s, 1H); 13C{1H} NMR (100 MHz, 
CDCl 3 ) δ 161.4, 140.7, 138.2, 137.3, 134.5, 128.6, 128.5, 127.3, 125.9, 124.7, 124.3, 122.9, 122.7, 91.6, 







(1‐Benzothiophen‐3‐yl)(4‐fluorophenyl)methyl 2,2,2-trichloroacetimidate (2.24a). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Clear oil (0.90 g, 71%); TLC R f = 
0.76 (10% ethyl acetate/90% hexanes); IR (DCM) 3338, 3052, 1665, 1606, 1510, 1265, 1071 cm-1; 1H NMR 
(300 MHz, CDCl 3 ) δ 8.50 (brs, 1H), 7.87-7.83 (m, 1H), 7.72-7.68 (m, 1H), 7.52-7.47 (m, 2H), 7.37 (d, J = 
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0.9 Hz, 1H), 7.35-7.31 (m, 3H), 7.06 (tt, J = 9.8, 2.9 Hz, 2H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 162.7 
(d, J = 246.3 Hz), 161.3, 140.7, 137.1, 134.2, 134.0, 129.3 (d, J = 6.7 Hz), 125.7, 124.7, 124.3, 122.9, 122.6, 
115.6 (d, J = 29.0 Hz), 91.5, 77.4. Anal. Calcd for C 17H 11 Cl 3 FNOS: C, 50.71; H, 2.75; N, 3.48. Found: C, 





1‐(1,1'‐Biphenyl]‐4‐yl)ethyl 2,2,2-trichloroacetimidate (2.25a). Purified by silica gel chromatography (5% 
ethyl acetate/ 1% triethylamine/ 94% hexanes); Off white solid (1.06 g, 81%); IR (DCM) 3333, 1661, 1661, 
798, 765, 702, 650 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.33 (brs, 1H), 7.60-7.57 (m, 4H), 7.49 (d, J = 8.2 
Hz, 2H), 7.43 (t, J = 7.3 Hz, 2H), 7.36-7.32 (m, 1H), 6.03 (q, J = 6.5 Hz, 1H), 1.69 (d, J = 6.6 Hz, 3H); 
13C{1H} NMR (75 MHz, CDCl 3 ) δ 161.7, 140.9, 140.8, 140.4, 128.8, 127.4, 127.3, 127.1, 126.3, 91.8, 





1‐(1,1'‐Biphenyl]‐4‐yl)pentyl 2,2,2-trichloroacetimidate (2.26a). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); White solid (0.71 g, 60%); TLC R f  = 0.68 (10% ethyl 
acetate/90% hexanes); IR (DCM) 3339, 2954, 2927, 2859, 1661, 1300 cm–1; 1H NMR (400 MHz, CDCl 3) 
δ 8.27 (brs, 1H), 7.57 (d, J = 8.2 Hz, 4H), 7.47-7.32 (m, 4H), 7.34-7.32 (m, 1H), 5.87-5.84 (m, 1H), 2.12-
2.03 (m, 1H), 1.92-1.84 (m, 1H), 1.51-1.34 (m, 4H), 0.90 (t, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz, 
CDCl 3 ) δ 161.7, 140.7, 140.7, 139.5, 128.7, 127.1, 127.1, 126.5, 91.8, 80.8, 36.6, 27.6, 22.4, 14.0 (one 
aromatic resonance was not resolved). Anal. Calcd for C 19 H 20 Cl 3 NO: C, 59.32; H, 5.24; N, 3.64. Found: 





1‐(1,1'‐Biphenyl]‐4‐yl)‐2‐methylpropyl 2,2,2-trichloroacetimidate (2.27a). Purified by silica gel 
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chromatography (10% ethyl acetate/ 1% triethylamine/ 89% hexanes); White solid (2.00 g, 66%), TLC R f  
= 0.42 (10% ethyl acetate/90% hexanes); IR (DCM) 3339, 2967, 1661, 1487, 1300, 1058, 990 cm-1; 1H 
NMR (400 MHz, CDCl 3 ) δ 8.16 (s,1H), 7.53-7.49 (m, 4H), 7.37-7.34 (m, 4H ), 7.28-7.26 (m, 1H), 5.52 (d, 
J = 7.1 Hz, 1H), 2.16 (octet, J = 6.8 Hz, 1H), 1.02 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H); 13C{1H} 
NMR (100 MHz, CDCl 3 ) δ 161.8, 140.8, 140.7, 138.2, 128.8, 127.4, 127.3, 127.2, 126.9, 92.0, 85.6, 34.4, 





1‐(Naphthalen‐2‐yl)propyl 2,2,2-trichloroacetimidate (2.28a). Purified by silica gel chromatography (1% 
triethylamine/ 99% hexanes); Yellow oil (1.39 g, 96 %); TLC Rf = 0.62 (10% ethyl acetate/90% hexanes); 
IR (DCM) 3332 ,2972, 1663, 1073, 831, 797, 704 cm–1; 1H NMR (300 MHz, CDCl 3 ) δ 8.26 (brs, 1H), 
7.85-7.81 (m, 4H), 7.52 (dd, J = 8.4, 1.6 Hz, 1H), 7.48-7.45 (m, 2H), 5.92 (m,1H), 2.20-2.09 (m, 1H), 2.05-
1.94 (m, 1H), 1.03 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 161.8, 137.5, 133.08, 133.06, 
128.2, 128.0, 127.7, 126.2, 126.0, 125.4, 124.0, 91.9, 82.3, 29.8, 10.0. Anal. Calcd for C 15 H 14 Cl 3 NO: C; 





1‐(1‐Benzothiophen‐3‐yl)propyl 2,2,2-trichloroacetimidate (2.29a). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Yellow viscous oil (2.38 g, 91%); IR (DCM) 3340, 
2972, 1664, 1428, 1082, 976, 760 cm-1; 1H NMR (300 MHz, CDCl 3 ) δ 8.32 (brs, 1H), 7.94-7.91 (m, 1H), 
7.85-7.82 (m, 1H), 7.45 (s, 1H), 7.37-7.30 (m, 2H), 6.24 (t, J = 8.1 Hz, 1H), 2.30-2.02 (m, 2H), 1.02 (t, J = 
9.8 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 161.9, 140.7, 137.1, 134.9, 124.5, 124.1, 123.6, 122.9, 
122.5, 91.9, 77.9, 28.1, 10.0. Anal. Calcd for C 13 H 12 Cl 3 NOS: C, 46.38; H, 3.59; N, 4.16. Found: C, 46.03; 
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O 2.30a  
3,4-Dimethoxybenzyl 2,2,2-trichloroacetimidate (2.30a). Purified by silica gel chromatography (30% ethyl 
acetate/ 1% triethylamine/ 69% hexanes); Yellow oil (3.00 g, 90%); TLC R f  = 0.28 (20% ethyl acetate/ 
80% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 8.38 (brs, 1H), 7.01-6.98 (m, 2H), 6.87 (d, J = 8.1 Hz, 1H), 
5.29 (s, 2H), 3.89 (s, 6H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 162.4, 149.1, 149.0, 127.9, 120.8, 111.3, 
111.0, 91.5, 70.8, 55.85, 55.83. Anal. Calcd for C 11H 12 Cl 3 NO 3 : C, 42.27; H, 3.87; N, 4.48. Found: C, 




1‐(Naphthalen‐1‐yl) ethyl 2,2,2-trichloroacetimidate (2.33a). Purified by silica gel chromatography (10% 
ethyl acetate/ 1% triethylamine/ 89% hexanes); Light brown oil (5.64 g, 85%); TLC Rf = 0.56 (10% ethyl 
acetate / 90% hexanes); IR (DCM) 3338, 1662, 1512, 1301, 1085, 774, 648 cm–1; 1H NMR (400 MHz, 
CDCl 3 ) δ 8.47 (brs, 1H), 8.04 (d, J = 8.0 Hz, 1H), 7.87 (t, J = 7.4 Hz, 2H), 7.62 (d, J = 8.0 Hz, 1H), 7.56-
7.44 (m, 3H), 5.77 (s, 2H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 162.8, 133.7, 131.6, 130.9, 129.5, 128.7, 
127.3, 126.5, 126.0, 125.2, 123.7, 91.5, 69.5. Anal. Calcd for C 13 H 10 Cl 3 NO: C, 51.60; H, 3.33; N, 4.63. 





1‐(Naphthalen‐2‐yl) ethyl 2,2,2-trichloroacetimidate (2.34a). Purified by silica gel chromatography (10% 
ethyl acetate/ 1% triethylamine/ 89% hexanes); White solid (1.89 g, 99%), TLC R f  = 0.70 (20% ethyl 
acetate/80% hexanes); IR (DCM) 3335, 3053, 1665, 1305, 1081, 817, 649 cm–1; 1H NMR (400 MHz, 
CDCl 3 ) δ 8.42 (brs, 1H), 7.90 (s, 1H), 7.87-7.84 (m, 3H), 7.54 (dd, J = 8.4, 1.4 Hz, 1H), 7.50-7.48 (m, 2H), 
5.50 (s, 2H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 162.6, 133.2, 133.1, 132.9, 128.4, 128.0, 127.7, 127.0, 
126.3, 126.3, 125.5, 91.4, 70.9. Anal. Calcd for C 13 H 10 Cl 3 NO: C, 51.60; H, 3.33; N, 4.63. Found: C, 51.71; 
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(1‐Benzothiophen‐3‐yl) methyl 2,2,2-trichloroacetimidate (2.35a). Purified by silica gel chromatography 
(10% ethyl acetate/ 1% triethylamine/ 89% hexanes); Off white solid (1.92 g, 68%); TLC R f  = 0.48 (10% 
ethyl acetate/90% hexanes); IR (DCM) 3340, 3052, 2984, 2304, 1664, 1460, 1295, 1265, 1076, 799, 737, 
705 cm-1; 1H NMR (400 MHz, CDCl 3 ) δ 8.46 (brs, 1H), 7.88-7.86 (m, 2H), 7.56 (s, 1H), 7.43-7.36 (m, 
2H), 5.57 (s, 2H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 162.7, 140.5, 137.8, 130.3, 126.5, 124.7, 124.4, 
122.9, 122.0, 91.0, 65.3. Anal. Calcd for C 11 H 8 Cl 3 NOS: C, 42.81; H, 2.61; N, 4.54. Found: C, 43.17; H, 





4-Nitrobenzyl 2,2,2-trichloroacetimidate (2.36a). Purified by silica gel chromatography (20% ethyl acetate/ 
1% triethylamine/ 79% hexanes); Yellow solid (3.75 g, 97%); TLC R f  = 0.23 (10% ethyl acetate / 90% 
hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 8.50 (s, 1H), 8.25 (d, J = 8.7 Hz, 2H), 7.61 (d, J = 8.8 Hz, 2H), 
5.45 (s, 2H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 162.1, 147.8, 142.7, 127.9, 123.8, 90.9, 69.1. Anal. Calcd 







2,2‐Diphenylethyl 2,2,2-trichloroacetimidate (2.37a). Purified by silica gel chromatography (5% ethyl 
acetate/ 1% triethylamine/ 89% hexanes); Clear oil (0.31 g, 87%); IR (DCM) 3337, 1663, 1081, 798 cm-1; 
TLC R f  = 0.68 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 8.30 (s, 1H), 7.32-7.20 
(m, 10H), 4.81 (d, J = 7.3 Hz, 2H), 4.54 (t, J = 7.2 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 162.8, 
141.0, 128.5, 128.4, 126.8, 91.3, 71.6, 49.5. Anal. Calcd for C 16 H 14 Cl 3 NO: C, 56.09; H, 4.12; N, 4.09. 
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tetrahydropyrrolo[2,3-b] indole-1,2(2H)-dicarboxylate (2.38). Purified by silica gel chromatography (40% 
ethyl acetate/ 1% triethylamine/ 59% hexanes); White foamy solid (0.08 g, 60%); TLC R f  = 0.57 (50% 
ethyl acetate/50% hexanes); [𝛼𝛼]𝐷𝐷 21 = +85.1 (c = 1.6, CHCl 3 ); IR (DCM) 3434, 2090, 1642 cm–1; 1H NMR 
(400 MHz, CDCl 3 , 50 °C) δ 8.49 (s, 1H), 7.98 (d, J = 7.2 Hz, 2H), 7.54-7.44 (m, 4H), 7.39-7.30 (m, 2H), 
7.07 (td, J = 7.7, 1.1 Hz, 1H), 6.71 (s, 1H), 4.83 (d, J = 9.0 Hz, 1H), 3.51 (brs, 3H), 3.26 (s, 3H), 3.17 (d, J 
= 12.9 Hz, 1H), 3.03 (dd, J = 12.8, 9.2 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl 3 , 50 °C) δ 170.3, 159.1, 
154.4, 144.8, 144.4, 132.5, 131.5, 129.0, 127.7, 126.6, 125.5, 124.3, 116.3, 93.4, 90.8, 81.6, 58.6, 52.7, 









3‐(N‐Methylbenzenesulfonamido)‐1S‐(thiophen‐2‐yl)propyl 2,2,2‐trichloroacetimidate (2.56). Purified by 
silica gel chromatography (20% ethyl acetate/ 1% triethylamine/ 79% hexanes); Yellow oil (0.25 g, 85%); 
TLC R f  = 0.62 (40% ethyl acetate/60% hexanes); [𝛼𝛼]𝐷𝐷 25 = +32.5 (c = 0.4, DCM); IR (DCM) 3375, 1693, 
1335, 1163, 1109, 834 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.46 (brs, 1H), 7.81-7.79 (m, 2H), 7.63-7.52 
(m, 3H), 7.31 (dd, J = 5.1, 1.1 Hz, 1H), 7.18 (d, J = 3.4 Hz, 1H), 7.01 (q, J = 3.6 Hz, 1H), 6.28 (q, J = 4.9 
Hz, 1H), 3.21 (t, J = 6.9 Hz, 2H), 2.81 (s, 3H), 2.47-2.38 (m, 1H), 2.32-2.24 (m, 1H); 13C{1H} NMR 
(100MHz, CDCl 3 ) δ 161.1, 141.4, 137.4, 132.7, 129.1, 127.4, 126.6, 126.5, 125.7, 91.4, 73.5, 46.8, 35.5, 
35.3. Anal. Calcd for C 16 H 17 Cl 3 N 2 O 3 S 2 : C, 42.16; H, 3.76; N, 6.15. Found: C, 42.16; H, 3.82; N, 6.12. 
The enantiomeric purity of this material was verified by NMR using the chiral shift reagent Europium 
tris[3-(heptafluoropropylhydroxymethylene) -(+)-camphorate] i.e. Eu(hfc) 3 . The addition of 0.8 equiv of 
Eu(hfc) 3  gave separation of the imidate NH peak at ~8.4 ppm in the 1H NMR (see supporting spectra for 
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details). 
General Procedures for the Displacement of Trichloroacetimidates with Trimethylaluminum. 
Method A. Aluminium trichloride (1 eq) was dissolved in dry DCM (0.162 M) under argon in a flame dried 
flask. Trimethylaluminium (3 equiv, 2M in hexanes) was slowly added and the mixture was stirred for 5 
min. After cooling to 0 °C the trichloroacetimidate (1 equiv) was added. The reaction mixture was then 
allowed to warm to rt. After 15 min the reaction was quenched with 10% aq. HCl. The mixture was poured 
into water and extracted with DCM (3x). The combined organic extracts were dried (Na 2 SO 4 ), filtered, 
and concentrated in vacuo. The residue was then purified by silica gel chromatography using the eluent 
listed for each example. Compounds 2.7, 2.12, 2.13, 2.14, 2.15, 2.16, 2.17, 2.18, 2.19, 2.20, 2.21, 2.22, 
2.23, 2.24, 2.25, 2.26, 2.28, 2.29, 2.39, and 2.57 were obtained by this method. 
Method B. Trimethylaluminium (3 equiv, 2M in hexanes) was suspended in dry DCM (0.162 M) under 
argon in a flame dried flask. The temperature of the reaction was then cooled to the temperature noted in 
Table 2. The trichloroacetimidate was the added. The reaction was monitored by TLC and quenched with 
the addition of 10% aq. HCl after the time listed in Table 2. The quenched mixture was poured into water 
and extracted with DCM (3x). The organic extracts were then dried using Na 2 SO 4 , filtered, and 
concentrated. The residue was purified by silica gel chromatography using the eluent listed for each 
example. Compounds 2.27, 2.30, 2.31, 2.32, 2.33, 2.34, 2.35 were obtained using this method. 
2.7  
1,1- Diphenylethane (2.7).31 Purified by silica gel chromatography (1% ethyl acetate/ 99% hexanes); Clear 
viscous oil (0.04 g, 91%); 1H NMR (400 MHz, CDCl 3 ) δ 7.20-7.08 (m, 10H), 4.07 (q, J = 7.2 Hz, 1H), 
1.56 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 146.4, 128.4, 127.7, 126.1, 44.8, 21.9.  
2.12  
1-Phenyl-1-(p-tolyl) ethane (2.12).31 Purified by silica gel chromatography (1% ethyl acetate/ 99% 
hexanes). Clear oil (0.03 g, 65%); TLC R f  = 0.74 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.29-
7.07 (m, 9H), 4.12 (q, J = 7.2 Hz, 1H), 2.3 (s, 3H), 1.62 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz, 
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CDCl 3 ) δ 146.6, 143.4, 135.5, 129.0, 128.3, 127.6, 127.5, 125.9, 44.4, 21.9, 21.0. 
2.13  
1-Phenyl-1-(o-tolyl) ethane (2.13).32 Purified by silica gel chromatography (100% hexanes). Clear viscous 
oil (0.08 g, 70%); TLC R f  = 0.83 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.27- 
7.11 (m, 9H), 4.30 (q, J = 7.2 Hz, 1H), 2.22 (s, 3H), 1.60, (d, J = 7.2 Hz, 3H); 13C{1H} NMR (75 MHz, 
CDCl 3 ) δ 146.3, 144.0, 136.2, 130.5, 128.4, 127.8, 126.8, 126.2, 126.1, 125.9, 41.1, 22.2, 19.8. 
Ph 2.14  
4-(1-Phenylethyl)biphenyl (2.14).33 Purified by silica gel chromatography (1% ethyl acetate/ 99% hexanes); 
Clear viscous oil (0.04 g, 91%); TLC R f  = 0.69 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, 
CDCl 3 ) δ 7.55 (dd, J = 8.4, 1.4 Hz, 2H), 7.51-7.49 (m, 2H), 7.40 (t, J = 7.3 Hz, 2H), 7.32-7.16 (m, 8H), 
4.18 (q, J = 7.2 Hz, 1H), 1.67 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 146.2, 145.5, 141.0, 
139.0, 128.7, 128.4, 128.0, 127.6, 127.1, 127.0, 127.0, 126.1, 44.5, 21.9. 
 
MeO 2.15  
4-(1-Phenylethyl)anisole (2.15).34 Purified by silica gel chromatography (1% ethyl acetate/ 99% hexanes); 
Clear viscous oil (0.03 g, 64%); TLC R f  = 0.37 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, 
CDCl 3 ) δ 7.29-7.12 (m, 7H), 6.83-6.81 (m, 2H), 4.10 (q, J = 7.2 Hz, 1H), 3.77 (s, 3H), 1.61 (d, J = 7.2 Hz, 




1-Chloro-3-(1-phenylethyl) benzene (2.16). Purified by silica gel chromatography (1% ethyl acetate/ 99% 
hexanes); Clear viscous oil (0.11 g, 92%); IR (DCM) 3434, 2090, 1642 cm–1 ;2968,1594, 1493, 1475, 1426, 
1082, 791; TLC R f  = 0.73 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.30-7.26 (m, 
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2H), 7.20-7.13 (m, 5H), 7.09-7.07 (m, 2H), 4.10 (q, J = 7.2 Hz, 1H), 1.61 (d, J = 7.2 Hz, 3H); 13C{1H} 
NMR (75 MHz, CDCl 3 ) δ 148.5, 145.5, 134.2, 129.7, 128.6, 127.8, 127.6, 126.4, 126.3, 125.9, 44.6, 21.7. 
Calcd for C 14 H 13 Cl: C, 77.59; H, 6.05; Found: C, 77.33; H, 5.76 
Br 2.17  
1-Bromo-4-(1-phenylethyl)benzene (2.17).35 Purified by silica gel chromatography (100% hexanes); Clear 
viscous oil (0.11 g, 86%); TLC R f  = 0.71 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, CDCl 3) 
δ 7.38 (d, J = 8.4 Hz, 2H), 7.27 (t, J = 7.7 Hz, 2H), 7.21-7.16 (m, 3H), 7.07 (d, J = 8.4 Hz, 2H), 4.09 (q, J 
= 7.2 Hz, 1H), 1.60 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 145.7, 145.4, 131.5, 129.4, 
128.5, 127.6, 126.3, 119.9, 44.3, 21.8. 
F
2.18  
1-Fluoro-3-(1-phenylethyl) benzene (2.18). Purified by silica gel chromatography (100% hexanes); Clear 
viscous oil (0.04 g, 87%); TLC R f  = 0.66 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.30-7.26 (m, 
2H), 7.23-7.17 (m, 4H), 6.99 (d, J = 7.7 Hz, 1H), 6.92-6.83 (m, 2H), 4.13 (q, J = 7.2 Hz, 1H), 1.62 (d, J = 
7.2 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 163.0 (d, J = 244.5 Hz), 149.0, 145.6, 129.7, 128.5, 127.6, 
126.3, 123.3, 114.5 (d, J = 22.5 Hz), 112.8 (d, J = 22.4 Hz), 44.5, 21.7. Anal. Calcd for C 14 H 13 F: C, 83.97; 
H, 6.54. Found: C, 83.88; H, 6.22. 
O2N 2.19  
1-Nitro-4-(1-phenylethyl)benzene (2.19).36 Purified by silica gel chromatography (1% ethyl acetate/ 99% 
hexanes); Yellow oil (0.08 g, 66%); TLC R f  = 0.55 (10% ethyl acetate/90% hexanes); 1H NMR (400 MHz, 
CDCl 3 ) δ 8.06 (d, J = 8.8, Hz, 2H), 7.29 (d, J = 8.6 Hz, 2H), 7.24 (t, J = 7.1 Hz, 2H), 7.18-7.12 (m, 3H), 
4.18 (q, J = 7.2 Hz, 1H), 1.60 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 154.1, 146.4, 144.5, 
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128.7, 128.5, 127.6, 126.7, 123.7, 44.7, 21.5. 
F3C
CF3 2.20  
1‐(1‐Phenylethyl) ‐3,5‐bis(trifluoromethyl)benzene (2.20). Purified by silica gel chromatography (100% 
hexanes); Clear viscous oil (0.13 g, 95%); TLC Rf  = 0.57 (100% hexanes); IR (DCM) 2801, 1420, 1374, 
1280, 1173, 1134, 897, 701 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 7.71 (s, 1H), 7.76 (s, 2H), 7.32 (t, J = 7.2 
Hz, 2H), 7.25-7.18 (m, 3H), 4.26 (q, J = 7.2 Hz, 1H), 1.68 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (100 MHz, 
CDCl 3 ) 148.9, 144.2, 131.7 (q, J = 44.6 Hz)), 128.9, 127.8 (q, J = 3.4 Hz), 127.5, 126.9, 123.5 (q, J = 361.0 




2-(1-Phenylethyl)-naphthalene (2.21).37 Purified by silica gel chromatography (100% hexanes); Clear 
viscous oil (0.07 g, 57%); TLC R f  = 0.52 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.79-7.76 (m, 
2H), 7.72 (d, J = 8.5 Hz, 1H), 7.69 (s, 1H), 7.42-7.38 (m, 2H), 7.30-7.24 (m, 5H), 7.20-7.16 (m, 1H), 4.30 
(q, J = 7.2 Hz, 1H), 1.72 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 146.3, 143.8, 133.6, 132.2, 




1-(1-Phenethyl)-naphthalene (2.22).38 Purified by silica gel chromatography (2% ethyl acetate/ 98% 
hexanes); Clear viscous oil (0.07 g, 57%); TLC R f  = 0.73 (10% ethyl acetate/90% hexanes). 1H NMR (400 
MHz, CDCl 3 ) δ 8.02-7.04 (m, 1H), 7.84-7.82 (m, 1H), 7.73 (d, J = 7.6 Hz, 1H), 7.47-7.39 (m, 4H), 7.25-
7.22 (m, 4H), 7.17-7.13 (m, 1H), 4.91 (q, J = 7.1 Hz, 1H), 1.76 (d, J = 7.1 Hz, 3H). 13C{1H} NMR (100 
MHz, CDCl 3 ) δ 146.6, 141.5, 134.0, 131.7, 128.7, 128.4, 127.6, 127.0, 125.9, 125.8, 125.4, 125.3, 124.3, 
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123.9, 40.5, 22.5. 
S 2.23  
3-(1-Phenylethyl)-benzo[b]thiophene (2.23).39 Purified by silica gel chromatography (2% ethyl acetate/ 
98% hexanes); White foam (0.07 g, 57%); TLC R f  = 0.38 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) 
δ 7.83-7.81 (m, 1H), 7.55-7.53 (m, 1H), 7.29-7.15 (m, 8H), 4.43 (q, J = 7.1 Hz, 1H), 1.73 (d, J = 7.1 Hz, 
3H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 145.4, 140.7, 140.6, 138.6, 128.6, 127.4, 126.3, 124.2, 123.8, 
122.8, 122.5, 121.5, 39.6, 22.4. 
S F2.24  
3-(1-(4-Fluorophenyl)ethyl)-benzo[b]thiophene (2.24).40 Purified by silica gel chromatography (100% 
hexanes); Clear viscous oil (0.09 g, 71%); TLC R f  = 0.76 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 
MHz, CDCl 3 ) δ 7.80 (d, J = 7.5 Hz, 1H), 7.49 (d, J = 7.7 Hz, 1H), 7.27-7.13 (m, 5H), 6.91 (t, J = 8.7 Hz, 
2H), 4.39, (q, J = 7.0 Hz, 1H), 1.67 (d, J = 7.1 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 161.5 (d, J = 
242.3 Hz), 141.2, 140.8, 140.4, 138.5, 128.9, 124.3, 123.9, 122.9, 122.5, 121.6, 115.4 (d, J = 21.7 Hz), 
38.9, 22.5. 
 
Ph 2.25  
4-Isopropylbiphenyl (2.25).41 Purified by silica gel chromatography (100% hexanes); Clear viscous oil 
(0.10 g, 87%); TLC R f  = 0.55 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.57 (d, J = 7.2 Hz, 2H), 
7.51 (d, J = 8.2 Hz, 2H), 7.40 (t, J = 7.4 Hz, 2H), 7.30 (t, J = 7.3 Hz, 3H), 2.94 (hept, J = 6.9 Hz, 1H), 1.28 
(d, J = 7.0 Hz, 6H); 13C{1H} NMR (100 MHz, CDCl 3) δ 148.1, 141.3, 138.8, 128.8, 127.2, 127.1, 127.0, 
126.9, 33.9, 24.1. 
Ph 2.26  
1-(1-Methylpentyl)-4-phenyl-benzene (2.26). Purified by silica gel chromatography (100% hexanes); Clear 
viscous oil (0.12 g, 97%); TLC R f  = 0.64 (100% hexanes); IR (DCM) 3027, 2957, 2926, 2856, 1486, 1455, 
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1008, 837, 732 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 7.60-7.58 (m, 2H), 7.52 (d, J = 8.2 Hz, 2H), 7.42 (t, J 
= 7.4, Hz, 2H), 7.34-7.30 (m, 1H), 7.26-7.24 (m, 2H), 2.72 (hextet, J = 6.8 Hz, 1H), 1.65-1.56 (m, 2H), 
1.33-1.15 (m, 7H), 0.87 (t, J = 6.9 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 147.2, 141.2, 138.7, 128.7, 
127.4, 127.0, 126.9, 39.6, 38.2, 30.0, 22.8, 22.3, 14.1 (one aromatic resonance was unresolved). Anal. Calcd 
for C 18 H 22 : C, 90.70; H, 9.30. Found: C, 90.79; H, 9.37. 
Ph 2.27  
4-(3-methylbutan-2-yl)-1,1'-biphenyl (2.27). Purified by silica gel chromatography (100% hexanes); Clear 
viscous oil (0.065 g, 90%); TLC R f  = 0.45 (100% hexanes); IR (DCM) 3416, 2960, 2872, 1598, 1486 cm-
1; 1H NMR (400 MHz, CDCl 3 ) δ 7.61 (d, J = 7.7 Hz, 2H), 7.53 (d, J = 8.2 Hz, 2H), 7.44 (t, J = 7.4 Hz, 2H), 
7.33 (t, J = 7.3 Hz, 1H), 7.25 (d, J = 9.1Hz, 2H), 2.50 (quintet, J = 7.1 Hz, 1H), 1.81 (octet, J = 6.6 Hz, 1H), 
1.29 (d, J = 7.0 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H), 0.82 (d, J = 6.6 Hz, 3H); 13C{1H} NMR (100 MHz, 
CDCl 3 ) δ 146.3, 141.2, 138.6, 128.7, 128.1, 127.02, 127.00, 126.8, 46.6, 34.5, 21.3, 20.2, 18.9 . Anal. 
Calcd for C 17 H 20 : C, 91.01; H, 8.99. Found: C, 91.18; H, 8.75. 
 2.28  
2-(1-Methylpropyl)-naphthalene (2.28).42 Purified by silica gel chromatography (100% hexanes); Clear 
viscous oil (0.07 g, 60%); TLC R f  = 0.71 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.80-7.75 (m, 
3H), 7.60 (s, 1H), 7.41 (qd, J = 6.9, 1.4 Hz, 2H), 7.33 (dd, J = 8.5, 1.6 Hz, 1H ), 2.75 (sextet, J = 7.0 Hz, 
1H), 1.74-1.62 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H), 0.84 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) 




3-(1-Methylpropyl)-benzo [b] thiophene (2.29).42 Purified by silica gel chromatography (100% hexanes); 
Clear viscous oil (0.07 g, 62%); TLC R f  = 0.65 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.86-7.84 
(m, 1H), 7.79-7.77 (m, 1H), 7.38-7.30 (m, 2H), 7.06 (s, 1H), 3.09 (sextet, J = 6.8 Hz, 1H), 1.89-1.79 (m, 
1H), 1.71-1.60 (m, 1H), 1.35 (d, J = 6.9 Hz, 3H), 0.93 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ) 
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4-Ethyl-1,3-dimethoxybenzene (2.30).43 Purified by silica gel chromatography (5% ethyl acetate/ 95% 
hexanes); Clear viscous oil (0.08 g, 92%); TLC Rf  = 0.66 (20 ethyl acetate/80% hexanes). 1H NMR (400 
MHz, CDCl 3 ) δ 6.80 (d, J = 8.6 Hz, 1H), 6.74-6.73 (m, 2H), 3.88 (s, 3H), 3.85 (s, 3H), 2.60 (q, J = 7.6 Hz, 
2H), 1.23 (t, J = 7.6 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl 3 ) δ 148.8, 147.0, 137.0, 119.5, 111.3, 111.3, 
56.0, 55.8, 28.5, 15.8. 
O 2.31  
4-Ethylanisole (2.31).45 Purified by silica gel chromatography (4% ethyl acetate/ 96% hexanes); Clear 
viscous oil (0.05 g, 52%); TLC R f  = 0.78 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 MHz, CDCl 3 ) 
δ 7.10 (d, J = 8.5 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 3.77 (s, 3H), 2.58 (q, J = 7.6 Hz, 2H), 1.20 (t, J = 7.6 
Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 157.7, 136.4, 128.7, 113.8, 55.3, 28.0, 15.9. 
Ph 2.32  
4-Ethylbiphenyl (2.32).45 Purified by silica gel chromatography (1% ethyl acetate/ 99% hexanes); Clear 
viscous oil (0.09 g, 81%); TLC R f  = 0.68 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) 7.59-7.57 (m, 
2H), 7.52-7.50 (d, J = 7.5 Hz, 2H), 7.42 (t, J = 7.4 Hz, 2H), 7.33-7.26 (m, 3H), 2.69 (q, J = 7.6 Hz, 2H), 
1.27 (t, J = 7.6 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl 3 ) δ 143.4, 141.2, 138.6, 128.7, 128.3, 127.1, 
127.0, 127.0, 28.5, 15.6. 
2.33  
1-Ethylnapthalene (2.33).46 Purified by silica gel chromatography (100% hexanes); Clear viscous oil (0.062 
g, 60%); TLC R f  = 0.66 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 8.04 (d, J = 8.2 Hz, 1H), 7.85-
7.83 (m, 1H), 7.69 (d, J = 8.1 Hz, 1H), 7.52-7.44 (m, 2H), 7.40 (t, J = 7.2 Hz, 1H), 7.33 (d, J = 6.9 Hz, 1H), 
3.12 (q, J = 7.5 Hz, 2H), 1.38 ( t, J = 7.6 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ) δ 140.3, 133.9, 131.8, 
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128.8, 126.4, 125.7, 125.4, 124.9, 123.8, 25.9, 15.1 (one aromatic resonance was unresolved). 
2.34  
2-Ethylnapthalene (2.34).47 Purified by silica gel chromatography (100% hexanes); Clear viscous oil (0.05 
g, 49%); TLC R f  = 0.62 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.79-7.74 (m, 3H), 7.60 (s, 1H), 
7.41-7.33 (m, 2H), 7.33 (dd, J = 8.4, 1.2 Hz, 1H), 2.80 (q, J = 7.6 Hz, 2H), 1.31 (t, J = 7.6 Hz, 3H); 13C{1H} 
NMR (100 MHz, CDCl 3 ) δ 141.7, 133.7, 131.9, 127.8, 127.6, 127.4, 127.1, 125.8, 125.5, 125.0, 29.0, 15.5. 
Me
S2.35  
3-Ethyl-benzo[b]thiophene (2.35).48 Purified by silica gel chromatography (100% hexanes); Clear viscous 
oil (0.08 g, 62%); TLC R f  = 0.57 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.85-7.83 (m, 1H), 7.74-
7.72 (m, 1H), 7.38-7.30 (m, 2H), 7.06 (s, 1H), 2.85 (qd, J = 7.5, 1.0 Hz, 2H), 1.36 (t, J = 7.5 Hz, 3H); 








1,2‐Dimethyl (2S) ‐8‐(benzenesulfonyl) ‐3a‐chloro‐1H,2H,3H,3aH,8H,8aH‐pyrrolo[2,3‐b] indole ‐1,2‐
dicarboxylate (2.39). Purified by silica gel chromatography (20% ethyl acetate/ 80% hexanes); White solid 
(0.06 g, 80%); [𝛼𝛼]𝐷𝐷 24 = +38.2 (c = 1.2, DCM); TLC R f  = 0.33 (50% ethyl acetate/50% hexanes ); 1H NMR 
(400 MHz, CDCl 3 ) δ 7.78 (d, J = 7.7 Hz, 2H), 7.58 (d, J = 8.1 Hz, 1H), 7.49 (t, J = 7.3 Hz, 1H), 7.40-7.34 
(m, 3H), 7.22 (d, J = 7.2 Hz, 1H), 7.14 (t, J = 7.5 Hz, 1H), 6.20 (s, 1H), 4.66 (d, J = 8.7 Hz, 1H), 3.70 (s, 
3H), 3.13 (s, 3H), 3.09-3.12 (m, 1H), 2.95-2.86 (m, 1H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 170.0, 154.3, 
142.2, 139.0, 133.3, 132.1, 131.3, 128.9, 127.3, 125.8, 124.4, 118.4, 86.3, 71.4, 59.3, 53.1, 52.3, 43.0. 





N‐Methyl‐N‐[3‐(thiophen‐2‐yl) butyl] benzenesulfonamide (2.58). Purified by silica gel chromatography 
(20% ethyl acetate/ 80% hexanes); Clear oil (0.070 g, 49%), TLC R f  = 0.62 (50% ethyl acetate/ 50% 
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hexanes); IR (DCM) 2923, 1446, 1340, 1164, 735, 691 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 7.67 (d, J = 
7.2 Hz, 2H), 7.49 (t, J = 7.3 Hz, 1H), 7.43 (t, J = 7.7 Hz, 2H), 7.06-7.04 (m, 1H), 6.84 (t, J = 3.5 Hz, 1H), 
6.75 (d, J = 3.3 Hz, 1H), 3.07 (sextet, J = 6.9 Hz, 1H), 2.93 (td, J = 7.4, 1.9 Hz, 2H), 2.63 (s, 3H), 1.84-
1.71 (m, 2H), 1.27 (d, J = 6.9 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ) δ 150.6, 137.5, 132.5, 129.0, 
127.4, 126.6, 123.1, 122.8, 48.4, 37.0, 34.9, 32.6, 23.1. Anal. Calcd for C 15 H 19 NO 2 S 2 : C, 58.22; H, 6.19; 
N, 4.53. Found: C, 58.10; H, 6.14; N, 4.89; Chiral HPLC analysis: OJ column (hexane/i-PrOH = 91/9, 0.9 
mL/min, 254 nm, 25 °C): t r  = 20.4, 22.2 min. 
NSO2PhHO
2.41  
1‐(Benzenesulfonyl)‐1,2,3,4‐tetrahydropyridin‐4‐ol (2.41). IBX (1.170 g, 4.17 mmol) was dissolved in dry 
DMSO (3.3 ml) and warmed to 75 °C for 5 min. The known 1-(benzenesulfonyl)-4-piperidone49 (0.500 g, 
2.08 mmol) was added and the reaction was allowed to proceed for 14 h at 75 °C. The reaction mixture was 
then poured into sat. aq. NaHCO 3  solution and partitioned with ethyl acetate. The organic phase was then 
filtered through Celite with ethyl acetate, and then the filtrate was washed with water and brine. The organic 
layer was then dried (Na 2 SO 4 ), filtered, and concentrated in vacuo. The residue was purified by silica gel 
chromatography (40 % ethyl acetate/ 60% hexanes) to provide crude 1-(benzenesulfonyl)-2,3-dehydro-4-
piperidone as an off-white solid (0.297 g, 60%). A portion of this solid (0.200 g, 0.83 mmol) was then 
dissolved in 2 mL of MeOH. The reaction was cooled to 0°C and CeCl 3 •7H 2 O (0.313 g, 0.83 mmol) was 
added followed by NaBH 4  (0.032 g, 0.83 mmol). Reaction mixture was then allowed to warm to room 
temperature. After 30 min the reaction was poured into water and extracted with ethyl acetate (3x). The 
combined organic layers were then dried (Na 2 SO 4), filtered and concentrated. The residue was purified by 
silica gel chromatography (50% ethyl acetate/ 50% hexanes) to provide alcohol 2.41 as white solid (0.191 
g, 95%). 
2.41. TLC R f  = 0.20 (40% ethyl acetate/ 60% hexanes); IR (DCM) 3398, 1643, 1446, 1170, 935 cm–1; 1H 
NMR (300 MHz, CDCl 3 ) δ 7.80-7.78 (m, 1H), 7.63-7.50 (m, 3H), 6.81 (d, J = 8.3 Hz, 1H), 5.13 (ddd, J = 
8.3, 4.8, 1.1 Hz, 1H), 4.12 (brs, 1H), 3.73-3.66 (m, 1H), 3.14 (td, J = 11.9, 3.2 Hz, 1H), 1.86-1.64 (m, 3H); 
13C{1H} NMR (75 MHz, CDCl 3 ) 137.9, 133.1, 129.3, 127.7, 127.0, 108.8, 59.9, 39.2, 30.0. Anal. Calcd 
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for C 11 H 13 NO 3 S: C, 55.21; H, 5.48; N, 5.85. Found: C, 54.82; H, 5.40; N, 6.25. 
NSO2Ph
2.42  
1‐(Benzenesulfonyl)‐4‐methyl‐1,2,3,4‐tetrahydropyridine (2.42). Alcohol 2.41 (0.150 g, 0.632 mmol) was 
dissolved in 1.1 mL of dry DCM under argon. The reaction was cooled to 0 °C and DBU (20 µL, 0.131 
mmol) was added followed by trichloroacetonitrile (70 µL, 0.698 mmol). The reaction mixture was then 
allowed to warm to rt and stirred for 15 min. In a separate flask AlCl 3  (84 mg, 0.632 mmol) was dissolved 
in DCM (2 mL) and AlMe3  (0.94 mL, 2M in hexanes, 1.92 mmol) was added. After 5 min the solution 
containing the trimethylaluminum was added to the imidate formed in the first solution at 0°C. After 5 min 
the reaction was quenched with 1 M HCl and the mixture extracted with DCM (3x). The combined organic 
layers were then dried (Na 2 SO 4 ), filtered and concentrated. The residue was purified by silica gel 
chromatography (15% ethyl acetate/ 85% hexanes) to provide alkene 2.42 as yellow oil (94 mg, 63%). 
2.42. TLC R f  = 0.25 (20% ethyl acetate/ 80% hexanes); IR (DCM) 3033, 2974, 2931, 1446, 1328, 
1279,1213, 1164, 1105, 980 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 7.83 (d, J = 7.2 Hz, 2H), 7.55 (t, J = 7.6 
Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 5.67-5.57 (m, 2H), 4.44 (brs, 1H), 3.85 (dd, J = 5.9, 1.4 Hz, 1H ), 3.19-
3.12 (m, 1H), 1.97-1.79 (m, 2H), 1.26 (d, J = 6.8 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl 3 ) δ 141.5, 
132.3, 129.4, 129.0, 126.8, 124.4, 49.6, 37.8, 23.7, 20.4. Anal. Calcd for C 12 H 15 NO 2 S: C, 60.73; H, 6.37; 






N‐[3S‐Hydroxy‐3‐(thiophen‐2‐yl) propyl] ‐N‐methylbenzenesulfonamide (2.55). (S)-3-(Methylamino)-1-
(2-thienyl) propan-1-ol50 (0.200 g, 1.17 mmol) was dissolved in dry DCM (5 mL) and cooled to 0 °C. 
Pyridine (0.113 ml, 1.46 mmol) was then added followed by benzenesulfonyl chloride (0.246 mg, 1.39 
mmol). The reaction mixture was then allowed to warm to rt and stirred for 14 h. The reaction mixture was 
then poured into water and extracted with ethyl acetate (3x). This organic extract were then dried (Na 2 SO 4 ), 
filtered, concentrated in vacuo. Purification by silica gel chromatography (40% ethyl acetate/ 60% hexanes) 
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gave sulfonamide S1 as a white solid (0.33 g, 90%). 
2.55. TLC R f  = 0.45 (40% ethyl acetate/ 60% hexanes); [𝛼𝛼]𝐷𝐷 24 = -7.4 (c = 0.8, DCM); IR (DCM) 3499, 
2925, 1446, 1331, 1160, 1089, 737, 691 cm–1; 1H NMR (300 MHz, CDCl 3 ) δ 7.74-7.71 (m, 2H), 7.61-7.48 
(m, 3H), 7.30 (d, J = 5.0 Hz, 1H), 6.98 (dd, J = 5.0, 3.5 Hz, 1H), 6.93 (dd, J = 3.4, 1.0 Hz, 1H ), 4.49 (dd, 
J = 8.1, 5.3 Hz, 1H), 3.24- 3.14 (m, 1H), 2.85-2.73 (m, 1H), 2.62 (s, 3H), 2.14-2.01 (m, 1H), 1.93- 1.82 
(m,1H). 13C{1H} NMR (75 MHz, CDCl 3 ) δ 144.7, 137.4, 132.5, 129.0, 127.4, 126.7, 126.4, 125.5, 71.8, 
47.3, 36.8, 34.9. Anal. Calcd for C 14 H 17 NO 3 S 2 : C, 54.00; H, 5.50; N, 4.50. Found: C, 53.72; H, 5.82; N, 
4.38. 
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Chapter 3 - Promoter Free Allylation of Trichloroacetimidates with Allyltributylstannanes under 
Thermal Conditions to Access the Common 1,1’-Diarylbutyl pharmacophore 
Abstract 
The 1,1’-diarylbutyl group is a common structural motif found in many pharmaceutically active 
compounds. These systems are often accessed from diarylmethyl halides and an appropriate coupling 
partner. Usually a strong base, transition metal catalyst, Brønsted acid or Lewis acid promoter is required 
to affect the displacement of diarylmethyl leaving groups. However, simply heating diarylmethyl 
trichloroacetimidates with the allyltributylstannane gives easy access to these systems. Best results are 
observed with electron rich benzylic trichloroacetimidate systems, where excellent yields are achieved just 
by refluxing the reactants together in nitromethane. Mechanistic studies were also carried out suggesting 








The 1,1’-diarylbutyl group is a common structural motif in many biologically active small molecules.1 
Structures of this type, especially with two aryl groups at one end of the alkyl chain and a basic amine or 
heterocycle on the other end of the linker have found great application in medicinal chemistry studies. 
Molecules with this substructure have a wide range of pharmacological properties (Fig. 3.1), like naphthol 
3.12 as anticancer agent, pimozide 3.23 for treatment of psychoses, MPV-1489 3.34  an aromatase inhibitor, 
and histaprodifen 3.45 histamine-H1 receptor agonist. 
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Figure 3.1. Biologically active 1,1’-diarylbutane containing structures 
These systems are most commonly synthesized in two ways which are summarized in Fig. 3.2. A 
diarylmethyl group is often employed either as the nucleophile or as an electrophile in these reactions. 
These direct carbon–carbon bond forming reactions usually requires the use of either stoichiometric strong 
base (to completely deprotonate a diarylmethane, as in the case of nucleophilic substitution of halides (and 
pseudohalides) like 3.8 with anions (like 3.7) derived from diarylmethanes6) or the use of promoters to 
generate diarylmethyl electrophiles that can then be trapped by less reactive allylmetal reagents, usually 
allylsilanes.7  
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Similar carbon–carbon bond forming reactions have been explored with trichloroacetimidate leaving 
groups. For example, trichloroacetimidates have been utilized in Friedel–Crafts type alkylation reactions 
with Lewis acid promoters,8 and have shown good reactivity even with electron poor imidates.9 Recently 
the first displacement of an imidate with trimethylaluminum (alkylmetal reagent) was  also reported, but in 
most cases this also required a Lewis acid promoter to achieve good results.10 In this study the reaction of 
allyltributylstannanes, a stable carbon nucleophile with benzylic trichloroacetimidates is 
investigated(Scheme 3.1), and is shown to provide access to 1,1′-diarylbutyl groups under mild, promoter-
free reaction conditions. 
3.2 Results and Discussion 
3.2.1 Optimization of Reaction Conditions 
Scheme 3.1 Reaction of allyltributylstannane with diphenylmethylimidate 3.11a 















The study was initiated with allyltributylstannane as nucleophilic partner, since it is known to be an 
excellent allyl anion equivalent11 and even reacts with aldehydes under thermal conditions.12 In most other 
cases where trichloroacetimidates react under thermal conditions a protic nucleophile is used, but with the 
allylstannane no proton is present, so the imidate cannot get activated with an acidic proton from the 
nucleophile. Therefore, there may be different reactivity trends compared to the systems that have 
previously been studied. Additionally, it should be noted that the similar allyltrimethylsilane has been 
reported to displace some trichloroacetimidates previously,13,14 but these reactions are all promoted or 
catalyzed by a Lewis acid, typically BF 3 ·OEt 2  or TMSOTf.   
Evaluation of suitable conditions began with the reaction of diphenylmethyl trichloroacetimidate 3.11a and 
allyltributylstannane (Table 3.1). Imidate 3.11a was chosen since it cannot undergo competing elimination 
and was found to be highly reactive previously.15 Toluene was selected as the solvent  for its high boiling 
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point and compatibility in other imidate alkylations with alcohols(entry 1,2).15 Trace amounts of the 
allylation product 3.12a was obtained by heating imidate 3.11a and one equivalent of allyltributylstannane, 
with the unreacted material being the starting imidate 3.11a (entry 1).With two equivalents of 
allyltributyltin the yield of the reaction increased to ∼30% (entry 2).  
















Entry Solvent Conditions Yield 
1 toluene reflux, 24 h tracea,b 
2 toluene reflux, 16 h 31 
3 1,2-DCE reflux, 24 h 32b 
4 DCM rt, 24 h 0b 
5 CF 3 Ph reflux, 48 h traceb 
6 1,4-dioxane reflux, 48 h 32 
7 DMF 100 °C, 24 h 32 
8 MeCN reflux, 24 h 8 
9 MeNO 2 reflux, 16 h 71 
10 MeNO 2 reflux, 24 h 30a 
 
aOne equiv of allyltributyltin was used. bStarting material was also recovered from the reaction. No significant improvement in yield was 
observed with other nonpolar solvents like 1,2-DCE, DCM and α, α,α-trifluorotoluene. 
Polar solvents like DMF gave better results (entry 7, 9); the reaction was more rapid with the same yield 
being obtained in 24 h. Nitromethane was found to be the solvent of choice, providing a 71% yield of the 
addition product (entry 9). Nitromethane is known as an excellent solvent for the rearrangement of imidate 
3.11a to acetamide 3.13,22 and  improves the yield of ether formation when tert-butyl trichloroacetimidate 
is employed to synthesize tert-butyl amines.16 The high dielectric constant of nitromethane combined with 
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the relatively weak Lewis basicity of the nitro group, makes it an excellent solvent for stabilizing polar 
intermediates.23 
3.2.2 Substrate Scope 
The substitution reaction was then evaluated with different diarylmethyl trichloroacetimidate reaction 
partners (Table 3. 2). Most of the simple electron rich trichloroacetimidates (Table 3.2, entries 1–4) gave 
good yield of the allylated product. However, electron withdrawing substituents like a halogen were 
detrimental to the transformation (entries 5–7). Strong electron withdrawing groups like a nitro group 
completely stopped the transformation, providing only starting material (entry 8).  The substitution of one 
of the phenyl groups with a benzothiophene (entry 9) was also successful, although the yield was more 
moderate.  
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Entry          Imidate                           Product  Yield 
1             
 

























aReaction was performed for 36 h bSome starting material was recovered. 
 
 
Next, a number of less complex imidates were evaluated for their reactivity under similar thermal 
displacement conditions (Table 3.3). Replacement of one of the aryl groups with an alkyl group was 
detrimental to the transformation (entries 1 and 2). As trichloroacetimidates with electron withdrawing 






































































donating groups were evaluated. As per our expectation, benzylic trichloroacetimidates with methoxy 
groups (entries 3 and 4) gave significantly higher yields than benzylic trichloroacetimidates functionalized 
with methyl groups (entries 5 and 6). 4-Chlorobenzyl trichloroacetimidate and benzyl trichloroacetimidate 
only showed starting material or trace amounts of addition product (entries 7 and 8). 































































































3.2.3 Reaction with Other Allylstannanes 
The thermal displacement reaction with other allylstannanes and an allylsilane were also studied (Scheme 
3.1).  Reaction of prenyltributylstannane 3.14 and methallyltributylstannane 3.16 provided moderate yields 
of the allylated products. However, similar transformations with allyltrimethylsilane or 
vinyltributylstannane proved futile and under no conditions were these nucleophiles able to displace the 
imidate without the addition of a Lewis or Brønsted acid promoter. Reaction conditions like higher 
temperatures (MeNO 2 , 100 °C, sealed tube) and using 5 equiv. nucleophile (MeNO2 , reflux) of nucleophile 
were similarly unsuccessful. Both allylsilanes and vinylmetal reagents have been reported to be 
significantly less reactive in general which explains the lack of reactivity in this system. 



















3.19 3.20  
Scheme 3.2. Reactivity of substituted allyl stannanes and other nucleophiles 
3.3 Mechanistic studies 
Two mechanisms were proposed for allylation of trichloroacetimidates with allyltributylstannane: an ionic 
pathway and a radical pathway (Scheme 3.2). The trends observed in the substrate scope suggest that the 
ionic pathway was operative where the reaction proceeds through the ion pair A and B, with the presence 
of electron withdrawing groups significantly reducing the yield of the transformation. However, the 
possibility of radical pathway cannot be neglected in the case of allyltributylstannane with a stabilized 
diphenyl methyl radical D. To test for the possibility of a radical intermediate the radical scavenger TEMPO 
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was added to the reaction.  The addition of 1 equiv. of TEMPO to the reaction of 3.11a lowered the yield 
of 3.12a to 30% but did not completely stop the transformation. This observation suggests that both the 
radical and the cationic pathways may be operative in these systems with the imidate substrate influencing 
which pathway is dominant. 
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Scheme 3.3. Proposed mechanistic pathways 
3.4. Conclusions 
The first promoter free displacement of a trichloroacetimidate with the stable allylmetal reagent 
allyltributylstannane has been reported in this study. The reaction provides a milder alternative to other 
methods involving strong acids or strong base to form the C–C bond. Diarylmethyl trichloroacetimidates 
gave the best results, however electron rich benzylic trichloroacetimidates also provide moderate amounts 
of product. This transformation provides ready access to 1,1′-diarylbutyl structures, which are a common 




General Procedure for Trichloroacetimidate Synthesis from an alcohol. A flame dried 25 mL round 
bottom flask was charged with the alcohol starting material (1 equiv) under argon. Dry DCM was then 
added to form a 0.5 M solution, and the flask was cooled to 0°C. 1,8-diazabicyclo [5.4.0] undec-7-ene (0.2 
equiv) was added to the solution, followed by trichloroacetonitrile (1.5 equiv). The reaction was monitored 
by TLC. After no alcohol starting material was observed, the reaction mixture was concentrated in vacuo. 
Purification by silica gel column chromatography was performed using the listed solvent system to provide 
the desired trichloroacetimidate. Trichloroacetimidates 3.11b, 3.11c, 3.11e, 3.11f, 3.11g, 3.11i, 3.11j, 
3.11k, 3.11l, and 3.11o were prepared by the general procedure. Trichloroacetimidates 3.11a,17 3.11d,18 








(2‐Methylphenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (3.11b). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Clear oil (2.38 g, 92%); TLC R f = 
0.59 (10% ethyl acetate/ 90% hexanes); IR (CH 2 Cl 2) 3339, 3053, 3032, 2983, 1664, 1286, 1265, 1075, 
913, 741 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.39 (brs, 1H), 7.46-7.43 (m, 1H), 7.38-7.28 (m, 5H), 7.24-
7.16 (m, 3H), 7.12 (s, 1H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl 3 ) δ 161.3, 138.9, 137.5, 136.2, 130.5, 
128.4, 128.1, 128.0, 127.3, 127.2, 126.1, 91.6, 79.0, 19.4. Anal. calcd for C 16 H 14 Cl 3 NO: C, 56.09; H, 4.12; 








[1,1'‐Biphenyl] ‐4‐yl] (phenyl)methyl 2,2,2-trichloroacetimidate (3.11c). Purified by silica gel 
chromatography (1% triethylamine/ 99% hexanes); White solid (0.35 g, 75%); IR (CH 2 Cl 2 ) 3339, 3052, 
1664, 1493, 1265, 1075, 984, 798, 739, 703 cm–1; 1H NMR (300 MHz, CDCl 3 ) δ 8.42 (brs, 1H), 7.58-7.29 
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(m, 14H), 6.97 (s, 1H); 13C NMR (100 MHz, CDCl 3 ) δ 161.4, 141.0, 140.7, 139.8, 138.8, 128.9, 128.6, 
128.2, 127.5, 127.4, 127.2, 127.0, 91.7, 81.3 (one aromatic resonance was unresolved). Anal. calcd for 








(3-Fluorophenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (3.11e). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Yellow oil (1.28 g, 90%); TLC R f  = 
0.52 (10% ethyl acetate/ 90% hexanes); IR (CH 2 Cl 2 ) 3054, 1666, 1076, 999 cm-1; 1H NMR (300 MHz, 
CDCl 3 ) δ 8.42 (brs, 1H), 7.42-7.30 (m, 7H), 7.03 (tt, J = 9.8 Hz, 2.9, 2H), 6.93 (s, 1H); 13C NMR (75 MHz, 
CDCl 3 ) δ 162.4 (d, J = 245.2 Hz), 161.3, 160.8, 139.64, 135.60, 128.9 (d, J = 8.2 Hz), 128.6, 128.1, 126.8, 
115.5 (d, J = 21.8 Hz), 91.5, 80.7. Anal. Calcd for C 15 H 11 Cl 3 FNO: C, 51.98; H, 3.20; N, 4.04. Found: C, 








(3-Chlorophenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (3.11f). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Viscous oil (1.23 g, 78%); TLC R f  = 
0.65 (10% ethyl acetate/ 90% hexanes); IR (CH2 Cl 2 ) 3341, 1664, 1354, 1266, 1007, 791, 720, 701 cm–1; 
1H NMR (400 MHz, CDCl 3 ) δ 8.44 (brs, 1H), 7.41 (d, J = 8.9 Hz, 3H), 7.37-7.21 (m, 6H), 6.90 (s, 1H); 
13C NMR (100 MHz, CDCl 3 ) δ 161.2, 141.9, 139.1, 134.5, 129.9, 128.7, 128.4, 128.3, 127.1, 127.0, 125.1, 






(4‐Bromophenyl) (phenyl)methyl 2,2,2‐trichloroacetimidate (3.11g). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); White solid (2.08 g, 90%); TLC R f  
 65 
= 0.59 (10% ethyl acetate/ 90% hexanes); IR (CH 2 Cl 2 ) 3054, 2986, 2305, 1667, 1487, 1421, 1265, 705 
cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.43 (brs, 1H), 7.48 (d, J = 8.5 Hz, 2H), 7.34-7.29 (m, 7H), 6.89 (s, 
1H); 13C NMR (100 MHz, CDCl 3 ) δ 161.2, 139.2, 138.8, 131.7, 128.7, 128.6, 128.3, 126.9, 122.1, 91.4, 








(1-Benzothiophen-3-yl) (phenyl)methyl 2,2,2-trichloroacetimidate (3.11i). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Viscous oil (0.34 g, 61%); IR 
(CH 2 Cl 2 ) 3335, 1664, 1264, 702 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.49 (brs, 1H), 7.86-7.84 (m, 1H), 
7.78-7.75 (m, 1H), 7.52 (d, J = 7.0 Hz, 1H), 7.40-7.32 (m, 7H), 7.25 (s, 1H); 13C NMR (100 MHz, CDCl 3 ) 
δ 161.4, 140.7, 138.2, 137.3, 134.5, 128.6, 128.5, 127.3, 125.9, 124.7, 124.3, 122.9, 122.7, 91.6, 77.2. Anal. 







1‐(1,1'‐Biphenyl] ‐4‐yl)ethyl 2,2,2-trichloroacetimidate (3.11j). Purified by silica gel chromatography 
(5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Off white solid (1.06 g, 81%); IR (CH 2 Cl 2 ) 3333, 
1661, 1661, 798, 765, 702 cm–1; 1H NMR (400 MHz, CDCl 3 ) δ 8.33 (brs, 1H), 7.60-7.57 (m, 4H), 7.49 (d, 
J = 8.2 Hz, 2H), 7.43 (t, J = 7.3 Hz, 2H), 7.36-7.32 (m, 1H), 6.03 (q, J = 6.5 Hz, 1H), 1.69 (d, J = 6.6 Hz, 
3H); 13C NMR (75 MHz, CDCl 3 ) δ 161.7, 140.9, 140.8, 140.4, 128.8, 127.4, 127.3, 127.1, 126.3, 91.8, 







1‐(1,1'‐Biphenyl] ‐4‐yl)‐2‐methylpropyl 2,2,2-trichloroacetimidate (3.11k). Purified by silica gel 
chromatography (10% ethyl acetate/ 1% triethylamine/ 89% hexanes); White solid (2.00 g, 66%), TLC R f  
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= 0.42 (10% ethyl acetate/ 90% hexanes); IR (DCM) 3339, 2967, 1661, 1487, 1300, 1058, 990 cm-1; 1H 
NMR (400 MHz, CDCl 3 ) δ 8.16 (s,1H), 7.53-7.49 (m, 4H), 7.37-7.34 (m, 4H ), 7.28-7.26 (m, 1H), 5.52 (d, 
J = 7.1 Hz, 1H), 2.16 (octet, J = 6.8 Hz, 1H), 1.02 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H); 13C NMR 
(100 MHz, CDCl 3 ) δ 161.8, 140.8, 140.7, 138.2, 128.8, 127.4, 127.3, 127.2, 126.9, 92.0, 85.6, 34.4, 19.0, 








3,4-Dimethoxybenzyl 2,2,2-trichloroacetimidate (3.11l). Yellow oil (3.00 g, 90%); TLC R f  = 0.28 (20% 
ethyl acetate/ 80% hexanes); Purified by silica gel chromatography (30% ethyl acetate/ 1% triethylamine/ 
69% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 8.38 (brs, 1H), 7.01-6.98 (m, 2H), 6.87 (d, J = 8.1 Hz, 1H), 
5.29 (s, 2H), 3.89 (s, 6H); 13C NMR (100 MHz, CDCl 3 ) δ 162.4, 149.1, 149.0, 127.9, 120.8, 111.3, 111.0, 
91.5, 70.8, 55.85, 55.83. Anal. Calcd for C 11 H 12 Cl 3 NO 3 : C, 42.27; H, 3.87; N, 4.48. Found: C, 42.39; H, 








(2,4,6‐Trimethylphenyl) methyl 2,2,2‐trichloroacetimidate (3.11o). Purified by silica gel 
chromatography (5% ethyl acetate/ 1% triethylamine/ 94% hexanes); Viscous oil (1.23 g, 78%); TLC R f  = 
0.65 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 8.35 (brs, 1H), 6.90 (s, 2H), 5.33 
(s, 2H), 2.39 (s, 6H), 2.29 (s, 3H); 13C NMR (100 MHz, CDCl 3 ) δ 163.1, 138.7, 138.6, 129.0, 128.6, 91.6, 
66.2, 21.1, 19.5. Anal. Calcd for C 12 H 14 Cl 3 NO: C, 48.92; H, 4.79; N, 4.75. Found: C, 49.29; H, 4.47; N, 
4.93 
General procedure for the allylation of benzylic trichloroacetimidates with allyltributylstannane. The 
trichloroacetimidate (1 eq) was dissolved in dry MeNO 2  (0.25 M) under argon in a flame dried round 
bottom flask. Allyltributylstannane (2 eq) was added to this flask and the mixture was heated to reflux. The 
reaction was monitored by TLC. After the imidate was consumed, the solution was allowed to cool to rt 
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and a KF solution (aq., 0.1M) was added. The mixture was poured into water extracted with ethyl acetate. 
The combined organic extracts were then dried with Na 2 SO 4, filtered, and concentrated. Purification by 




(1‐Phenylbut‐3‐en‐1‐yl)benzene (3.12a).24 Purified by silica gel chromatography (1% ethyl acetate/ 99% 
hexanes); Clear oil (0.127 g, 71%); TLC R f = 0.59 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 MHz, 
CDCl 3 ) δ 7.31- 7.24 (m, 8H ), 7.20-7.16 (m, 2H ), 5.79-5.68 (m, 1H), 5.04 (dd, J = 17.2, 1.7 Hz, 1H ), 4.96 
(dt, J = 10.1, 1.0 Hz, 1H), 4.02 (t, J = 7.9 Hz, 1H), 2.85-2.82 (m, 2H). 13C NMR (100 MHz, CDCl 3 ) δ 




1‐Methyl‐2‐(1‐phenylbut‐3‐en‐1‐yl)benzene (3.12b).25 Purified by silica gel chromatography (100% 
hexanes); Clear oil (0.05 g, 77%); TLC R f  = 0.83 (10% ethyl acetate/ 90% hexanes); 1H NMR (300 MHz, 
CDCl 3 ) δ 7.33-7.10 (m, 9H), 5.81-5.68 (m, 1H), 5.06-4.93 (m, 2H), 4.19 (t, J = 7.7 Hz, 2H), 2.78 (t, J = 
7.7 Hz, 1H), 2.25 (s, 3H); 13C NMR (75 MHz, CDCl 3 ) δ 144.1, 142.2, 137.0, 136.3, 130.5, 128.3, 126.9, 





4‐(1‐Phenylbut‐3‐en‐1‐yl)‐1,1'‐biphenyl (3.12c). Purified by silica gel chromatography (0.5% ethyl 
acetate/ 99.5% hexanes); Clear oil (0.05 g, 71%); TLC R f = 0.68 (10% ethyl acetate/ 90% hexanes); 1H 
NMR (400 MHz, CDCl 3 ) δ 7.47 (d, J = 7.6 Hz, 2H), 7.42 (d, J =  8.0 Hz, 2H), 7.32 (t, J = 7.4 Hz, 2H), 
7.24-7.20 (m, 7H), 7.12-7.09 (m, 1H), 5.72-5.62 (m, 1H), 4.98 (d, J = 17.1 Hz, 1H), 4.89 (d, J = 10.2 Hz, 
1H), 3.97 (t, J = 7.8 Hz, 1H), 2.77 (t, J = 7.2 Hz, 2H); 13C NMR (100 MHz, CDCl 3 ) δ 143.4, 142.6, 139.9, 
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138.0, 135.7, 127.7, 127.4, 127.3, 126.9, 126.1, 126.02, 126.00, 125.2, 115.3, 49.9, 38.9. Anal. Calcd for 




2-(1-Phenylbut-3-en-1-yl)naphthalene (3.12d).26 Purified by silica gel chromatography (1% ethyl 
acetate/99% hexanes); clear oil (0.08 g, 78%); TLC R f  = 0.72 (10% ethyl acetate/ 90% hexanes); 1H NMR 
(400 MHz, CDCl 3 ) δ 7.78 (t, J = 7.1 Hz, 2H), 7.74 (d, J = 8.6 Hz, 1H), 7.70 (s, 1H), 7.43 (dd, J = 6.8, 1.44 
Hz, 2H), 7.33 (dd, J = 8.5, 1.6 Hz, 1H), 7.28 (d, J = 4.3 Hz, 4H), 7.18 (sextet, J = 4.1 Hz, 1H), 5.81- 5.71 
(m, 1H), 5.06 (dd, J = 17.1, 1.5 Hz, 1H), 4.95 (dd, J = 10.2, 0.6 Hz, 1H), 4.17 (t, J = 7.84 Hz, 1H), 2.98-
2.86 (m, 2H); 13C NMR (100 MHz, CDCl 3 ) δ 144.4, 141.9, 136.8, 133.5, 132.2, 128.4, 128.1, 127.8, 127.6, 





1‐Fluoro‐4‐(1‐phenylbut‐3‐en‐1‐yl)benzene (3.12e).27 Purified by silica gel chromatography (100% 
hexanes); clear oil (0.035 g, 36%); TLC R f  = 0.77 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 MHz, 
CDCl 3 ) δ 7.30- 7.16 (m, 7H), 6.96 (t, J = 8.7 Hz, 2H), 5.75-5.64 (m, 1H), 5.02 (dd, J = 17.1, 1.7 Hz, 1H), 
4.96 (d, J = 10.2 Hz, 1H), 3.99 (t, J = 7.9 Hz, 1H); 2.81-2.76 (m, 2H); 13C NMR (100 MHz, CDCl 3 ) δ 162.6 
(d, J = 243.0 Hz), 144.4, 140.2, 136.6, 129.3 (d, J = 8.1 Hz), 128.5, 127.8, 126.3, 116.5, 115.1 (d, J = 21.0 





1‐Chloro‐3‐(1‐phenylbut‐3‐en‐1‐yl) benzene (3.12f). Purified by silica gel chromatography (0.5% ethyl 
acetate/ 99.5% hexanes); Clear oil (0.035 g, 52%); TLC R f  = 0.74 (10% ethyl acetate/ 90% hexanes); 1H 
NMR (300 MHz, CDCl 3 ) δ 7.32-7.09 (m, 9H), 5.76-5.62 (m, 1H), 5.03 (dq, J = 17.1, 1.5 Hz, 1H), 4.98-
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4.93 (m, 1H), 3.98 (t, J = 7.9 Hz, 1H), 2.79 (t, J = 7.0 Hz, 2H); 13C NMR (75 MHz, CDCl 3 ) δ 146.6, 143.7, 
136.3, 134.2, 129.7, 128.6, 128.1, 127.9, 126.5, 126.4, 126.2, 116.7, 51.0, 39.7. Anal. Calcd for C 16 H 15 Cl: 





1-Bromo-4-(1-phenylbut-3-en-1-yl)benzene (3.12g)27 Purified by silica gel chromatography (0.5% ethyl 
acetate/ 99.5% hexanes); clear oil (0.045 g, 64%); TLC R f  = 0.82 (10% ethyl acetate/ 90% hexanes); 1H 
NMR (400 MHz, CDCl 3 ) δ 7.39 (d, J = 8.4 Hz, 2H), 7.30-7.25 (m, 2H), 7.19 (d, J =  7.4, Hz, 3H), 7.10 (d, 
J = 8.3 Hz, 2H), 5.74-5.64 (m, 1H), 5.02 (dd, J = 17.1, 1.6 Hz, 1H), 4.96 (dd, J = 10.2, 0.7 Hz, 1H), 3.97 
(t, J = 7.9 Hz, 1H), 2.84-2.72 (m, 2H); 13C NMR (75 MHz, CDCl 3 ) δ 143.9, 143.5, 136.4, 131.5, 129.8, 





3‐(1‐Phenylbut‐3‐en‐1‐yl) ‐1‐benzothiophene (3.12i). Purified by silica gel chromatography (1% ethyl 
acetate/ 99% hexanes); Clear oil (0.030 g, 42%); TLC R f  = 0.41 (10% ethyl acetate/ 90% hexanes); 1H 
NMR (400 MHz, CDCl 3 ) δ 7.83-7.81 (m, 1H), 7.62- 60 (m, 1H), 7.29-7.26 (m, 7H), 7.21-7.15 (m, 1H), 
5.85 (m, 1H), 5.07 (dd, J = 17.1, 1.6 Hz, 1H), 4.99 (d, J = 10.2 Hz, 1H), 4.36 (t, J = 7.6 Hz, 1H), 3.00- 2.93 
(m, 1H), 2.88-2.78 (m, 1H). 13C NMR (100 MHz, CDCl 3 ) δ 143.2, 140.5, 138.8, 138.7, 136.6, 128.5, 128.0, 
126.5, 124.2, 123.9, 122.8, 122.3, 121.8, 116.6, 45.4, 40.4. Anal. Calcd for C 18H 16 S: C, 81.77; H, 6.10. 




 4‐(Pent‐4‐en‐2‐yl)‐1,1'‐biphenyl (3.12j).28 Purified by silica gel chromatography (1% ethyl acetate/ 99% 
hexanes); clear oil (0.020 g, 31%); TLC R f  = 0.52 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 7.58 (d, 
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J = 7.1 Hz, 2H), 7.53 (d, J = 8.3 Hz, 2H), 7.42 (t, J = 7.3 Hz, 2H), 7.34-7.23 (m, 3H), 5.80-5.70 (m, 1H), 
5.04-4.96 (m, 2H), 2.84 (sextet, J = 7.0 Hz, 1H ), 2.46-2.39 (m, 1H), 2.35-2.28 (m, 1H), 1.28 (d, J = 7.0 
Hz, 3H); 13C NMR (75 MHz, CDCl 3 ) δ 166.1, 146.2, 141.1, 138.9, 137.1, 128.7, 127.4, 127.1, 127.0, 116.0, 





4‐(But‐3‐en‐1‐yl)‐1,2‐dimethoxybenzene (11l).29 Purified by silica gel chromatography (5% ethyl acetate/ 
95% hexanes); Clear oil (0.045 g, 61%); TLC R f  = 0.41 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 
MHz, CDCl 3 ) δ 6.80 (d, J = 8.4 Hz, 1H), 6.73 (d, J = 7.2 Hz, 2H), 5.91-5.81 (m, 1H), 5.05 (dd, J = 17.1, 
1.6 Hz, 1H), 4.98 (dd, J = 10.2, 0.6 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 2.66 (t, J = 7.4 Hz, 2H), 2.36 (q, J 
= 6.8 Hz, 2H); 13C NMR (75 MHz, CDCl 3 ) δ 148.8, 147.2, 138.2, 134.6, 120.2, 114.9, 111.8, 111.2, 55.9, 




1‐(But‐3‐en‐1‐yl)‐4‐methoxybenzene (3.12m).26 Purified by silica gel chromatography (2% ethyl acetate/ 
98% hexanes); Clear oil (0.050 g, 43%); TLC R f = 0.72 (10% ethyl acetate/ 90% hexanes); 1H NMR (400 
MHz, CDCl 3 ) δ 7.02 (d, J = 8.3 Hz, 2H), 6.75 (d, J = 8.5 Hz , 2H), 5.82-5.73 (m, 1H), 4.95 (d, J = 17.1 Hz, 
1H), 4.89 (d, J = 10.2 Hz, 1H), 3.70 (s, 3H), 2.57 (t, J = 7.4 Hz, 2H), 2.26 (d, J = 6.7 Hz, 2H). 13C NMR 





2‐(But‐3‐en‐1‐yl)‐1,3,5‐trimethylbenzene (3.12o).30 (C.-L. Sun, H. Krause and A. Fürstner, Adv. Synth. 
Catal., 2014, 356, 1281.)Purified by silica gel chromatography (100% pentane); Clear oil (0.015 g, 13%); 
TLC R f  = 0.38 (100% hexanes); 1H NMR (400 MHz, CDCl 3 ) δ 6.83 (brs, 2H), 5.98-5.88 (m, 1H), 5.08 
 71 
(dd, J = 17.1, 1.6 Hz, 1H), 4.99 (d, J = 10.2 Hz, 1H), 2.69-2.65 (m, 2H), 2.29 (s, 9H), 2.20-2.18 (m, 2H); 
13C NMR (100 MHz, CDCl 3 ) δ 138.6, 136.0, 135.6, 135.0, 128.9, 114.5, 33.3, 28.9, 20.8, 19.7. 
MeO
MeO 3.15  
4‐(2,2‐Dimethylbut‐3‐en‐1‐yl)‐1,2‐dimethoxybenzene (3.15). Purified by silica gel chromatography (2% 
ethyl acetate/ 98% hexanes); Clear oil (0.036 g, 50%); TLC R f  = 0.61 (10% ethyl acetate/ 90% hexanes); 
1H NMR (400 MHz, CDCl 3) δ 6.70-6.57 (m, 3H), 5.78 (dd, J = 17.5, 10.8 Hz, 1H), 4.85-4.76 (m, 2H), 3.78 
(s, 6H), 2.45 (s, 2H), 0.92 (s, 6H); 13C NMR (100 MHz, CDCl 3 ) δ 148.3, 148.0, 147.3, 131.5, 122.6, 114.1, 
110.5 (2C), 55.8, 48.7, 37.7, 26.5. Anal. Calcd for C 14H 20 O 2 : C, 76.33; H, 9.15. Found: C, 75.93; H, 9.19. 
MeO
MeO 3.17  
1,2‐Dimethoxy‐4‐(3‐methylbut‐3‐en‐1‐yl)benzene (3.17). Purified by silica gel chromatography (2% 
ethyl acetate/ 98% hexanes); Clear oil (0.035 g, 45%); TLC R f  = 0.61 (10% ethyl acetate/ 90% hexanes); 
1H NMR (400 MHz, CDCl 3 ) δ 6.79-6.73 (m, 3H), 4.73 (s, 1H), 4.71 (s, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 
2.69 (t, J = 7.6 Hz, 2H), 2.29 (t, J = 7.6 Hz, 2H), 1.76 (s, 3H); 13C NMR (100 MHz, CDCl 3 ) δ 148.8, 147.2, 
145.4, 134.9, 120.1, 111.7, 111.2, 110.2, 55.9, 55.8, 39.8, 33.9, 22.6. Anal. Calcd for C 13 H 18 O 2 : C, 75.69; 











1. E. Teodori, E. Baldi, S. Dei, F. Gualtieri, M. N. Romanelli, S. Scapecchi, C. Bellucci, C. Ghelardini and 
R. Matucci. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine 
derivatives as N-type calcium channel blockers active on pain and neuropathic pain. J. Med. Chem., 2004, 
47, 6070. 
2. B. Das, C. R. Reddy, J. Kashanna, S. K. Mamidyala and C. G. Kumar.Multicomponent one-pot synthesis 
of 2-napthol derivatives and evaluation of their anticancer activity.Med. Chem. Res., 2012, 21, 3321. 
3. R. Smyj, X.-P. Wang and F. Han, Profiles Drug Subst., Excipients, Relat. Methodol., 2012, 37, 287 
4. A. Karjalainen, A. Kalapudas, M. Sodervall, O. Pelkonen and R. Lammintausta. Synthesis of new potent 
and selective aromatase inhibitors based on long-chained diarylalkylimidazole and diarylalkyltriazole 
molecule skeletons. Eur. J. Pharm. Sci., 2000, 11, 109. 
5. S. Elz, K. Kramer, H. H. Pertz, H. Detert, A. M. Ter Laak, R. Kuehne and W. Schunack. Histaprodifens: 
synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and 
selective histamine H (1)-receptor agonists. J. Med. Chem., 2000, 43, 1071. 
6. H. Sharma, S. Santra, J. Debnath, T. Antonio, M. Reith and A. Dutta. Flexible and biomimetic analogs 
of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl) amino) methyl) phenol: 
Synthesis, biological characterization, and development of a pharmacophore model. Bioorg. Med. Chem., 
2014, 22, 311. 
7. J. A. Cella. Reductive alkylation/arylation of arylcarbinols and ketones with organosilicon compounds. 
J. Org. Chem., 1982, 47, 2125; (b) G. Kaur, M. Kaushik and S. Trehan.  Bis (fluorosulfuryl) imide: A 
Brønsted acid catalyst for the coupling of allylic and benzylic alcohols with allyltrimethylsilane. 
Tetrahedron Lett., 1997, 38, 2521. 
 73 
8. (a) R. R. Schmidt and M. Hoffmann, C-glycosides from O-glycosyl trichloroacetimidates. Tetrahedron 
Lett., 1982, 23, 409; (b) J.-A. Mahling and R. R. Schmidt, Aryl C-glycosides from O-
glycosyltrichloroacetimidates and phenol derivatives with trimethylsilyl trifluoromethanesulfonate 
(TMSOTf) as the catalyst. Synthesis, 1993, 1993, 325. 
9. A. A. Adhikari, L. Radal and J. D. Chisholm. Synthesis of 3,3′-Disubstituted Indolenines Utilizing the 
Lewis Acid Catalyzed Alkylation of 2,3-Disubstituted Indoles with Trichloroacetimidates.  Synlett, 2017, 
2335. 
10. N. S. Mahajani and J. D. Chisholm. Synthesis of 1, 1′-Diarylethanes and Related Systems by 
Displacement of Trichloroacetimidates with Trimethylaluminum. J. Org. Chem., 2018, 83, 4131. 
11. J. Burfeindt, M. Patz, M. Mueller and H. Mayr. Determination of the Nucleophilicities of Silyl and 
Alkyl Enol Ethers. J. Am. Chem. Soc., 1998, 120, 3629 
12. C. Servens and M. Pereyre. Stereochemistry of the addition of allylic organostannanes to aldehydes. J. 
Organomet. Chem., 1972, 35, C20. 
13. I. A. I. Ali, E. S. H. El Ashry and R. R. Schmidt.  Imidomethylation of C-nucleophiles using O-
phthalimidomethyl trichloroacetimidate and catalytic amounts of TMSOTf. Tetrahedron, 2004, 60, 4773. 
14. 1 M. G. Hoffmann and R. R. Schmidt, Liebigs. O ‐ glycosylimidates, 19. Reactions of glycosyl 
trichloroacetimidates with silylated C nucleophiles. Ann. Chem., 1985, 2403 
15. K. T. Howard, B. C. Duffy, M. R. Linaburg and J. D. Chisholm. Formation of DPM ethers using O-
diphenylmethyl trichloroacetimidate under thermal conditions.  Org. Biomol. Chem.,2016, 14, 1623. 
16. J. W. Cran, D. V. Vidhani and M. E. Krafft. Copper-Catalyzed N-tert-Butylation of Aromatic Amines 
under Mild Conditions Using tert-Butyl 2,2,2-Trichloroacetimidate. Synlett, 2014, 1550. 
17. I. A. I. Ali, E. S. H. El Ashry and R. R. Schmidt.  Protection of hydroxy groups with diphenylmethyl 
and 9-fluorenyl trichloroacetimidates - effect on anomeric stereocontrol.  Eur. J. Org. Chem., 2003, 4121. 
 74 
18. Q. Zhang, J. C. Mixdorft, G. J. Reynders and H. M. Nguyen.  Rhodium-catalyzed benzylic fluorination 
of trichloroacetimidates. Tetrahedron, 2015, 71, 5932. 
19. A. A. Adhikari, T. Suzuki, R. T. Gilbert, M. R. Linaburg and J. D. Chisholm. Rearrangement of 
Benzylic Trichloroacetimidates to Benzylic Trichloroacetamides. J. Org. Chem., 2017, 82, 3982. 
20. H. Tokuyama, K. Okano, H. Fujiwara, T. Noji and T. Fukuyama. Total synthesis of dictyodendrins A-
E. Chem. Asian J., 2011, 6, 560. 
21.  A. A. Adhikari, L. Radal and J. D. Chisholm. Synthesis of 3,3′-Disubstituted Indolenines Utilizing the 
Lewis Acid Catalyzed Alkylation of 2,3-Disubstituted Indoles with Trichloroacetimidates.  Synlett, 2017, 
2335. 
22. H.-P. Wessel, T. Iversen and D. R. Bundle. Acid-catalysed benzylation and allylation by alkyl 
trichloroacetimidates. J. Chem. Soc. Pekin 1, 1985, 2247. 
23. C. K. Li, W. B. Li and J. B. Wang.  Gold (I)-catalyzed arylmethylation of terminal alkynes. Tetrahedron 
Lett., 2009, 50, 2533. 
24. Y.-L. Lai and J.-M. Huang. Palladium-catalyzed electrochemical allylic alkylation between alkyl and 
allylic halides in aqueous solution. Org. Lett., 2017, 19, 2022. 
25. S. K. De and R. A. Gibbs, Bismuth (III) chloride-catalyzed direct deoxygenative allylation of substituted 
benzylic alcohols with allyltrimethylsilane. Tetrahedron Lett., 2005, 46, 8345. 
26. T. Lebleu and J.-F. Paquin.  Direct allylation of benzyl alcohols, diarylmethanols, and triarylmethanols 
mediated by XtalFluor-E. Tetrahedron Lett., 2017, 58, 442. 
27. S.-C. Sha, H. Jiang, J. Mao, A. Bellomo, S. A. Jeong and P. J. Walsh, Nickel-Catalyzed Allylic 
Alkylation with Diarylmethane Pronucleophiles: Reaction Development and Mechanistic Insights. Angew. 
Chem., Int. Ed., 2016, 55, 1070. 
28. Y.-M. Wang and S. L. Buchwald.  Enantioselective CuH-catalyzed hydroallylation of vinylarenes. J. 
Am. Chem. Soc., 2016, 138, 5024. 
 75 
29. I. Solic, P. Seankongsuk, J. K. Loh, T. Vilaivan and R. W. Bates. Scandium as a pre-catalyst for the 
deoxygenative allylation of benzylic alcohols. Org. Biomol. Chem., 2018, 16, 119. 
30. C.-L. Sun, H. Krause and A. Fürstner. A Practical Procedure for Iron‐Catalyzed Cross‐Coupling 
Reactions of Sterically Hindered Aryl‐Grignard Reagents with Primary Alkyl Halides. Adv. Synth. Catal. 

























Chapter 4. Ester Formation via Symbiotic Activation Utilizing Trichloroacetimidate Electrophiles 
ABSTRACT 
Trichloroacetimidates are used for ester synthesis under mild conditions with no addition of an exogenous 
promoter. Absence of promoter avoids the undesired decomposition of substrates with sensitive functional 
groups that are often observed with the use of strong Lewis or Brønsted acids. These conditions even 
performed well for simple benzylic imidates, providing benzyl esters by simply refluxing the imidate with 
an unprotected carboxylic acid. These simple and inexpensive methods will be useful in the esterification 















Esterification is an important reaction in organic chemistry, and therefore large efforts have been taken to 
develop this chemistry. Three main approaches to carry out these transformations are1 (Figure 4.1): (1) 
carbonyl activation (where an alcohol is added to an activated carboxylate), (2) carboxylate alkylation 
(where the carboxylic acid is deprotonated to improve nucleophilicity and added to an electrophile), and 
(3) symbiotic activation, where reagents combine to form a reactive ion pair that leads to the ester. 
Compared to the first two methods,2,3 symbiotic activation avoids the use of strong acids and bases that 
often characterize the other two methods, making these transformations more amenable for use in complex 
polyfunctional molecules These processes avoid the use of strong acids and bases that often characterize 
the other two methods, making these transformations more amenable for use in complex polyfunctional 
molecules that are often prepared in natural product synthesis and pharmaceutical environments. 































4.2. RESULTS AND DISCUSSION 
4.2.1. Esterification with different trichloroacetimidates 
At first, esterifications with different trichloroacetimidates were explored to determine which imidates 
would successfully participate in the esterification process. Benzoic acid was used as the common substrate 
(Table 4.1). No reaction was observed with simple alkyl trichloroacetimidates at room temperature or in 
refluxing toluene (unreacted starting materials were recovered, entries 1−3, Table 4.1). However, the tert-
butyl trichloroacetimidate 4.5 (entry 4, Table 4.1) was an exception. A higher yield in esterification with 
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4.5 and benzoic acid at room temperature was observed as opposed to refluxing toluene. This may be due 
to the tendency of imidate 4.5 to undergo elimination at elevated temperatures, decomposing to isobutylene 
and trichloroacetamide. Prenyl trichloroacetimidate 4.7 gave 73% yield of product at room temperature 
(entry 6, Table 4.1). Although, most of the product was the prenyl ester 4.7a, a trace amount of the tert-
prenyl isomer was detected in the crude 1H NMR. Allyl imidate 4.6 and propargyl trichloroacetimidate 4.8 
were unreactive (with only starting materials being observed). This is consistent with a carbocation 
intermediate, as the prenyl carbocation is more stable than the allyl or propargyl cation.  
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 MeOBz 4.2a 0 (48 h) 0 (18 h) 
2 O CCl3
NH 4.3
 EtOBz 4.3a 0 (48 h) 0 (18 h) 




 0 (48 h) 0 (18 h) 









OBz4.6a  - 0 (48 h) 
6 O CCl3
NH 4.7
 OBz4.7a  





4.8a  - 0 (48 h) 
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MeO 4.13a  
















O2N 4.15a  






4.16a  34 (22 h) 96 (18 h) 





34 (48 h) 95 (23 h) 















 Next, the formation of benzyl esters was studied in detail as it is one of the most common 
carboxylate protecting groups.4 Benzyl trichloroacetimidate 4.9 gave a useful 76% yield of product only 
after heated in toluene. Addition of electron donating groups to the benzene ring led to increased yields of 
the esterification, as seen with 2,4,6-trimethylbenzyl imidate 4.10 and 2-methoxybenzyl 
trichloroacetimidate 4.11. However, for imidate 4.12, 4.13 and 4.14 (Table 4.1, entries 11−13) excellent 
conversion was observed in DCM at room temperature. Moreover, with the dimethoxybenzyl systems, the 
esterifications were typically complete in only a few hours. Dimethoxybenzyl esters are important 
synthetically, as these can be removed via oxidative methods (typically with DDQ5, 6), which is not the case 
with benzyl esters. Benzyl trichloroacetimidates functionalized with strong electron withdrawing groups 
like nitro groups showed no reaction. The furfuryl trichloroacetimidate 4.16 gave an excellent yield (entry 
15, Table 4.1) by heating in toluene, as did the phenethyl imidate 4.17. The diphenylmethyl 
trichloroacetimidate showed a complete conversion to ester at room temperature. From these results, it is 
evident that the esterifications proceed best with electron-rich alkyl groups. The more reactive imidates can 
form esters at room temperature, while heating is necessary for the less reactive systems. Sterics also 
influenced reactivity, as can be seen with the low reactivity of the 2-methoxybenzyl imidate 4.11 compared 
to that of the 4-methoxybenzyl imidate 4.12 (Table 4.1, entry 10 and 11). 
4.2.2. Reaction of Complex Carboxylic Acids with Different Trichloroacetimidates 
  After studying reactivity of different trichloroacetimidates, effects of carboxylic acid structure were 
examined (Table 4.2). Firstly, the effects of the steric environment near the carboxylic acid were evaluated. 
High yields of the corresponding esters were observed with diphenylacetic acid 4.19 (entry 1-4, Table 4.2). 
The more sterically encumbered 2-methyl-2-phenylpropionic acid 4.20 provided a lowest yield with the 
hindered tert-butyl imidate 4.5 as expected (entry 5, Table 4.2). Then, a number of substrates were evaluated 
with respect to functionality. The 2-bromododecanoic acid 4.21 was esterified in good yield without any 
side reactions such as elimination or other competing substitution (entry 9-12, Table 4.2). Mandelic acid 
4.22, demonstrated that the presence of an alcohol can be well tolerated in these reactions (entry 13-16, 
Table 4.2). The amino acid (±)-Boc-phenylalanine 4.23 was also esterified under these conditions in good 
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yield (entry 17-23, Table 4.2). Alkene isomerization under these reaction conditions was also explored. 
Vinyl acetic acid 4.24 demonstrated no isomerization of the alkene (entry 21-24, Table 4.2). The tert-butyl 
ester of vinyl acetic acid 4.5g was the only exception (30 % isolated yield, entry 21, Table 4.2), as it was 
quite volatile and therefore difficult to isolate. Cinnamic acid 4.25 is another good example, providing the 
corresponding esters in good yields (entry 25-28, Table 4.2). The cis alkenoic acid 4.26 was also studied, 
as similar systems have a tendency to undergo cis/trans isomerization under esterification conditions.7 No 
isomerization of the alkene was observed with the given imidates (Table 4.2, entries 29−32), demonstrating 
the significance of this study for the protection of esters. Picolinic acid 4.27 is another excellent example 
as a heterocyclic substrate, with good yields being achieved with all four imidates tested (entry 33-36, Table 
4.2). 
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R’DCM, rt  








t-Bu (4.5) 48 81 (4.5b) 
2 4.19 PMB (4.12) 24 96 (4.12b) 
3 4.19 DMB (4.13) 1 88 (4.13b) 





 t-Bu (4.5) 48 60 (4.5c) 
6 4.20 PMB (4.12) 24 86 (4.12c) 
7 4.20 DMB (4.13) 24 85 (4.13c) 




Br8 4.21  
t-Bu (4.5) 48 94 (4.5d) 
10 4.21 PMB (4.12) 24 93 (4.12d) 
11 4.21 DMB (4.13) 20 81 (4.13d) 








t-Bu (4.5) 48 59 (4.5e) 
14 4.22 PMB (4.12) 24 79 (4.12e) 
15 4.22 DMB (4.13) 1 94a (4.13e) 









t-Bu (4.5) 48 62 (4.5f) 
18 4.23 PMB (4.12) 24 91 (4.12f) 
19 4.23 DMB (4.13) 24 80 (4.13f) 





 t-Bu (4.5) 48 30b (4.5g) 
22 4.24 PMB (4.12) 24 83 (4.12g) 
23 4.24 DMB (4.13) 0.5 73 (4.13g) 





 t-Bu (4.5) 48 60 (4.5h) 
26 4.25 PMB (4.12) 24 94 (4.12h) 
27 4.25 DMB (4.13) 24 88 (4.13h) 





t-Bu (4.5) 48 76 (4.5i) 
30 4.26 PMB (4.12) 24 84 (4.12i) 
31 4.26 DMB (4.13) 4 92 (4.13i) 







t-Bu (4.5) 48 81 (4.5j) 
34 4.27 PMB (4.12) 24 83 (4.12j) 
35 4.27 DMB (4.13) 24 83 (4.13j) 
36 4.27 DPM (4.18) 18 71 (4.18j) 
     
aOnly 1 equiv imidate was used, bYield determined by 1H NMR using a mesitylene standard as product was volatile) 
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4.2.3. Esterifications of Benzyl Trichloroacetimidate 
  Benzyl groups are common carboxylate-protecting groups. Therefore, the scope of the esterification 
reaction with benzyl trichloroacetimidate 4.18 was also explored (Table 4.3). Similar results were observed, 
as the same series of carboxylic acids underwent esterification in good yields. Moreover, no elimination 
products from the α-bromoacid 4.21, and no isomerization of the alkenes in carboxylates 4.24, 4.25, or 4.26 
was observed. In case of Mandelic acid 4.22, the alcohol remained unaffected. Although in case of more 
reactive imidates (like the diphenylmethyl trichloroacetimidate 4.18 8) ethers are formed under similar 
conditions, but imidate 4.9 is not reactive enough to access this reactivity. 










































































4.2.4. Effects of esterification reactions on a chirality center 
  Effects of the esterification reactions on a chirality center next to the carboxylate were also investigated. 
Naproxen 4.28 was utilized for this study, as it can racemize rapidly since the chirality center is both 
benzylic and next to the electron-withdrawing carboxylate. Reaction of naproxen with imidate 4.18 at room 
temperature in DCM gave the desired ester products in high yields (Scheme 4.1). Chiral high-performance 
liquid chromatography (HPLC) analysis of the product showed that no racemization had occurred. A similar 
study was performed to see the effect of high temperature on the chirality center. Naproxen was heated in 
refluxing toluene with benzyl trichloroacetimidate 4.18 to provide a 79% yield of benzyl ester 4.18k. Chiral 
HPLC analysis of 4.18k showed that no racemization had occurred even with this substrate. 





















4.3. Mechanistic Studies 
  The mechanism of the reaction was briefly probed by the use of two chiral imidate substrates in the 
esterification reaction. Chiral phenethyl trichloroacetimidate 4.17 has already been reported9 and was 
therefore employed in the esterification reaction. In addition, the imidate of (S)-(2- methoxyphenyl) 
phenylmethanol 4.19 (imidate 4.30) was also prepared. During the course of the esterification with chiral 
imidate 4.17 significant racemization was observed, with a completely racemic mixture being observed in 
refluxing toluene and a 71:29 mixture of enantiomers being observed in DCM at room temperature (Table 
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4.4). Similar results were observed with imidate 4.30, with a nearly racemic mixture being isolated from 
the reaction in refluxing toluene and a scalemic 67:33 mixture being isolated from the esterification in DCM 
at room temperature. These results implicate a radical or a cationic mechanism for the reaction. However, 
the radical reaction should even work well with an electron poor imidate (like 4.15), it seemed unlikely that 
a radical intermediate was involved. The available observations therefore implicate a cationic mechanism 
(S N 1).  






















R = 2-OMePh  
entry imidate Conditions yield (%)       e. r. 
1 4.17 toluene, ∆, 24 h 95 50:50 (4.17a) 
2 4.17 DCM, rt, 24 h 35 71:29 (4.17a) 
3 4.30 toluene, ∆, 24 h 73 55:45 (4.31) 




  Esterification reactions of different trichloroacetimidate electrophiles have been studied under promoter 
free conditions. Some of the substrates undergo esterification at room temperature, however several others 
can be prepared by simple heating the trichloroacetimidate in refluxing toluene. No alkylation of other 
functional groups (like alcohols or amides) or alkene isomerization was observed under these conditions. 
This reaction to form esters from imidates in the absence of an acid or base promoter will be useful in the 





Compounds 4.2, 4.3, 4.5, 4.6, and 4.9 used in these studies were purchased from commercial sources. 
Cyclohexyl2,2,2-trichloroacetimidate 4.4, 32 prenyl-2,2,2-trichloroacetimidate 4.7, 33 propargyl-2,2,2-
trichloroacetimidate 4.8, 34 (2,4,6- trimethylphenyl)methyl-2,2,2-trichloroacetimidate 4.10, 35 (4- 
methoxyphenyl)methyl-2,2,2-trichloroacetimidate 4.12 18a (3,4- dimethoxoxyphenyl)methyl-2,2,2-
trichloroacetimidate 4.14 36 (4- nitrophenyl)methyl-2,2,2-trichloroacetimidate 4.15, 21 furfuryl-2,2,2-
trichloroacetimidate 4.16, 34 1-phenethyl-2,2,2-trichloroacetimidate 4.17 26a,37 diphenylmethyl-2,2,2-
trichloroacetimidate 4.18, 18b,38 were synthesized as previously reported.  
General Procedure for the Synthesis of Trichloroacetimidates from the Corresponding Alcohol. A 
flame-dried 25 mL round bottom flask was charged with the alcohol starting material (1 equiv) under argon. 
Dry DCM was then added to form a 0.5 M solution, and the flask was cooled to 0 °C. DBU (0.2 equiv) was 
added to the solution, followed by trichloroacetonitrile (1.5 equiv). The reaction was monitored by thin-
layer chromatography (TLC). After completion of the reaction, the reaction mixture was concentrated, and 






(2-Methoxyphenyl) methyl-2,2,2-trichloroacetimidate (4.11). It was obtained as clear oil (1.49 g, 73%) and 
purified by silica gel chromatography (4% ethyl acetate/1% triethylamine/95% hexanes). TLC Rf = 0.55 
(10% ethyl acetate/90% hexane); 1H NMR (300 MHz, CDCl 3 ): δ 8.38 (br s, 1H), 7.45 (dd, J = 7.5, 1.6 Hz, 
1H), 7.32 (td, J = 8.0, 1.7 Hz, 1H), 6.98 (td, J = 7.5, 0.9 Hz, 1H), 6.91 (d, J = 8.2 Hz, 1H), 5.40 (s, 2H), 
3.85 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 162.8, 157.2, 129.4, 128.7, 124.0, 120.4, 110.4, 91.6, 







(2,4-Dimethoxyphenyl) methyl-2,2,2-trichloroacetimidate (4.13). It was obtained as yellow oil (7.40 g, 
99%) and purified by silica gel chromatography (30% ethyl acetate/69% hexanes/1% triethylamine). 1H 
NMR (400 MHz, CDCl 3 ): δ 8.33 (s, 1H), 7.33 (d, J = 8.4 Hz, 1H), 6.49 (t, J = 2.4 Hz, 2H), 5.30 (s, 2H), 
3.81 (s, 3H), 3.81 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 162.9, 161.3, 158.8, 130.6, 116.4, 104.0, 
98.6, 98.4, 91.7, 66.6, 55.4; Anal. Calcd for C 11 H 12 Cl 3 NO 3 : C, 42.27; H, 3.87; N, 4.48. Found: C, 42.28; 
H, 3.56; N, 4.57.  
General Procedure for Esterification by Method A. In a flame-dried flask, the trichloroacetimidate (2 
equiv) was dissolved in dichloromethane (0.25 M) under argon. The carboxylic acid (1 equiv) was then 
added, and the mixture was stirred at room temperature. The reaction progress was monitored by thin layer 
chromatography. After completion, the reaction mixture was poured into 2 N NaOH and extracted with 
DCM (3×). organic extracts were then dried over sodium sulfate, filtered, and concentrated. The residue 
was purified by silica gel column chromatography to give the ester product.  
General Procedure for Esterification by Method B. The carboxylic acid (1 equiv) and 
trichloroacetimidate (2 equiv) were placed in a flame-dried round bottom flask under argon. Anhydrous 
toluene (0.25 M) was then added and the reaction was heated to reflux. The reaction progress was monitored 
by thin layer chromatography. After disappearance of the carboxylic acid, the mixture was allowed to cool 
to rt, poured into 2 N NaOH, and extracted with DCM (3×). The combined organic extracts were then dried 
over sodium sulfate, filtered, and concentrated. The residue was purified by silica gel column 
chromatography to give the ester product.  
OBz
4.5a  
tert-Butyl Benzoate (4.5a).  It was obtained as clear oil (0.097 g, 84%) and purified by silica gel 
chromatography (1% ethyl acetate/ 99% hexane). TLC R f  = 0.53 (10% ethyl acetate/90% hexane); 1H NMR 
(300 MHz, CDCl 3 ): δ 8.01−7.91 (m, 2H), 7.55−7.49 (m, 1H), 7.41 (t, J = 7.6 Hz, 2H), 1.60 (s, 9H); 13C{1H} 







tert-Butyl 2,2-Diphenylacetate (4.5b). 40 It was obtained as a white solid (0.064 g, 91%) and purified by 
silica gel chromatography (2% ethyl acetate/98% hexanes). TLC R f  = 0.68 (10% ethyl acetate/90% 
hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 7.30−7.23 (m, 10 H), 4.91 (s, 1H), 1.44 (s, 9H). 13C{1H} NMR 





 tert-Butyl 2-Methyl-2-phenylpropanoate (4.5c). It was obtained as clear oil (0.087 g, 30%) and purified by 
silica gel chromatography (3% ethyl acetate/97% hexanes). TLC R f  = 0.71 (10% ethyl acetate/ 90% 
hexanes); 1H NMR (300 MHz, CDCl 3 ): δ 7.33−7.26 (m, 5H), 1.53 (s, 6H), 1.38 (s, 9H). 13C{1H} NMR 
(100 MHz, CDCl 3 ): δ 176.2, 145.5, 128.4, 126.6, 125.8, 80.5, 47.3, 28.0, 26.7. 
O
O
Br8 4.5d  
 tert-Butyl 2-Bromododecanoate (4.5d). It was obtained as an amorphous solid (0.091 g, 94%) and purified 
by silica gel chromatography (100% diethyl ether). TLC R f  = 0.54 (100% hexanes); 1H NMR (400 MHz, 
CDCl3): δ 4.08 (t, J = 7.1 Hz, 1H), 2.02−1.87 (m, 2H), 1.46 (s, 9H), 1.41−1.11 (m, 16 H), 0.86 (t, J = 5.5 
Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 169.0, 82.2, 47.9, 35.0, 31.9, 29.54, 29.47, 29.33, 29.30, 






(±)-tert-Butyl-2-hydroxy-2-phenylacetate (4.5e).  It was obtained as a white solid (0.079 g, 59%) and 
purified by silica gel chromatography (5% ethyl acetate/95% hexanes). TLC R f  = 0.65 (50% ethyl 
acetate/50% hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 7.41−7.30 (m, 5H), 5.03 (d, J = 6.0 Hz, 1H), 3.53 
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(d, J = 6.0 Hz, 1H), 1.40 (s, 9H); 13C{1H} NMR (125 MHz, CDCl 3 ): δ 172.9, 139.0, 128.4, 128.1, 126.4, 







(±)-tert-Butyl-2-[(tert-butoxycarbonyl) amino] phenylpropionate (4.5f). 44 It was obtained as clear oil (0.90 
g, 90%) and purified by silica gel chromatography (4% ethyl acetate/96% hexanes). TLC Rf = 0.75 (10% 
ethyl acetate/90% hexanes); 1H NMR (300 MHz, CDCl 3 ): δ 7.31−7.16 (m, 5H), 5.00 (br s, 1H), 4.45−4.44 
(m, 1H), 3.05 (d, J = 5.8 Hz, 2H), 1.42 (s, 9H), 1.40 (s, 9H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 171.0, 




2,2-Dimethylpropyl But-3-enoate (4.5g). 45 It was obtained as clear colorless oil (70 mg, 35% yield) and 
purified by silica gel column chromatography (10% diethyl ether, 90% pentane). TLC R f  = 0.76 (10% ethyl 
acetate/90% hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 5.88−5.78 (m, 1H), 5.06 (dq, J = 14.0, 1.6 Hz, 2H), 






(E)-tert-Butyl Cinnamate (4.5h).  It was obtained as clear oil (0.052 g, 60%) and purified by silica gel 
chromatography (1−4% ethyl acetate/hexanes). TLC R f  = 0.71 (10% ethyl acetate/90% hexanes); 1H NMR 
(400 MHz, CDCl 3 ): δ 7.59 (d, J = 16.0 Hz, 1H), 7.50−7.49 (m, 2H), 7.36−7.36 (m, 3H), 6.37 (d, J = 16.0 
Hz, 1H), 1.54 (s, 9H); 13C{1H} NMR (125 MHz, CDCl 3 ): δ 166.3, 143.5, 134.7, 129.9, 128.8, 128.0, 120.2, 
80.5, 28.2.  
O
O
MeO 4.5i  
 90 
tert-Butyl (2Z)-3-(2-Methoxyphenyl) prop-2-enoate (4.5i). It was obtained as clear oil (0.100 g, 76%) and 
purified by silica gel chromatography (8% ethyl acetate/92% hexanes). TLC R f  = 0.52 (20% ethyl 
acetate/80% hexanes); IR (film, cm−1 ): 2979, 1716, 1629, 1463, 1110, 1049, 738; 1H NMR (400 MHz, 
CDCl 3 ): δ 7.47 (d, J = 7.3 Hz, 1H), 7.31−7.27 (m, 1H), 7.07 (d, J = 12.3 Hz, 1H), 6.94−6.86 (m, 2H), 5.91 
(d, J = 12.4 Hz, 1H), 3.84 (s, 3H), 1.39 (s, 9H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 165.8, 157.0, 137.5, 
130.6, 130.0, 124.7, 122.3, 120.0, 110.2, 80.3, 55.5, 28.0. Anal. Calcd for C 14 H 18 O 3 : C, 71.77; H, 7.74. 





tert-Butyl 2-Pyridinecarboxylate (4.5j).  It was obtained as clear oil (0.095 g, 81%) and purified by silica 
gel chromatography (45% ethyl acetate/55% hexanes). TLC R f  = 0.40 (50% ethyl acetate/50% hexanes); 1 
H NMR (400 MHz, CDCl 3): δ 8.74 (dd, J = 4.7, 0.7 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.80 (td, J = 7.7, 
1.8 Hz, 1H), 7.42 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 1.64 (s, 9H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 164.5, 
150.0, 149.8, 137.0, 126.6, 125.0, 82.5, 28.3.  
OBz
4.7a  
3-Methylbut-2-en-1-yl Benzoate (4.7a). It was obtained as clear colorless oil (0.126 g, 63% yield) and 
purified by silica gel column chromatography (10% ethyl acetate, 90% hexanes). TLC R f  = 0.60 (10% 
ethyl acetate/90% hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 8.08−8.06 (m, 2H), 7.58−7.53 (m, 1H), 7.44 
(t, J = 7.8 Hz, 2H) 5.52−5.48 (m, 1H), 4.85 (d, J = 7.2 Hz, 2H), 1.80 (d, J = 6.3 Hz, 6H); 13C{1H} NMR 






(Phenyl)methyl Benzoate (4.9a). 49 It was obtained as clear oil (0.082 g, 58%) and purified by silica gel 
chromatography (2% ethyl acetate/98% hexane). TLC R f = 0.57 (10% ethyl acetate/90% hexane); 1H NMR 
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(400 MHz, CDCl 3 ): δ 8.08 (d, J = 7.2 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.46−7.34 (m, 7H), 5.37 (s, 2H); 






 (Phenyl)methyl 2,2-Diphenylacetate (4.9b). 50 It was obtained as a white solid (0.079 g, 88%) and purified 
by silica gel chromatography (2% ethyl acetate/98% hexanes). TLC R f  = 0.60 (10% ethyl acetate/ 90% 
hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 7.29−7.25 (m, 15H), 5.17 (s, 2H), 5.07 (s, 1H); 13C{1H} NMR 





 (Phenyl)methyl 2-Methyl-2-phenylpropanoate (4.9c). It was obtained as clear oil (0.157 g, 94%) and 
purified by silica gel chromatography (4% ethyl acetate/96% hexanes). TLC R f  = 0.50 (100% hexanes); IR 
(film, cm−1 ): 3089, 2976, 1729, 1497, 1425, 1412, 737; 1H NMR (400 MHz, CDCl 3 ): δ 7.32−7.19 (m, 
10H), 5.10 (s, 2H), 1.60 (s, 6H); 13C{1 H} NMR (100 MHz, CDCl 3 ): δ 176.5, 144.5, 136.2, 128.40, 128.36, 




Br8 4.9d  
 (Phenyl)methyl 2-Bromododecanoate (4.9d). It was obtained as clear oil (0.193 g, 80%) and purified by 
silica gel chromatography (3% ethyl acetate/97% hexane). TLC R f  = 0.68 (10% ethyl acetate/90% 
hexanes); IR (film, cm−1 ): 3054, 2928, 2305, 1740, 1422, 1265, 738; 1H NMR (400 MHz, CDCl 3 ): δ 
7.39−7.35 (m, 5H), 5.20 (s, 2H), 4.25 (t, J = 7.3 Hz, 1H), 2.06−1.95 (m, 2H), 1.35−1.21 (m, 16H), 0.88 (t, 
J = 6.6 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 169.7, 135.2, 128.8, 128.6, 128.5, 128.3, 128.2, 70.7, 
67.5, 46.0, 34.9, 31.9, 29.5, 29.5, 29.3, 28.8, 27.2, 22.7, 14.1. Anal. Calcd for C19H 29 BrO 2 : C, 61.79; H, 







(±)-(Phenyl)methyl-2-hydroxy-2-phenylacetate (4.9e).  It was obtained as a white solid (0.209 g, 88%) and 
purified by silica gel chromatography (10% ethyl acetate/90% hexanes). TLC R f  = 0.48 (30% ethyl 
acetate/70% hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 7.42−7.30 (m, 8H), 7.21−7.19 (m, 2H), 5.25−5.12 
(m, 3H), 3.42 (d, J = 5.8 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 173.5, 138.2, 135.0, 128.60, 128.56, 







Boc-phenylalanine (Phenyl)methyl Ester (4.9f).  It was obtained as clear oil (0.251 g, 94%) and purified by 
silica gel chromatography (10% ethyl acetate/90% hexanes). TLC R f  = 0.57 (20% ethyl acetate/ 80% 
hexanes); 1H NMR (300 MHz, CDCl 3 ): δ 7.36−7.21 (m, 8H), 7.06−7.03 (m, 2H), 5.13 (q, J = 12.3 Hz, 
2H), 4.97 (d, J = 7.7 Hz, 1H), 4.63 (q, J = 7.7 Hz, 1H), 3.08 (t, J = 5.2 Hz, 2H), 1.41 (s, 9H); 13C{1H} NMR 
(100 MHz, CDCl 3 ): δ 171.8, 155.1, 135.9, 135.2, 129.4, 128.6, 128.6, 127.0, 79.9, 67.1, 54.5, 38.3, 28.3.  
O
OBn4.9g  
(Phenyl)methyl But-3-enoate (4.9g).  It was obtained as clear oil (0.180 g, 88%) and purified by silica gel 
chromatography (2% ethyl acetate/98% hexanes). TLC R f  = 0.62 (10% ethyl acetate/90% hexanes); 1H 
NMR (400 MHz, CDCl 3 ): δ 7.39 (m, 5H), 6.00−5.90 (m, 1H), 5.20−5.14 (m, 4H), 3.15 (d, J = 7.0 Hz, 2H); 





 (Phenyl)methyl Cinnamate (4.9h). It was obtained as viscous oil (0.120 g, 77%) and purified by silica gel 
chromatography (2% ethyl acetate/98% hexanes). TLC R f  = 0.63 (10% ethyl acetate/90% hexanes); 1H 
NMR (300 MHz, CDCl 3 ): δ 7.66 (d, J = 15.9 Hz, 1H), 7.47−7.44 (m, 2H), 7.36−7.27 (m, 8H), 6.42 (d, J = 
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16.2 Hz, 1H), 5.18 (s, 2H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.8, 145.2, 136.1, 134.4, 130.4, 128.9, 
128.6, 128.3, 128.3, 128.1, 117.9, 66.4.  
OBn
O
MeO 4.9i  
Benzyl (2Z)-3-(2-Methoxyphenyl) prop-2-enoate (4.9i). It was obtained as clear oil (0.120 g, 80%) and 
purified by silica gel chromatography (6% ethyl acetate/94% hexanes). TLC R f  = 0.38 (20% ethyl 
acetate/80% hexanes); IR (film, cm−1): 3054, 1721, 1600, 1488, 1265, 1157, 1028, 745; 1H NMR (400 
MHz, CDCl 3 ): δ 7.52 (d, J = 7.5 Hz, 1H), 7.32−7.18 (m, 7H), 6.89−6.85 (m, 2H) 6.03 (d, J = 12.4 Hz, 1H), 
5.13 (s, 2H), 3.81 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.3, 161.2, 158.9, 157.2, 138.9, 131.3, 
130.8, 130.3, 124.1, 120.0, 120.0, 116.8, 110.2, 104.0, 98.5, 61.3, 55.4. Anal. Calcd for C17 H 16 O 3 : C, 





(Phenyl)methyl Picolinate (4.9j). 54 It was obtained as yellow oil (0.120 g, 57%) and purified by silica gel 
chromatography (50% ethyl acetate/50% hexanes). TLC R f  = 0.47 (50% ethyl acetate/50% hexanes); 1 H 
NMR (400 MHz, CDCl 3 ): δ 8.77 (d, J = 4.6 Hz, 1H), 8.13 (d, J = 7.9 Hz, 1H), 7.82 (dt, J = 7.7, 1.7 Hz, 
1H), 7.50−7.45 (m, 3H), 7.40−7.33 (m, 3H), 5.46 (s, 2H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 165.0, 





(S)-(Phenyl) methyl-2-(6-methoxynaphthalen-2-yl)propanoate (4.9k). It was obtained as a yellow solid 
(0.110 g, 79%) and purified by silica gel chromatography (2% ethyl acetate/98% hexanes). [α]D 23 −3.7 (c 
0.35, DCM); mp = 72−73 °C; TLC R f  = 0.48 (10% ethyl acetate/ 90% hexanes); IR (film, cm−1 ): 3055, 
2982, 1733, 1634, 1265, 738; 1H NMR (400 MHz, CDCl 3 ): δ 7.70−7.65 (m, 3H), 7.41 (d, J = 1.6 Hz, 1H), 
7.28−7.25 (m, 5H), 7.14−7.11 (m, 2H), 5.11 (q, J = 12.4 Hz, 2H), 3.93−3.88 (m, 4H), 1.59 (d, J = 7.2 Hz, 
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3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 174.5, 157.6, 136.0, 135.6, 133.7, 129.3, 128.9, 128.5, 128.1, 
127.9, 127.1, 126.3, 126.0, 119.0, 105.6, 66.5, 55.3, 45.5, 18.5. Anal. Calcd for C 17 H 16 O 3 : C, 76.10; H, 
6.01. Found: C, 76.35; H, 5.64. The er was determined by chiral HPLC (OD-H), n-hexane/i-PrOH = 99:1, 
1 mL/min; t1 = 10.1; t2 = 12.2 min. (2,4,6-Trimethylphenyl) methyl Benzoate (18a). 8f It was obtained as 
clear oil (0.171 g, 82%) and purified by silica gel chromatography (4−6% ethyl acetate/96−94% hexane). 
TLC R f = 0.66 (20% ethyl acetate/80% hexane); 1H NMR (400 MHz, CDCl 3 ): δ 8.03 (dd, J = 8.2, 1.0 Hz, 
2H), 7.56−7.39 (m, 1H), 7.41 (t, J = 7.7 Hz, 2H), 6.92 (s, 2H), 5.42 (s, 2H), 2.42 (s, 6H), 2.30 (s, 3H); 
13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.8, 138.5, 138.4, 132.9, 130.2, 129.7, 129.2, 129.1, 128.3, 61.6, 




(2-Methoxyphenyl) methyl Benzoate (4.11a).  It was obtained as clear oil (0.080 g, 96%) and purified by 
silica gel chromatography (1% ethyl acetate/99% pentane). TLC Rf  = 0.49 (10% ethyl acetate/90% hexane); 
1 H NMR (400 MHz, CDCl 3 ): δ 8.08 (d, J = 7.6 Hz, 2H), 7.52 (t, J = 7.6 Hz, 1H), 7.41 (t, J = 7.6 Hz, 3H), 
7.30 (td, J = 8.0, 1.6 Hz, 1H), 6.98 (t, J = 0.4 Hz, 1H), 6.89 (d, J = 8.0 Hz, 1H), 5.42 (s, 2H), 3.83 (s, 3H); 
13C{1H} NMR (100 MHz, CDCl 3 ): δ 162.6, 157.6, 132.9, 130.5, 129.7, 129.53, 129.45, 128.4, 124.5, 120.5, 






(4-Methoxyphenyl) methyl Benzoate (4.12a).  It was obtained as colorless oil (0.530 g, 89%) and purified 
by silica gel chromatography (10% ethyl acetate/90% hexanes). TLC R f  = 0.57 (20% ethyl acetate/ 80% 
hexanes); 1H NMR (300 MHz, CDCl 3 ): δ 8.10−8.03 (m, 2H), 7.59−7.51 (m, 1H), 7.47−7.36 (m, 4H), 6.92 
(d, J = 8.8 Hz, 2H), 5.31 (s, 2H), 3.82 (s, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 166.7, 159.9, 133.2, 







(4-Methoxyphenyl) methyl 2,2-Diphenylacetate (4.12b). It was obtained as a white solid (0.120 g, 96%) 
and purified by silica gel chromatography (4% ethyl acetate/96% hexanes). TLC R f  = 0.50 (20% ethyl 
acetate/80% hexanes); IR (film, cm−1 ): 3054, 2986, 1734, 1613, 1516, 1265, 739, 703; 1H NMR (400 MHz, 
CDCl 3 ): δ 7.30−7.21 (m, 12H), 6.85 (d, J = 8.7 Hz, 2H), 5.12 (s, 2H), 5.04 (s, 1H), 3.80 (s, 3H); 13C{1H} 
NMR (100 MHz, CDCl 3 ): δ 172.4, 159.6, 138.6, 130.1, 128.6, 128.6, 127.8, 127.2, 113.9, 66.8, 57.1, 55.3. 





(4-Methoxyphenyl) methyl 2-Methyl-2-phenylpropanoate (4.12c).  It was obtained as clear oil (0.120 g, 
86%) and purified by silica gel chromatography (8% ethyl acetate/92% hexanes). TLC R f  = 0.51 (50% 
ethyl acetate/50% hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 7.31−7.20 (m, 5H), 7.14 (d, J = 8.6 Hz, 2H), 
6.82 (d, J = 8.7 Hz, 2H), 5.03 (s, 2H), 3.77 (s, 3H), 1.57 (s, 6H); 13C{1H} NMR (100 MHz, CDCl 3 ) 176.5, 





(4-Methoxyphenyl) methyl 2-Bromododecanoate (4.12d). It was obtained as yellow oil (0.407 g, 93%) and 
purified by silica gel chromatography (15% ethyl acetate/85% hexanes). TLC R f  = 0.65 (25% ethyl 
acetate/75% hexanes); IR (film, cm−1 ): 3001, 2906, 2851, 1724, 1514, 1229; 1H NMR (300 MHz, CDCl 3): 
δ 7.25 (d, J = 9.0 Hz, 2H), 6.82 (d, J = 9.0 Hz, 2H), 5.07 (s, 2H), 4.15 (t, J = 7.4 Hz, 1H), 3.73 (s, 3H), 
1.98−1.91 (m, 2H), 1.30−1.10 (m, 16H), 0.82 (t, J = 6.0 Hz, 3H); 13C{1 H} NMR (75 MHz CDCl 3 ): δ 170.0, 
160.8, 130.4, 127.6, 114.2, 67.6, 55.5, 46.4, 35.2, 32.1, 29.8, 29.7, 29.6, 29.1, 27.5, 22.9, 14.6. Anal Calcd 







(±) -(4-Methoxyphenyl)methyl-2-hydroxy-2-phenylacetate (4.12e).  It was obtained as colorless oil (0.495 
g, 79%) and purified by silica gel chromatography (20% ethyl acetate/80% hexanes). TLC R f  = 0.65 (30% 
ethyl acetate/70% hexanes); 1H NMR (300 MHz, CDCl 3 ): δ 7.35−7.25 (m, 5H), 7.09 (d, J = 9.0 Hz, 2H), 
6.78 (d, J = 9.0 Hz, 2H), 5.11−4.96 (m, 3H), 3.71 (s, 3H), 3.57 (d, J = 6.0 Hz, 1H); 13C{1H} NMR (75 MHz 







(±) -(4-Methoxyphenyl) methyl-2-[(tert-butoxycarbonyl)amino]- phenylpropionate (4.12f).  It was obtained 
as colorless oil (0.342 g, 89%) and purified by silica gel chromatography (20% ethyl acetate/ 80% hexanes). 
TLC R f = 0.61 (30% ethyl acetate/70% hexanes); 1 H NMR (300 MHz, CDCl 3 ): δ 7.20−7.11 (m, 5H), 
6.99−6.87 (m, 2H), 6.75 (d, J = 9.0 Hz, 2H), 5.03−4.97 (m, 3H), 4.60−4.45 (m, 1H), 3.73 (s, 3H), 3.11−2.90 
(m, 2H), 1.35 (s, 9H); 13C{1H} NMR (75 MHz CDCl 3 ): δ 173.5, 160.1, 155.5, 138.6, 132.3, 130.3, 129.5, 
127.8, 127.5, 114.6, 80.2, 67.1, 55.5, 54.0, 39.1, 28.5.  
O
OPMB4.12g  
(4-Methoxyphenyl) methyl But-3-enoate (4.12g). It was obtained as colorless oil (0.389 g, 93% yield) and 
purified by silica gel chromatography (5% ethyl acetate/95% hexanes). TLC R f  = 0.50 (5% ethyl 
acetate/95% hexanes); 1 H NMR (300 MHz, CDCl 3): δ 7.23 (d, J = 9.0 Hz, 2H), 6.81 (d, J = 9.0 Hz, 2H), 
5.92−5.82 (m, 1H), 5.13− 5.11 (m, 1H), 5.08−5.03 (m, 1H), 5.00 (s, 2H), 3.72 (s, 3H), 3.06− 3.03 (m, 2H); 





(4-Methoxyphenyl) methyl Cinnamate (4.12h).  It was obtained as a white solid (0.508 g, 94%) and purified 
by silica gel chromatography (10% ethyl acetate/90% hexanes). TLC R f  = 0.64 (20% ethyl acetate/ 80% 
hexanes); mp = 61−63 °C; 1H NMR (300 MHz, CDCl 3 ): δ 7.71 (d, J = 16.2 Hz, 1H), 7.55−7.48 (m, 2H), 
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7.41−7.33 (m, 5H), 6.92 (d, J = 8.8 Hz, 2H), 6.47 (d, J = 16.2 Hz, 1H), 5.19 (s, 2H), 3.82 (s, 3H); 13C{1H} 




MeO 4.12i  
(4-Methoxyphenyl) methyl (2Z)-3-(2-Methoxyphenyl) prop-2- enoate (4.12i). It was obtained as clear oil 
(0.140 g, 84%) and purified by silica gel chromatography (10% ethyl acetate/90% hexanes). TLC R f  = 0.42 
(20% ethyl acetate/80% hexanes); IR (film, cm−1 ): 2958, 2837, 1720, 1613, 1515, 1262, 1030, 737; 1H 
NMR (400 MHz, CDCl 3 ): δ 7.50 (dd, J = 7.6, 1.1 Hz, 1H), 7.31−7.20 (m, 3H), 7.14 (s, 1H), 6.89−6.82 (m, 
4H), 5.98 (d, J = 12.4 Hz, 1H), 5.05 (s, 2H), 3.77 (s, 6H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.2, 
159.6, 157.2, 139.4, 130.8, 130.4, 130.2, 128.1, 124.1, 120.0, 119.8, 113.9, 110.3, 65.8, 55.4, 55.3. Anal. 





(4-Methoxyphenyl) methyl Picolinate (4.12j). It was obtained as yellow oil (0.516 g, 83%) and purified by 
silica gel chromatography (50% ethyl acetate/50% hexanes). TLC Rf = 0.30 (50% ethyl acetate/ 50% 
hexanes); IR (film, cm−1 ): 3057, 3005, 2957, 2837, 1717; 1H NMR (300 MHz, CDCl 3 ): δ 8.76 (d, J = 7.2 
Hz, 1H), 8.12 (d, J = 8.7 Hz, 1H), 7.85−7.79 (m, 1H), 7.48−7.42 (m, 3H), 6.90 (d, J = 8.7 Hz, 2H), 5.40 (s, 
2H), 3.81 (s, 3H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 165.2, 159.8, 150.0, 148.2, 137.0, 130.6, 127.9, 
127.0, 125.3, 114.0, 67.4, 55.3. Anal Calcd for C14 H 13NO 3 : C, 69.12; H, 5.39; N, 5.76. Found C, 69.52; 






(2,4-Dimethoxyphenyl) methyl Benzoate (4.13a). It was obtained as clear oil (0.062 g, 90%) and purified 
by silica gel chromatography (6% ethyl acetate/94% hexanes). TLC Rf  = 0.29 (10% ethyl acetate/90% 
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hexane); IR (film, cm−1 ): 3003, 2837, 1721, 1275, 712; 1H NMR (400 MHz, CDCl 3 ): δ 8.05 (d, J = 7.2 
Hz, 2H), 7.51 (t, J = 7.2 Hz, 1H), 7.39 (t, J = 8.0 Hz, 2H), 7.34−7.32 (m, 1H), 6.49−6.46 (m, 2H), 5.34 (s, 
2H), 3.81 (s, 3H), 3.80 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.7, 161.3, 159.0, 132.8, 131.2, 
130.6, 129.7, 128.3, 116.9, 104.1, 98.6, 62.1, 55.5, 55.4. Anal. Calcd for C 16 H 16 O 4 : C, 70.58; H, 5.92. 






(2,4-Dimethoxyphenyl) methyl 2,2-Diphenylacetate (4.13b). It was obtained as clear oil (0.120 g, 88%) 
and purified by silica gel chromatography (15% ethyl acetate/85% hexanes). TLC R f  = 0.27 (20% ethyl 
acetate/80% hexanes); IR (film, cm−1 ): 1731, 1616, 1209, 1035, 701; 1H NMR (400 MHz, CDCl 3 ): δ 
7.30−7.23 (m, 10H), 7.15 (d, J = 8.7 Hz, 1H), 6.42−6.39 (m, 2H), 5.16 (s, 2H), 5.04 (s, 1H), 3.79 (s, 3H), 
3.70 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 172.4, 161.3, 159.0, 138.9, 131.3, 128.7, 128.5, 127.1, 
116.6, 103.9, 98.5, 62.6, 57.1, 55.4, 55.3. Anal. Calcd for C 23 H 22 O 4 : C, 76.22; H, 6.12. Found: C, 76.08; 





(2,4-Dimethoxyphenyl) methyl 2-Methyl-2-phenylpropanoate (4.13c). It was obtained as clear oil (0.200 
g, 85%) and purified by silica gel chromatography (8% ethyl acetate/92% hexanes). TLC R f  = 0.45 (10% 
ethyl acetate/90% hexanes); IR (film, cm−1 ): 3061, 2936, 1718, 1612, 1508, 1206, 1098, 1029, 731, 697; 
1H NMR (400 MHz, CDCl 3 ): δ 7.26−7.11 (m, 5H), 6.98 (d, J = 7.8 Hz, 1H), 6.32− 6.30 (m, 2H), 5.00 (s, 
2H), 3.71 (s, 3H), 3.63 (s, 3H), 1.50 (s, 6H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 176.6, 161.0, 158.7, 144.9, 
130.5, 128.2, 126.5, 125.8, 117.1, 103.8, 98.4, 62.1, 55.4, 55.3, 46.7, 26.5. Anal. Calcd for C19 H 22 O 4 : C, 
72.59; H, 7.05. Found: C, 72.36; H, 7.17.  
O
ODMB
Br8 4.13d  
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(2,4-Dimethoxyphenyl) methyl 2-Bromododecanoate (4.13d). It was obtained as clear oil (0.099 g, 81%) 
and purified by silica gel chromatography (5% ethyl acetate/95% hexane). TLC R f  = 0.57 (20% ethyl 
acetate/80% hexanes); IR (film, cm−1): 3054, 1422, 1265, 1038, 896, 739. 1H NMR (400 MHz, CDCl 3 ): δ 
7.24 (s, 1H), 6.48−6.46 (m, 2H), 5.18 (s, 2H) 4.22 (t, J = 7.4 Hz, 1H), 3.81 (s, 6H), 2.11−1.92 (m, 2H), 
1.49−1.19 (m, 16H), 0.88 (t, J = 6.6 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 169.9, 161.5, 159.0, 
131.4, 116.1, 104.0, 98.6, 63.1, 55.4, 55.4, 46.4, 35.0, 31.9, 29.6, 29.5, 29.3, 29.3, 28.9, 27.2, 22.7, 14.1. 






 (±) -(2,4-Dimethoxyphenyl)methyl-2-hydroxy-2-phenylacetate (4.13e). It was obtained as a white 
amorphous solid (0.150 g, 94%) and purified by silica gel chromatography (50% ethyl acetate/50% 
hexanes). TLC Rf = 0.37 (50% ethyl acetate/50% hexanes); mp = 290−292 °C; IR (film, cm−1 ) : 3054, 
2835, 1729, 1274, 762; 1H NMR (400 MHz, CDCl 3 ): δ 7.41−7.39 (m, 2H), 7.34−7.28 (m, 3H), 7.07 (d, J 
= 8.9 Hz, 1H), 6.39 (br s, 2H), 5.16−5.15 (m, 3H), 3.78 (s, 3H), 3.67 (s, 3H), 3.54 (br s, 1H); 13C{1 H} NMR 
(100 MHz, CDCl 3 ): δ 173.6, 161.5, 159.0, 138.5, 131.2, 128.4, 128.3, 126.6, 115.8, 103.9, 98.5, 72.9, 63.5, 







 (±) -(2,4-Dimethoxyphenyl)methyl-2-[(tert-butoxycarbonyl)- amino]phenylpropionate (4.13f). It was 
obtained as clear oil (0.101 g, 80%) and purified by silica gel chromatography (15% ethyl acetate/ 85% 
hexanes). TLC R f  = 0.37 (40% ethyl acetate/60% hexanes); IR (film, cm−1 ): 3054, 2985, 1709, 1421, 1261, 
739; 1H NMR (300 MHz, CD 3 OD): δ 7.26−7.16 (m, 6H), 6.56 (d, J = 2.2 Hz, 1H), 6.50 (dd, J = 8.3, 2.3 
Hz, 1H), 5.11 (q, J = 12.1 Hz, 2H), 4.38 (q, J = 6.0 Hz, 1H), 3.84 (s, 3H), 3.82 (s, 3H), 3.10 (dd, J = 13.9, 
5.6 Hz, 1H), 2.91 (dd, J = 13.7, 8.6 Hz, 1H), 1.39 (s, 9H); 13C{1H} NMR (75 MHz, CD 3 OD): δ 172.3, 
161.7, 159.0, 156.4, 136.9, 131.2, 128.9, 128.0, 126.4, 116.0, 104.1, 97.9, 79.2, 62.1, 55.2, 54.6, 54.4, 37.3, 




(2,4-Dimethoxyphenyl) methyl But-3-enoate (4.13g). It was obtained as clear oil (0.163 g, 73%) and 
purified by silica gel chromatography (15% ethyl acetate/85% hexanes). TLC R f  = 0.40 (15% ethyl 
acetate/85% hexanes); IR (film, cm−1 ): 2963, 2838, 2616, 1464, 1371, 1209, 739; 1H NMR (300 MHz, 
CDCl 3 ): δ 7.23 (d, J = 8.9 Hz, 1H), 6.46 (hextet, J = 2.4 Hz, 2H), 6.00−5.87 (m, 1H), 5.18−5.11 (m, 4H), 
3.81 (s, 3H), 3.80 (s, 3H), 3.11 (dt, J = 6.9, 1.4 Hz, 2H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 171.6, 161.3, 
159.0, 131.4, 130.5, 118.4, 116.7, 104.1, 98.6, 61.9, 55.5, 55.4, 39.2. Anal. Calcd for C 13 H 16 O 4 : C, 66.09; 





(2,4-Dimethoxyphenyl) methyl Cinnamate (4.13h). It was obtained as viscous oil (0.139 g, 88%) and 
purified by silica gel chromatography (4% ethyl acetate/98% hexanes). TLC R f = 0.38 (20% ethyl 
acetate/80% hexanes); IR (film, cm−1): 1708, 1510, 1161, 737. 1 H NMR (400 MHz, CDCl 3 ): δ 7.70 (d, J 
= 16.1 Hz, 1H), 7.51−7.49 (m, 2H), 7.37−7.35 (m, 3H), 7.30 (d, J = 8.9 Hz, 1H), 6.49−6.51−6.43 (m, 3H), 
5.23 (s, 2H), 3.83 (s, 3H), 3.81 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 167.1, 161.3, 159.1, 144.7, 
134.6, 131.5, 130.2, 128.9, 128.1, 118.4, 116.8, 104.1, 98.6, 61.8, 55.5, 55.4. Anal. Calcd for C18 H 18 O 4 : 
C, 72.47; H, 6.08. Found: C, 72.20; H, 5.71.  
ODMB
O
MeO 4.13i  
(2,4-Dimethoxyphenyl) methyl (2Z)-3-(2-Methoxyphenyl)prop-2- enoate (4.13i). It was obtained as clear 
oil (0.170 g, 92%) and purified by silica gel chromatography (20% ethyl acetate/80% hexanes). TLC R f  = 
0.29 (20% ethyl acetate/80% hexanes); IR (film, cm−1 ): 3054, 2986, 2839, 1717, 1616, 1488, 1209, 1159, 
739, 705; 1H NMR (400 MHz, CDCl 3 ): δ 7.57 (d, J = 7.5 Hz, 1H), 7.31−7.26 (m, 1H), 7.18−7.15 (m, 2H), 
6.90−6.85 (m, 2H), 6.44−6.41 (m, 2H), 6.01 (d, J = 12.5 Hz, 1H), 5.14 (s, 2H), 3.81 (s, 6H), 3.78 (s, 3H); 
13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.3, 161.2, 158.9, 157.2, 138.9, 131.3, 130.8, 130.3, 124.1, 120.00, 
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119.94, 116.8, 110.3, 104.0, 98.5, 61.3, 55.41, 55.40. Anal. Calcd for C 19 H 20 O 5 : C, 69.50; H, 6.14. Found: 





 (2,4-Dimethoxyphenyl) methyl Picolinate (4.13j). It was obtained as yellow oil (0.150 g, 83%) and purified 
by silica gel chromatography (50% ethyl acetate/50% hexanes). TLC R f  = 0.25 (50% ethyl acetate/ 50% 
hexanes); IR (film, cm−1 ): 2964, 1721, 1616, 1377, 927; 1H NMR (400 MHz, CDCl 3 ): δ 8.76 (dd, J = 4.7 
Hz, 0.7 Hz, 1H), 8.10 (d, J = 7.8 Hz, 1H), 7.79 (td, J = 7.8, 1.7 Hz, 1H), 7.41 (ddd, J = 7.6, 4.8, 1.1 Hz 1H), 
7.34 (d, J = 9.0 Hz, 1H), 6.48−6.46 (m, 2H), 5.43 (s, 2H), 3.82 (s, 3H), 3.80 (s, 3H); 13C{1H} NMR (75 
MHz, CDCl 3 ): δ 165.2, 161.4, 159.1, 150.0, 148.5, 136.8, 131.6, 126.7, 125.2, 116.5, 104.1, 98.6, 62.9, 





3,4-Dimethoxybenzyl Benzoate (4.14a).  It was obtained as clear oil (0.17 g, 96%) and purified by silica 
gel chromatography (5% ethyl acetate/95% hexanes). TLC R f  = 0.40 (20% ethyl acetate/80% hexane); 1 H 
NMR (400 MHz, CDCl 3 ): δ 8.06 (d, J = 7.2 Hz, 2H), 7.52 (t, J = 7.6 Hz, 1H), 7.40 (t, J = 7.6 Hz, 2H), 
7.03−6.97 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 5.29 (s, 2H), 3.88 (s, 3H), 3.86 (s, 3H); 13C{1H} NMR (100 
MHz, CDCl 3 ): δ 166.5, 149.1, 149.0, 133.0, 130.2, 129.7, 128.6, 128.4, 121.3, 111.9, 111.1, 66.8, 55.9.  
O OBz
4.16a  
(Furan-2-yl) methyl Benzoate (4.16a). It was obtained as yellow oil (0.127 g, 96%) and purified by silica 
gel chromatography (1% ethyl acetate/99% hexane). TLC R f  = 0.46 (10% ethyl acetate/90% hexane); 1 H 
NMR (400 MHz, CDCl 3 ): δ 8.06 (d, J = 8.2 Hz, 2H), 7.57−7.53 (m, 1H), 7.45−7.41 (m, 3H), 6.49 (d, J = 
3.2 Hz, 1H), 6.39−6.38 (m, 1H), 5.31 (s, 2H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 166.3, 149.6, 143.3, 




1-Phenethyl Benzoate (4.17a).  It was obtained as clear oil (0.140 g, 95%) and purified by silica gel 
chromatography (2% ethyl acetate/ 98% hexane). TLC R f = 0.23 (10% ethyl acetate/90% hexane); 1 H 
NMR (300 MHz, CDCl 3 ): δ 8.10−8.06 (m, 2H), 7.55−7.22 (m, 8H), 6.14 (q, J = 6.6 Hz, 1H), 1.66 (d, J = 
6.6 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 165.8, 141.9, 133.0, 130.6, 129.7, 128.6, 128.4, 127.9, 






Diphenylmethyl Benzoate (4.18a). It was obtained as a white solid (2.58 g, 99%) and purified by silica gel 
chromatography (1% triethylamine/10% ethyl acetate/89% hexanes). mp = 88−89 °C; TLC R f  = 0.42 (10% 
ethyl acetate/90% hexanes); IR (KBr, cm−1): 3090, 3031, 2948, 1712, 1267, 1189; 1H NMR (300 MHz, 
CDCl 3 ): δ 8.17−8.13 (m, 2H), 7.60−7.55 (m, 1H), 7.50−7.26 (m, 12H), 7.13 (s, 1H); 13C{1H} NMR (75 
MHz, CDCl 3 ): δ 165.8, 140.5, 133.4, 130.4, 130.0, 128.8, 128.7, 128.2, 127.4, 77.7. Anal. Calcd for 






Diphenylmethyl 2,2-Diphenylacetate (4.18b).  It was obtained as a white solid (0.120 g, 84%) and purified 
by silica gel chromatography (8% ethyl acetate/92% hexanes). TLC R f  = 0.52 (20% ethyl acetate/ 80% 
hexanes); 1H NMR (400 MHz, CDCl 3 ): δ 7.28−7.19 (m, 20H), 6.91 (s, 1H), 5.15 (s, 1H); 13C{1H} NMR 





 Diphenylmethyl 2-Methyl-2-phenylpropanoate (4.18c). It was obtained as clear oil (0.120 g, 75%) and 
purified by silica gel chromatography (6% ethyl acetate/94% hexanes). TLC R f  = 0.50 (20% ethyl 
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acetate/80% hexanes); IR (film, cm−1 ): 3088, 3031, 1730, 1600, 1495, 1142, 1100; 1H NMR (400 MHz, 
CDCl 3 ): δ 7.29− 7.23 (m, 11H), 7.14−7.12 (m, 4H), 6.80 (s, 1H), 1.62 (s, 6H). 13C{1H} NMR (100 MHz, 
CDCl 3 ): δ 175.5, 144.3, 142.3, 140.3, 129.0, 128.42, 128.37, 127.7, 127.5, 127.3, 126.9, 126.7, 125.9, 80.1, 
46.7, 26.3. Anal. Calcd for C 23 H 22 O 2 : C, 83.60; H, 6.71. Found: C, 83.93; H, 6.99.  
O
ODPM
Br8 4.18d  
Diphenylmethyl 2-Bromododecanoate (4.18d). It was obtained as clear colorless oil (0.40 g, 83%) and 
purified by silica gel chromatography (1% triethylamine/5% ethyl acetate/94% hexanes). TLC R f  = 0.78 
(10% ethyl acetate/90% hexanes); IR (film, cm−1 ): 3064, 3032, 2924, 2854, 1741, 1495, 1454, 1257, 1144, 
1080; 1H NMR (300 MHz, CDCl 3 ): δ 7.38−7.26 (m, 10H), 6.89 (s, 1H), 4.31 (t, J = 7.5 Hz, 1H), 2.07−2.00 
(m, 2H), 1.23 (br s, 16H), 0.88 (t, J = 6.3 Hz, 3H); 13C{1H} NMR (75 MHz CDCl 3 ): δ 169.0, 139.8, 139.7, 
128.80, 128.79, 128.4, 127.4, 127.3, 78.5, 46.4, 35.2, 32.2, 29.8, 29.7, 29.6, 29.1, 27.4, 23.0, 14.4. Anal. 






(±)-Diphenylmethyl-2-hydroxy-2-phenylacetate (4.18e). It was obtained as a white solid (0.58 g, 92%) and 
purified by silica gel chromatography (1% triethylamine/30% ethyl acetate/69% hexanes). mp = 113−114 
°C; TLC R f  = 0.65 (30% ethyl acetate/70% hexanes); IR (KBr, cm−1 ): 3221, 2815, 2800, 1699, 1240; 1H 
NMR (300 MHz, CDCl 3 ): δ 7.42−7.18 (m, 13H), 6.91−6.87 (m, 3H), 5.28 (d, J = 5.4 Hz, 1H), 3.45 (d, J = 
5.7 Hz, 1H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 173.0, 139.5, 139.4, 138.3, 128.9, 128.83, 128.79, 128.6, 
128.5, 128.1, 127.6, 127.0, 126.5, 79.0, 73.3. Anal. Calcd for C 21 H 18 O 3 : C, 79.22; H, 5.70. Found: C, 








 (±)-Diphenylmethyl-2-[(tert-butoxycarbonyl) amino]- phenylpropionate (4.18f). It was obtained as clear 
oil (0.072 g, 54%) and purified by silica gel chromatography (20% ethyl acetate/80% hexanes). TLC R f = 
0.27 (20% ethyl acetate/80% hexanes); IR (film, cm- 1): 3054, 2985, 1709, 1421, 1260. 1H NMR (300 MHz, 
CD 3 OD): δ 7.37−7.13 (m, 15H), 6.85 (s, 1H), 4.50 (q, J = 6.1 Hz, 1H), 3.13 (dd, J = 13.8, 6.0 Hz, 1H), 
2.95 (dd, J = 13.8, 8.7 Hz, 1H), 1.40 (s, 9H); 13C{1H} NMR (75 MHz, CD 3 OD): δ 171.4, 156.4, 140.0, 
136.8, 128.9, 128.1, 127.6, 126.9, 126.7, 126.4, 79.3, 77.8, 55.5, 37.1, 27.4. Anal. Calcd for C27 H 29 NO 4: 
C, 75.15; H, 6.77 N, 3.25. Found: C, 75.16; H, 6.73; N, 3.61.  
O
ODPM4.18g  
Diphenylmethyl But-3-enoate (4.18g).  It was obtained as colorless oil (0.35 g, 76%) and purified by silica 
gel chromatography (1% triethylamine/5% ethyl acetate/94% hexanes). TLC R f  = 0.44 (10% ethyl 
acetate/90% hexanes); IR (film, cm−1) νmax: 3064, 3031, 2983, 2938, 1740, 1642, 1543, 1030. 1H NMR 
(300 MHz, CDCl 3 ): δ 7.35−7.26 (m, 10H), 6.90 (s, 1H), 6.02−5.90 (m, 1H), 5.22−5.15 (m, 2H), 3.23−3.20 





(E)-Diphenylmethyl Cinnamate (4.18h).  It was obtained as a white solid (0.401 g, 93%) and purified by 
silica gel chromatography (1% triethylamine/10% ethyl acetate/89% hexanes). mp = 74−77 °C; TLC R f  = 
0.57 (10% ethyl acetate/90% hexanes); 1H NMR (300 MHz, CDCl 3 ): δ 7.78 (d, J = 16.2 Hz, 1H), 7.57−7.54 
(m, 2H), 7.44−7.26 (m, 13H), 7.05 (s, 1H), 6.58 (d, J = 15.9, 0.6 Hz, 1H); 13C{1H} NMR (75 MHz, CDCl 3 ): 
δ 166.2, 145.7, 140.5, 134.5, 130.7, 129.1, 128.8, 128.4, 128.2, 127.4, 118.2, 77.2.  
ODPM
O
MeO 4.18i  
Diphenylmethyl (2Z)-3-(2-Methoxyphenyl)prop-2-enoate (4.18i). It was obtained as a white solid (0.099 
g, 52%) and purified by silica gel chromatography (4% ethyl acetate/96% hexanes); mp = 72−74 °C; TLC 
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R f = 0.71 (10% ethyl acetate/80% hexanes); IR (film, cm−1 ): 3031, 2836, 1725, 1627, 1110; 1H NMR (400 
MHz, CDCl 3 ): δ 7.39 (d, J = 2.0 Hz, 1H), 7.21−7.13 (m, 12H), 6.85−6.75 (m, 3H), 6.06−6.02 (m, 1H), 
3.68 (s, 3H); 13C{1H} NMR (100 MHz, CDCl 3 ): δ 165.2, 157.1, 140.3, 140.0, 130.8, 130.4, 128.4, 127.8, 
127.3, 124.2, 120.1, 120.0, 110.3, 76.7, 55.4. Anal. Calcd for C 23 H 20 O 3 : C, 80.21; H, 5.85. Found: C, 





Diphenylmethyl Picolinate (4.18j). It was obtained as a white solid (0.210 g, 71%) and purified by silica 
gel chromatography (10% acetone/90% hexanes). mp = 101−103 °C; TLC R f  = 0.23 (20% acetone/80% 
hexanes); IR (film, cm−1 ) νmax: 3052, 1744, 1130. 1H NMR (300 MHz, CDCl 3 ): δ 8.80 (dq, J = 4.8, 0.9 
Hz, 1H), 8.19 (dt, J = 7.8, 1.1 Hz, 1H), 7.85 (dt, J = 7.8, 1.8 Hz, 1H), 7.50−7.44 (m, 5H), 7.39−7.27 (m, 
6H), 7.22 (s, 1H); 13C{1H} NMR (75 MHz, CDCl 3 ): δ 164.3, 150.3, 148.3, 140.0, 137.1, 128.8, 128.2, 
127.5, 127.1, 125.4, 78.2; Anal. Calcd for C 19 H 15 NO 2 : C, 78.87; H, 5.23; N, 4.84. Found: C, 78.89; H, 





(S)-Diphenylmethyl 2-(2-Methoxynaphthalen-6-yl)propanoate ((+)-4.18k). It was obtained as a white solid 
(1.38 g, 89%) and purified by silica gel chromatography (20% ethyl acetate/80% hexanes). mp = 132−134 
°C; [α]D 20  +55.7 (c 1.1, CHCl 3 ); TLC R f  = 0.42 (20% ethyl acetate/80% hexanes); IR (KBr, cm−1 ): 3059, 
3000, 2942, 2359, 1723, 1604, 1162, 705; 1 H NMR (300 MHz, CDCl 3): δ 7.70−7.60 (m, 3H), 7.37 (dd, J 
= 8.4, 1.8 Hz, 1H), 7.29−7.04 (m, 12H), 6.84 (s, 1H), 4.01−3.93 (m, 4H), 1.59 (d, J = 6.9 Hz, 3H); 13C{1H} 
NMR (75 MHz, CDCl 3 ): δ 173.7, 157.8, 140.4, 140.3, 135.7, 133.9, 129.5, 129.1, 128.7, 128.5, 128.1, 
127.9, 127.4, 127.3, 126.9, 126.7, 126.3, 119.2, 105.8, 77.4, 55.5, 45.9, 18.6. Anal. Calcd for C27 H 24 O 3 : 
C, 81.79; H, 6.10. Found: C, 81.54; H, 6.11. The enantiomeric ratio was determined by HPLC using a chiral 
column (OD-H), n-hexane/iPrOH = 99:1, 1 mL/min; compared to a racemic sample which showed two 






(2-Methoxyphenyl) (Phenyl)methyl [1,1′-Biphenyl]-4-carboxylate (4.31). It was obtained as a white solid 
(73 mg, 73% yield) and purified by silica gel column chromatography (10% ethyl acetate, 90% hexanes). 
mp = 136−137 °C; TLC R f  = 0.35 (10% ethyl acetate/90% hexanes); IR (film, cm−1 ): 3064, 2938, 1715, 
1604, 1491, 1278, 1100, 857; 1H NMR (400 MHz, CDCl 3 ): δ 8.12 (d, J = 8.2 Hz, 2H), 7.58 (d, J = 8.2 Hz, 
2H), 7.54−7.52 (m, 2H), 7.44−7.15 (m, 10H), 6.91−6.80 (m, 2H), 3.75 (s, 3H); 13C{1H} NMR (100 MHz 
CDCl 3 ): δ 165.4, 156.5, 145.8, 140.3, 140.1, 130.3, 129.2, 129.1, 129.0, 128.9, 128.3, 128.2, 127.7, 127.3, 
127.2, 127.1, 127.0, 120.7, 110.9, 72.2, 55.6. Anal Calcd for C 27 H 22 O 3 : C, 82.21; H, 5.62. Found: C, 
82.28; H, 5.67. The enantiomeric ratio was determined by HPLC using a chiral column (AD), n-hexane/i-
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Chapter 5- Synthesis of a small library of GOAT inhibitors 
Abstract 
Ghrelin is a peptide hormone which plays a key role in regulating hunger and energy balance within the 
body. Inhibition of ghrelin O-acyltransferase (GOAT), which catalyzes an essential octanoylation step in 
ghrelin maturation, offers a potential target for controlling ghrelin signaling. Through screening a small 
molecule library, classes of synthetic triterpenoids based on oleanolic acid were identified that efficiently 
inhibit ghrelin acylation. To find out which functional group on these inhibitors was responsible for activity 
against hGOAT, a small library of minimally functionalized steroid derivatives was synthesized. These 
compounds act as covalent reversible inhibitors, providing the first evidence of the involvement of a 
nucleophilic amino acid residue in hGOAT catalysis. The activated Michael acceptor plays the most 
important role in the biological activity, leading to a new steroid based alphacyanoenone compound which 
was shown to be an equivalent inhibitor to CDDO. This study may lead to a viable treatment for diabetes 
and obesity in the future. The small molecules used in this study were synthesized and characterized by me. 












  Ghrelin O-acyltransferase (GOAT), an integral membrane enzyme, catalyzes the posttranslational serine-
octanoylation of the peptidic hormone ghrelin.1a,b,c,d Ghrelin is a 28 amino acid peptide which plays a vital 
role in glucose metabolism and energy homeostasis, as secretion of ghrelin regulates appetite.2a,b,c 
Accordingly, appetite disorders like anorexia nervosa and Prader Willi syndrome show increased ghrelin 
secretion.3a,b A link between ghrelin and posttraumatic stress disorder is also suggested as the hormone is 
known to affect neurological processes such as learning, depression and memory.4 Ghrelin does not 
exhibit appreciable biological activity until it has undergone multiple covalent modifications.2c 
Preproghrelin, an initial 117-amino acid precursor, undergoes several changes prior to its secretion as 
ghrelin in the bloodstream. O-n-Octanoylation at serine 3 of proghrelin1b is a key step in this process (Figure 
5.1) followed by proteolysis of acyl proghrelin to yield mature ghrelin.  
------------------------------------------------------------------------------------------------------------------------------- 











  Ghrelin O-acyltransferase (GOAT) is the enzyme responsible for ghrelin octanoylation. This protein was 
discovered by Kojima and coworkers2 in 1991 and is a member of the membrane-bound O-acyltransferase 
(MBOAT) family. Because acylation is necessary for ghrelin’s biological activity, and because ghrelin is 
GOAT’s only known or predicted substrate 1a,b,c,d, inhibiting GOAT is an attractive target for the treatment 
of diseases and disorders involving aberrant ghrelin signaling, such as obesity, diabetes, and Prader-Willi 
syndrome. Residues Asn307 and His338 in the C-terminal section of GOAT are proposed to be involved 
in catalysis, however the mechanism of the GOAT catalytic cycle and the structure of the enzyme active 
site are not known.1 Because GOAT is an integral membrane protein these studies are hampered by the 
difficulty in obtaining a high resolution x-ray crystal structure of the protein.  
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  Various approaches have been adopted to synthesize GOAT inhibitors for the treatment of appetite related 
disorders. Peptide-based bisubstrate inhibitors (GO-CoA-Tat) were designed by Cole and co-workers.5 
Increased glucose tolerance and anti-obesity effects were observed in mice treated with this inhibitor. 
Similarly, ghrelin pentapeptides with a diaminopropionic acid residue in place of Ser-3 were developed by 
Goldstein and Brown.6 A number of non-peptide small-molecule GOAT antagonists have also been 
synthesized by Garner and Janda (5.3, Figure 5.2).7 As these inhibitors showed only low potency, a search 
for more efficient, drug like GOAT antagonists is1 still ongoing. Some new inhibitors have also been 
introduced by Takeda Pharmaceuticals8 (5.5, Figure 5.2), Eli Lilly and company9a, b after our research got 
published. Additionally, similar α-cyanoenones were disclosed by Shotwell10 as IDH1 inhibitors. 
----------------------------------------------------------------------------------------------------------------------------- 
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5.1.2. Search for New Small Molecule GOAT Inhibitors 
  Following the same interest our collaborator at Syracuse University (Professor James Hougland) screened 
a library of small molecules for GOAT inhibition and came across CDDO 5.6 (Figure 5.2) as a potent 
inhibitor. CDDO possesses several functional groups which may be responsible for GOAT inhibition, but 
the most reactive appears to be the α-cyano-unsaturated ketone, which is a potent Michael acceptor and is 
known to react with thiols11 and histidine sidechains12. To better understand the mode of inhibition, a 
structure-activity relationship (SARs) study was then undertaken. A number of molecules containing 
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similar Michael acceptors have been prepared and compared against CDDO for their ability to inhibit 
GOAT. Starting from the commercially available epiandosterone 5.8 (Figure 5.3), some simplified systems 
(compound 5.7, Figure 5.2) were synthesized to determine which reactive functionality in CDDO was 
responsible for GOAT inhibition.  
-------------------------------------------------------------------------------------------------------------------------- 
Figure 5.3 Simple Scaffolds similar to CDDO 


























5.2 Results and Discussion 
5.2.1 Retrosynthesis for inhibitor 5.7 
  A retrosynthetic analysis of compound 5.7 has been shown in Scheme 5.1. The cyano derivative was 
obtained from corresponding vinyl bromide 5.10 which in turn can be synthesized from α, β-unsaturated 
ketone 5.11. Wolf Kishner reduction of epiandosterone followed by PCC oxidation can easily give the α, 
β-unsaturated ketone. 
------------------------------------------------------------------------------------------------------------------------------- 


























5.2.2. Inhibitor Synthesis 
  The Wolf Kishner reduction of epiandosterone 5.8 gave 88% yield of alcohol 5.12 (Scheme 5.2). Alcohol 
5.12 was then readily oxidized to ketone (5.11) with PCC. Reaction with pyridinium tribromide in acetic 
acid13 produced α -bromo ketone 5.13. Steric hindrance due to the 1,3-diaxial interaction with the methyl 
group at C10 explains the generation of a single isomer of 5.13.  
---------------------------------------------------------------------------------------------------------------------------- 













HOHCH2CH2OH PCC, siica gel




















  Syntheses of cyano and bromo derivatives of enone 5.11 were then pursued (Scheme 5.3). Elimination of 
bromine 5.13 with lithium carbonate generated the enone 5.11. A bromine addition elimination sequence 
then produced the bromoenone derivative 5.10. An established protocol from the literature14 was then 
followed to obtain the corresponding cyano derivative 5.7. The next challenge was to figure out the 
importance of the oleanane/steroid skeleton.   

























5.13 5.11 5.10 5.7  
  Synthesis of smaller analogs of 5.7 were undertaken to fulfill this goal (Scheme 5.4). Starting with easily 
available cyclohexenone, the bromo derivative 5.13 was prepared following the previous sequence. The 
bromide substitution with CuCN failed to give 5.15, however. The high temperature required for this 
reaction seems to the reason for failure as both the starting material and the product have stability issues 
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with the high temperature required for the substitution reaction. Finally compound 5.15 was synthesized 
following a literature procedure.15  
-------------------------------------------------------------------------------------------------------------------------- 










5.9 5.14 5.15  
------------------------------------------------------------------------------------------------------------------------------ 
5.2.3 Structure –Activity analysis of inhibitors 
  CDDO 5.6 showed an IC 50  = 8+/-4 μM against GOAT. The α-bromoketone 5.13 with a potential 
electrophile was unable to show similar inhibition with IC 50  > 400 μM. A clear effect on inhibition was 
observed based on the Michael acceptor group present. The inhibitor potency increases with the level of 
activation of enone toward nucleophilic addition from the most activated, α-Cyanoenone 5.7 (IC 50  = 8+/-2 
μM) to nonactivated enone 5.11 (IC 50  = 170+/-60 μM). The equivalent potency of CDDO and α -
cyanoenone 5.7 suggests that the distal ring E and carboxyl substituent of CDDO are not required for 
binding to hGOAT. Meaning, the strong α-cyanoenone group is responsible for the observed high inhibition 
potency. On the contrary, the contribution of the steroid scaffold to hGOAT binding was evaluated by 
comparison with cyclohexenone and its derivatives. Both α–cyanocyclohexenone 5.15 (IC 50  = 1.2+/-0.2 
mM) and α–bromocyclohexenone 5.14 (IC 50  = 500+/-100 μM) were less potent than their steroid analogs 
5.7 and 5.10. Additionally, cyclohexenone 5.13 was shown to have an IC 50  > 1000 μM. Therefore, 
suggesting that the hydrophobicity delivered by steroid scaffold is also important, as there is a ~150-fold 
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  Structure−activity analysis of the CDDO-type inhibitors provides the first clue of the involvement of a 
functionally requisite nucleophilic amino acid in hGOAT-catalyzed ghrelin acylation and suggests that the 
synthetic triterpenoids may function as the first reported mechanism-based inhibitors for GOAT. The 
regioselective requirement of an α,β-unsaturated ketone, is consistent with inhibitor alkylation of an 
hGOAT nucleophilic amino acid residue acting as a Michael donor. The catalytic involvement of a  
nucleophilic amino acid in ghrelin acylation by hGOAT, while defining a new mode of inhibition targeting 
this enzyme, can also be useful to potentially identify the location of the active site within an MBOAT 
family acyltransferase. 
  Our discovery of synthetic triterpenoid inhibitory activity against GOAT presents an exciting and 
unexpected mode of action for these compounds, several of which have been investigated in clinical trials.19 
Earlier studies of CDDO derivatives as potential therapeutics have focused on controlling inflammation 
and oxidative stress in multiple tissues.20 Inhibition of ghrelin acylation could explain several outcomes 
observed in human and rodent studies with these compounds, given ghrelin’s known roles in regulating 
body energy balance and glucose metabolism.2,3 These outcomes utilizing CDDO derivatives, such as 
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effects on  weight loss, fat deposition, reduction of insulin resistance, and improved glucose tolerance, in 




 In this work, we demonstrate that synthetic triterpenoids containing an α-cyanoenone moiety can 
efficiently block ghrelin acylation by hGOAT involving alkylation, through a covalent reversible inhibition 
mechanism. Hopefully our discovery of this new class of small molecule hGOAT inhibitors will enhance 
inhibitor development targeting ghrelin octanoylation, ultimately leading to therapeutics for treating 














Compound 5.1316, 17 5.14,18 5.15 15 were synthesized as described the literature. Ketones 5.8 and 5.13 









A suspension of α-bromoketone 5.13(0.600 g, 1.70 mmol), lithium bromide (0.884 g, 10.2 mmol), and 
lithium carbonate (0.752 g, 10.2 mmol) in DMF (6.6 mL) was heated to 80 °C. After ~18 h the reaction 
mixture was cooled to room temperature and then poured over crushed ice. The quenched reaction mixture 
was extracted with ethyl acetate (3 x 20 mL). The organic layers were collected, combined, washed with 
cold water and brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The 
residue was purified using silica gel column chromatography (2% ethyl acetate/98% hexane), which 
afforded enone 5.11 (0.371 g, 80%) as a white solid.  
5.11. TLC Rf = 0.52 (10% ethyl acetate/90% hexane); [𝛼𝛼]𝐷𝐷 23 = +32.8 (c = 0.87, CHCl 3 ); 1H NMR (400 
MHz, CDCl 3 ) δ 7.13 (d, J = 10.2 Hz, 1H), 5.82 (dd, J = 10.2, 0.9 Hz, 1H), 2.34 (dd, J = 13.2, 10.6 Hz, 1H), 
2.21 (ddd, J = 17.6, 4.1, 0.9 Hz, 1H), 1.93–1.85 (m, 1H), 1.79–1.69 (m, 3H), 1.66– 1.51 (m, 3H), 1.49–1.33 
(m, 5H), 1.18–1.10 (m, 3H), 1.02–0.90 (m, 6H), 0.71 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 200.2, 158.6, 
127.4, 54.5, 50.2, 44.3, 41.0, 40.9, 40.3, 39.1, 38.7, 36.1, 31.7, 27.7, 25.4, 21.3, 20.5, 17.6, 13.0. HRMS 
(ESI+) calcd for C 19 H 28 ONa: 295.2032, Found: 295.2030. Anal. calcd for C 19 H28 O: C, 83.77; H, 10.36; 













To a stirred solution of bromo enone 5.10 (0.210 g, 0.597 mmol) in anhydrous dimethyl formamide (5.9 
mL) was added copper (I) cyanide (0.059 g, 0.657 mmol) and potassium iodide ((0.02 g, 0.2 mmol), and 
the resulting reaction mixture was heated to 120 o C for 36 h. After the completion of reaction, it was cooled 
to room temperature, quenched with water (5 mL), and diluted with ethyl acetate (15 mL). The organic 
phase was washed with saturated NaHCO 3  (2 x 5 mL), brine (5 mL), and dried over Na 2 SO 4 . Removal of 
solvent and flash column chromatography over silica gel using 30% ethyl acetate/70% hexanes provided 
0.07 g (70 %) of 5.7 as white solid. 
5.7. mp = 171-173 oC; TLC R f  = 0.61 (20% ethyl acetate/80% hexanes); IR (CH 2 Cl 2 , film) 3411,2230, 
1693, 1447, 1216 cm–1;  [𝛼𝛼]𝐷𝐷 26.2  = +20.1 (c 0.05, DCM); 1H NMR 400 MHz, CDCl 3 ) δ 7.87 (s, 1H), 2.47-
2.34 (m, 2H), 2.00-1.92 (m, 1H), 1.84-1.54 (m, 7H), 1.50-1.38 (m, 5H), 1.22-1.12 (m, 3H), 1.08 (s, 3H), 
1.05-0.94  (m, 2H), 0.73 (s, 3H); 13C NMR (75 MHz, CDCl 3 ) δ 192.4, 169.8, 115.8, 114.5, 54.3, 49.4, 43.2, 
40.9, 40.7, 40.1, 40.1, 38.4, 35.9, 35.8, 31.3, 27.3, 25.3, 22.6, 21.2, 20.5, 17.6, 12.6. Anal. Calcd for 










 To a solution of cyclohexenone 5.11 (0.100 g, 0.367 mmol) in DCM (1 mL) under argon at 0 °C, a solution 
of bromine (0.019 mL, 0.367 mmol) in DCM (1 mL) was added dropwise over 15 min. Triethylamine 
(0.087 mL, 0.623 mmol) was added and the resulting mixture was allowed to warm to room temperature 
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and stirred for another 1.5 h before it was quenched with 1M HCl. The layers were separated, and the 
organic layer was washed twice with sodium thiosulfate, dried over sodium sulfate, filtered and 
concentrated under reduced pressure. The residue was purified by silica gel column chromatography (2% 
ethyl acetate/98% hexane), which afforded bromo enone 5.10 (0.103 g, 80%) as a white solid. mp = 111-
116 oC ; TLC R f  = 0.52 (10% ethyl acetate/90% hexanes); IR (thin film from DCM) 2964, 2848, 1691, 
1436, 954, 755 cm–1 ; [𝛼𝛼]𝐷𝐷 23  = +22.3 (c = 0.50, CHCl 3 ); 1H NMR (400 MHz, CDCl 3 ) δ 7.60 (s, 1H), 2.56-
2.43 (m, 2H), 2.04-1.96 (m, 1H), 1.83-1.57 (m, 6H), 1.48-1.34 (m, 5H), 1.22-1.12 (m, 3H), 1.05 (s, 3H), 
1.02-0.93 (m, 3H), 0.73 (s, 3H); 13C NMR (100 MHz, CDCl 3 ) δ 191.5, 158.9, 123.1, 54.4, 50.2, 44.2, 42.8, 
41.0, 40.9, 40.2, 38.5, 35.7, 31.5, 27.2, 25.4, 21.4, 20.5, 17.6, 12.9. HRMS (ESI+) calcd for C 19 H 28 BrONa: 
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Determination of Enantiopurity for Imidate 2.56 
 
Racemic 2.55 was synthesized by oxidation of (S)-2.55 via Swern oxidation followed by reduction of the 
resulting ketone with sodium borohydride as shown in the scheme below. The imidate was then 

























Determination of Enantiopurity for Thiophene 2.57 
 
In order to obtain a racemic sample of thiophene 2.57, the racemic imidate was subjected to the reaction 
conditions and the enantiomers separated by chiral HPLC. The substitution reaction with the chiral imidate 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(S) - 4.9 K
1% i-PrOH/ hexanes 
 














(S,R) - 4.9 K
1% i-PrOH/ hexanes 
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